Serum-free cell growth and differentiation studies in cultured cell lines by Meleady, Paula
Serum-free Cell Growth 
and
Differentiation Studies 
in
Cultured Cell Lines 
Paula Meleady
Ph.D 1997
SERUM-FREE CELL GROWTH 
AND 
DIFFERENTIATION STUDIES 
IN 
CULTURED CELL LINES
by Paula Meleady B.Sc.
a thesis submitted for the degree of Ph.D 
Dublin City University
The research work described in this thesis was carried out
under the supervision of
Professor Martin Clynes
National Cell and Tissue Culture Centre,
School of Biological Sciences.
1997
I hereby certify that this material, which I now submit for assessment on the 
programme of study leading to the award of Ph.D is entirely my own work and has not 
been taken from the work of others save and to the extent that such work has been cited 
and acknowledged within the text of my work.
Signed: Date: Q -
ABSTRACT
The thesis is divided into two main sections investigating growth and differentiation in 
cultured cell lines. Investigations were carried out into the establishment of serum-free 
media (SFM) for the long-term subcultivation of the industrially important cell line, 
CHO-K1. When the cell line was cultured in a high calcium containing medium, 
cellular growth was found to be inhibited after 4 to 6 passages on average. However, 
by growing the cells in a low calcium medium, continuous cultivation was possible. It 
appears that the calcium concentration in the SFM is critical to this long-term growth. 
The SFM developed were also capable of supporting growth of CHO-K1 in suspension 
culture with Pluronic F68 supplementation and in microcarrier culture.
Serum-free media was also developed for the growth and sub-cultivation of a human 
lung cancer cell line, DLKP. This cell line contains three morphologically distinct sub­
populations. The growth pattern of the three clones differed in serum-free medium with 
only one of them, DLKP-I, capable of proliferating in the above medium. However, 
the addition of fibronectin to the SFM permitted growth of the other two clones. All 
sub-populations could be subcultured indefinitely in SFM. DLKP-A, a multiple drug 
resistant variant of the parental DLKP cell line, was also successfully grown and 
subcultured in SFM.
Differentiation studies were also carried out on DLKP. This cell line was originally 
histologically diagnosed as a ‘poorly differentiated carcinoma of the lung’. Treatment 
of the cells with the differentiation-inducing agent, 5-bromodeoxyuridine (BrdU) 
resulted in the induction of integrin and upregulation of a2p, integrin expression. 
Associated with this change in integrin expression was a functional change in the 
properties of the cells themselves with BrdU treatment. The cells developed different 
adhesive properties showing more rapid attachment to the extracellular matrix proteins, 
collagen, laminin and fibronectin, and to basement membrane compared to untreated 
cells. Addition of an anti-integrin blocking antibody to BrdU-treated cells reversed the 
changes in adhesive properties of the cells.
BrdU treatment of DLKP cells also induced the expression of a number of epithelial 
antigens, including epithelial specific antigen (a cellular adhesion molecule) and keratin 
19 filaments. A significant upregulation of keratin 19 protein expression was also 
observed in the human lung adenocarcinoma cell line, A549, after BrdU treatment. 
Preliminary RT-PCR analysis has shown that the effect of BrdU on keratin 19 mRNA 
expression appears to be at the post-transcriptional/ translational level.
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1.0 INTRODUCTION
1.0 IN TRO D UCTION
The growth of cells in serum-free medium is of particular benefit to study cellular 
functions in a completely defined system. Serum, which is an obligatory component of 
most cell culture media, is very poorly defined and often there is variability in 
composition between different batches. Extracellular matrix (ECM) proteins appear to 
be important supplements to SFM to control growth and differentiation of many normal 
and transformed cell lines, especially tumour cell lines.
Cellular adhesion molecules, especially integrins, are gaining wider recognition as 
important factors for normal cellular functions including growth and differentiation. 
Alterations in the structure of the ECM and in the expression of various adhesion 
molecules have been implicated in pathogenesis of disease and tumour progression. 
Integrins appear to be consistently down-regulated in poorly-differentiated epithelial 
carcinomas.
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1.1 SERUM -FREE M EDIUM
1.1.1 Background
Mammalian cells, in general, require serum for growth in vitro. When cells are 
removed from their original tissues and placed in culture, the medium must provide 
environmental conditions similar to those to which the cell has been exposed to in the 
body. Only then will the cells be able to survive and proliferate in vitro. This 
extracellular medium must provide the essential requirements for growth and survival; it 
must provide nutritional, hormonal and adhesion factors. Serum is an extremely 
complex mixture of many small and large biomolecules with different physiologically 
balanced growth-promoting and growth-inhibiting activities. It provides hormonal 
factors capable of stimulating cell growth and differentiation, attachment and spreading 
factors essential for cell survival, and transport proteins such as albumin and transferrin 
which carry hormones, vitamins, lipids, trace elements and other essential nutrients. It 
is usually added to most basal media at concentrations ranging from 5 to 20%.
In most of the serum-free media (SFM) formulations developed, insulin and transferrin 
appear to be the most important components. Many cell lines require spreading and 
attachment factors such as fibronectin and collagen. Hormones and growth factors 
appear to be specific for different cell lines. Bovine serum albumin (BSA) is often 
added to serum-free formulations but this component is not totally defined and its use in 
'defined' media is quite controversial. Many cell lines have an obligatory lipid 
requirement, while other cell lines grow perfectly well in media without any lipids 
present. Cells in culture appear to have more of a requirement for the water soluble 
vitamins rather than the fat soluble vitamins. A number of trace elements are required in 
serum-free formulations especially selenium, iron, zinc and cadmium. Conditioned 
media are sometimes used in serum-free formulations to support the growth of specific 
cell lines that otherwise would not grow in media lacking serum. It is thought that one 
of the main reasons why cells do not achieve the same growth rates and same cell 
densities in serum-free media as cells grown in serum-supplemented media is due to 
trypsinisation damage during passaging of the cells. Cells in serum-supplemented 
media (SSM) tend to recover faster from such damage than cells in SFM.
1.1.1.1 Advantages of growing cells in SFM
There are many advantages to growing cells in serum-free conditions. Selective culture 
of differentiated and functional cell types is possible from heterogenous populations of 
primary cultures without stimulation of variant sub-populations (Suzuki et al., 1989;
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Birkenfeld et al., 1988). This takes advantage of different rates of cellular attachment 
and proliferation especially in primary cultures where fibroblast overgrowth can be a 
major problem in preventing the isolation of epithelial cells (Bottenstein and Sato, 
1978). SFM has also been used to allow the selective growth of tumours from fresh 
clinical samples (Carney et al., 1984; Oie etal., 1996).
Serum introduces an ambiguous factor into cell cultivation because of its undefined 
composition and tends to vary between batches. Serum can be extremely expensive 
often accounting for up to 84% of the media costs (Griffiths, 1986) thus using SFM 
may provide cost savings. It is also a potential source of contamination from viruses, 
fungi and especially mycoplasma. The use of serum can often reduce the difficulty and 
cost of purification of required product on an industrial scale with less serum protein 
contamination of the final product. This leads to difficulties in reproducing experimental 
results on a small scale and in maintaining consistent yields of cells and their products 
on a large scale. The international regulations for good manufacturing procedures 
(GMP-procedures) for vaccine production restrict the amount of serum constituents in 
the final product when making injectible vaccines, since allergic reactions could be 
provoked (Bjare, 1992).
Defined media are of great advantage when investigating cellular processes affected by 
growth factors, cellular mediators and other specific agents as the background of 
possible effects caused by serum components can be diminished. Vonen et al. (1992) 
found that in the long-term cultivation of rat pancreatic islet cells, a higher daily insulin 
and somatostatin secretion rate was achieved in serum-free medium than in serum 
supplemented medium. They concluded that serum contains insulin degrading factors.
Serum often suffers from batch-to-batch variation in biological activity, protein or lipid 
concentration etc., which can lead to significant problems in in vitro studies and on an 
industrial scale. HepG2 cells, a human heptocellular carcinoma cell line, are useful for 
model studies such as drug-metabolising enzyme induction. Cytochrome P450s of 
HepG2 cells are induced by many carcinogens or mutagens. As a method of human 
risk assessment, the effects of environmental chemicals can be observed in these cells. 
However, if serum-supplemented medium is used for such studies, the cell conditions 
are always unstable because of the ill-defined nature of serum and batch to batch 
variation. Serum-free culture allows the creation of constant culture conditions which 
lead to stable data vital for such drug investigations (Nakama and Yamada, 1993). The 
SHE (Syrian Hamster Embryo) system has been widely employed to identify, quantify 
and study the mechanism of action of chemical carcinogens. A major problem with one 
of the assays used in the system (MTA - morphological transformation assay) is the
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absolute necessity to screen many batches of FBS for use in the assay. Kaighn et al. 
(1993) developed a SFM for the clonal growth of SHE cells which avoided the problem 
of serum variability and facilitated the investagation of autocrine factor expression at 
various stages of neoplastic progression in the SHE system.
Chemically defined media may be very useful in controlling the proliferation and 
differentiation of cells (Rahemtulla et a l,  1989; Reyne et al., 1989). Hoshi et al. 
(1991) developed a serum-free medium to study the mechanisms of the growth and 
function of granulosa cells which are important for the formation of ovarian follicles 
and maturation of oocytes. The complex, ill-defined nature of serum is a complication 
when assessing the effect(s) of regulatory agents, such as hormones and 
neurotransmitters, on differentiated properties of nervous system cells in culture. 
Bottenstein and Sato (1979) developed a serum-free medium for the growth of the rat 
neuroblastoma cell line, B104.
Another main advantage of serum-free culture is that it allows for selection of cells 
which have been transformed with the SV40 virus. The growth of NIH-3T3 cells in 
serum-free medium is critically dependant on the presence of insulin, EGF and HDL. 
Growth-restrictive conditions (i.e. media lacking HDL, EGF or insulin) allows for the
selection of cells transformed with SV40 virus (Chiang et al., 1985).
1.1.1.2 Disadvantages of growing cells in SFM
There are also many disadvantages to the use of serum-free media in the culture of
mammalian cells. Serum-free media are often highly specific to one cell type and so
medium optimisation may be required for each cell line. Often lag phases are longer 
and cell growth rate, maximum cell density and cell number are often lower (Aheam et 
a l,  1992).
In the serum-free growth of many cell lines, supplementing the medium with hormones 
and growth factors can prove to be very expensive, even more expensive than 
supplementing with serum.
Protease inhibitors in serum may help protect the cells from enzymes such as trypsin. 
Cell recovery from trypsinisation damage is much slower in serum-free medium than in 
serum-supplemented medium.
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1.1.2 M EDIA SUPPLEM ENTS
The media supplements required in SFM will vary from one cell type to another due to 
the different origins of the cells from different sites in the body, or whether they are 
normal or transformed. In addition, cells grown in SFM are usually much more 
density-dependent than cells grown in serum-supplemented medium. Media 
supplements can be categorised into the following groups: growth promoters including 
hormones, growth factors and cytokines; attachment factors; transporter molecules; 
lipids; trace elements and vitamins.
1.1.2.1 Growth promoters
1.1.2.1.1 Insulin
Insulin is the most common hormone supplement of culture media. It is considered to 
be essential for the growth of nearly all cells in culture including hybridomas (Glassy et 
al, 1988). It is a relatively small polypeptide with a molecular weight of about 5700Da 
and is known to have multiple effects on cell metabolism. It is known to be involved in 
cell membrane substrate transport, the stimulation of uridine and glucose uptake and the 
biosynthesis of nucleic acids particularly RNA, proteins and fatty acids. The classical 
insulin responses such as increased fatty acid and glycogen synthesis are seen in the 
serum-free medium for a number of cell lines (Barnes and Sato, 1980a,b). Insulin is 
included in most culture media at superphysiological levels ranging from 5-10^g/ml. 
High concentrations are needed due to its short half-life and its inactivation by cysteine 
via the reduction of disulphide bonds on the insulin molecule. In the mouse melanoma 
cell line, MR2, insulin caused maximal stimulation of growth at 5fig/ml in Ham's F I2 
(with cysteine) and at 0.5pg/ml in Ham's F12 in which the cysteine has been replaced 
by cystine. Mather and Sato (1979) reported that the incorporation of glucose into both 
glycogen and fatty acids is actually stimulated by increasing glucose concentrations. It 
is not known, however, if either of these phenomena is directly or indirectly 
responsible for the growth-stimulatory effect of insulin in MR2 cells as these cells are 
not derived from classical insulin target tissues such as fat, liver, etc. Hayashi et al. 
(1978) have shown that insulin also increases glucose incorporation into both glycogen 
and fatty acids in the rat pituitary cell line, GH3. Another reason why insulin might be 
required in such high doses is that it may be mimicking insulin-like factors such as 
somatomedin C for some cell lines, and high insulin concentrations may be necessary in 
order to occupy receptors which have a high affinity for insulin-like factors and a lower 
affinity for insulin (Barnes and Sato, 1980a).
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Suzuki el al. (1989) have shown that neonatal rat cardiac myocytes show a requirement 
for insulin when grown in serum-free medium. They found that insulin elicited an 
increase in DNA and protein synthesis in these cells. The stimulatory effect of insulin 
was found to be dose-dependant with a concentration of 10|ig/ml being optimal for 
maximal growth of these cells. Insulin was required for serum-free growth of a human 
colon carcinoma cell line (Murakami and Masui, 1980), rat neuroblastoma cells 
(Bottenstein and Sato, 1979) and HeLa cells (Hutchings and Sato, 1978).
Hybridomas also require insulin for maximal growth under serum-free conditions 
(Glassy et al., 1988). Murakami el al. (1982a) found that deletion of insulin from the 
media of the hybridoma cell line MPC11-BL completely inhibited growth. Leukaemic 
stem cells require insulin at a concentration of 8|ig/ml for optimal growth (Dai et al.,
1992). The rat glioma cell line derived from a rat brain tumour can grow in serum-free 
media once insulin is present at a concentration of 25(Xg/ml (Wolfe et al., 1980). BHK- 
21 cells require insulin at a concentration of 5(ig/ml for optimal growth (Bradshaw et 
al., 1983). SV-40 transformed Balb/c-3T3 cells also show a requirement for insulin 
(Rockwell et al., 1980).
Mendiaz et al. (1986) have developed a serum-free medium for the growth of CHO-K1 
cells. They have shown that insulin stimulated the growth of these cells in serum-free 
media over a wide range of concentrations from lng to 10|lg/ml. On the basis of their 
results, they concluded that insulin itself was showing a true mitogenic effect and that 
insulin was acting through both the insulin receptor and the receptor for IGF-1.
Liu et al. (1993) have investigated the interactions of a number of cell lines including 
mouse fibroblasts with cell growth proteins, insulin and transferrin, which are 
immobilised on non-biodegradable polymer membranes. They found that immobilised 
insulin or coimmobilised insulin/ collagen possessed cell-growth acceleration activity 
almost equivalent to the addition of serum. One major benefit of this procedure is that 
the system is stable for repeated uses which would be beneficial in the large-scale 
production of biologicals from animal cells under serum-free conditions.
However, Zhou and Hu (1995) questioned the need for insulin supplementation to 
SFM for hybridoma cells. They found that insulin affected neither the cell growth nor 
the antibody production. However, elimination of insulin from the medium allowed 
antibody to accumulate to a concentration substantially higher than that in insulin- 
containing medium.
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1.1.2.1.2 S tero id  horm ones
The principal steroid hormones used in the serum-free culture of mammalian cells are 
the glucocorticoids, hydrocortisone and dexamethasone, oestradiol, testosterone and 
progesterone. The glucocorticoids have been found to inhibit or stimulate cells in 
culture depending on cell type and density. They may modulate cell proliferation by 
altering responsiveness to growth factors. Dexamethasone acted synergistically with 
IGF-1 to stimulate the growth of fibroblasts and smooth muscle cells (Concover et al., 
1989) but down-regulated the insulin receptor substrate-1 in 3T3-Li adipocytes 
(Tumbow et al., 1994). Dexamethasone has been shown to be required for the serum- 
free growth of neonatal rat cardiac myocytes (Suzuki et al., 1989); these authors found 
that dexamethasone in either hormone-free or hormone-supplemented, serum-free 
medium increased the ratio of beating to non-beating cells and markedly increased 
beating rate per cell. Dexamethasone at a concentration of 0.2[ig/ml has been included 
in the serum-free media developed for the growth of human diploid fibroblasts (HDF) 
(Bettger et al., 1981). In a study of the mode of growth stimulation of steroids, Baker 
etal. (1978) found that synthetic dexamethasone increased the binding capacity of cell 
membrane receptors for insulin and EGF. This increased binding enhanced the 
mitogenic action of these compounds. Hutchings and Sato (1978) have shown that 
hydrocortisone is an essential component of the serum-free medium developed for the 
growth of HeLa cells.
Prostaglandins E, and E2 have been found to be stimulatory for the growth of the 
MCDK cell line under serum-free conditions. Evidence suggests that this stimulation is 
brought about by an increased cAMP level in the cell, since other agents which are 
known to increase intracellular cAMP, dibutryl cAMP, isobutryl methyl-xanthine and 
glucagon, are also stimulatory (Taub etal., 1979).
The mouse melanoma cell line, MR2, has been found to grow in a serum-free medium 
containing insulin, NGF, FSH, testosterone and leutinising releasing hormone. Mather 
and Sato (1979) originally found that progesterone was stimulatory to the growth of 
these cells but later found that testosterone could replace progesterone and was, in fact, 
more stimulatory to growth. Progesterone has been found to be stimulatory to the 
growth of the rat neuroblastoma cell line, B104. The effects of progesterone in the 
central nervous system include modulation of single unit and electrocephalogram 
activity, as well as behaviour (Bottenstein and Sato, 1979). Oestrogen has been found 
to be stimulatory to the growth of MCF-7, breast carcinoma cells (Dickson et al.,
1986).
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Triiodothyronine (T3), a thyroid hormone, and hydrocortisone were found to 
significantly enhance the growth of a human colon carcinoma cell line, HC84S 
(Murakami and Masui, 1980). The intestinal hormone gastrin also gave some 
stimulation of growth. All of the prostaglandins inhibited growth apart from 
prostaglandin E,. Progesterone, testosterone and oestradiol also inhibited cell growth 
(Murakami and Masui, 1980). This result and the demonstration that the hormone- 
supplemented, serum-free medium allows better growth of HC84S cells than does 
serum-supplemented medium raise the possibility that there are hormones present in 
serum that are inhibitory to the growth of human carcinoma cells and other cell lines.
1.1.2.1.3 Growth Factors
There are a number of growth factors that are frequently added to serum-free 
formulations for the various cell lines. These include EGF, FGF, NGF, PDGF and IL- 
2 among many others.
EGF is a low molecular weight (6,100Da) acidic protein originally isolated from the 
submaxillary gland of adult male mice. Its physiological role is uncertain but it has 
been found to be mitogenic for many cell lines. The response range for the growth of 
cell lines in vitro is l-100ng/ml (Barnes and Sato, 1980b). Steroids have been found to 
enhance the activity of EGF. Increased binding of EGF to the cellular membrane of 
human fibroblasts is found in the presence of the synthetic glucocorticoid steroid, 
dexamethasone (Baker et al., 1978). The serum-free medium developed for the growth 
of NIH-3T3 cells contains EGF (Chiang et al., 1985).
FGF is a class of polypeptides which was first isolated from bovine pituitary glands 
and subsequently from bovine brain (Gospodarowicz et al., 1981a) and exists in both 
basic and acidic forms. This growth factor at a concentration of 200ng/ml was found to 
be required for the growth of BHK-21 cells in serum-free medium (Bradshaw et al., 
1983). FGF at a concentration of 50ng/ml is required for the growth of the rat glioma 
cell line, C6 (Wolfe et al., 1980). FGFs are also potent mitogens for endothelial, 
mesoderm and neuroectodemal- derived cells.
NGF was one of the first growth factors to be described and is known to stimulate the 
growth and differentiation of the cells of the peripheral nervous system. NGF has been 
shown to have a minor but reproducible stimulatory effect on MR2, human melanoma 
cells (Mather and Sato, 1979).
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IL-2 is a mitogenic protein which is released into the medium by T-lymphocytes and its 
target cells in terms of mitogenic activity include the T-lymphocytes from which it was 
extracted. A serum-free medium was developed by Brown et al. (1983) that supported 
the growth of a gibbon ape lymphoma T-cell line, MLA144. These cells produce IL-2 
which they release into the serum-free medium. This serum-free, conditioned medium 
was then used to support the growth of IL-2-dependent cell lines.
PDGF is a serum protein derived from platelets during the clotting process (Stiles et al., 
1983). It is a potent mitogen for connective tissue including smooth muscle cells, 
fibroblasts and glial cells (Koher and Lipton, 1974). When PDGF was incorporated 
into the medium, a lower level of EGF was required for growth of mouse CBH/lOTl/2 
cells (Carpenter and Cohen, 1979).
1.1.2.2 Attachment factors
The attachment of cells to their extracellular matrix is important in maintaining the 
structural integrity of tissues and is also important in regulating gene expression 
controlling cellular proliferation and differentiation. Serum provides many attachment 
and spreading factors such as fibronectin and vitronectin; thus, the absence of serum 
from the media may have consequences for regulating growth and differentiation of the 
cells. Many cell lines are capable of synthesising attachments factors such as 
fibronectin thus SFM have been developed which do not contain exogenous attachment 
factors (Hahm et al., 1990; Taub et al., 1979). However, some cell lines especially 
primary lines appear to have a requirement for supplemented attachment factors 
(Gospodarowicz etal., 1981b).
The extracellular matrix (ECM) is a complex network of collagenous, non-collagenous 
glycoproteins and proteoglycans. The role of collagens, fibronectin, laminin and 
vitronectin will be discussed in greater detail in Section 1.2.
1.1.2.3 Transport protein
The main transport proteins used in most serum-free media are albumin and transferrin 
which transport lipids and iron respectively.
1.1.2.3.1 Albumin
The role of albumin in the serum-free growth of mammalian cells in culture is quite 
controversial. No conclusive evidence has actually been published demonstrating a
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need for a specific protein as a serum substitute. The physiological functions of 
albumin are diverse. It is involved in the maintenance of blood osmotic pressure, the 
transport of fatty acids and various hormones, tryptophan and cysteine. It is also a 
source of amino acids for peripheral tissues (Kan and Yamane, 1982).
Albumin has been used widely as an essential substitute for serum in defined media for 
a number of different cell types. Albumin has the ability to act as a carrier for the 
essential fatty acids and trace minerals. It can also transport hormones and peptide 
growth factors to the site of action. Albumin can also act as a detoxifying agent for 
H20 2(Darfler and Insel, 1983) and excess trace elements (Kan and Yamane, 1982). It 
can also provide cells with protection against mechanical shear damage (Lambert, 
1985). BSA also works in a serum-free system by buffering changes in pH during the 
culture time (Dai et al., 1992).
The principal role of bovine serum albumin appears to be that of a carrier of fatty acids, 
protecting the cells against the toxic effects of fatty acids in free solution (Nilhausen, 
1978). This group found that by removing the fatty acids from the albumin eliminated 
most of the growth stimulating effect of BSA on CHEF cells and recombination of 
albumin with the previously extracted and subsequently purified fatty acids returned the 
growth promoting activity to its original levels. These findings agree well with the 
view that albumin is a carrier and storer of fatty acids which are gradually made 
available to the cells in suitable, dilute non-toxic concentrations. Kan and Yamane 
(1982) also found that the growth promoting effect of BSA on human diploid 
fibroblasts (HDF) was virtually abolished when BSA was delipidised.
1.1.2.3.2 Transferrin
Transferrin is a protein constituent of the (3-globulin fraction of blood serum and has a 
molecular weight of 86,000Da. It is responsible for the transfer of iron in blood under 
normal physiological conditions. It is an obligatory ingredient of most serum-free 
media formulations as virtually every cell line, investigated under serum-free 
conditions, shows positive growth response to transferrin. Typical concentrations in 
serum-free media range from l-3O|0,g/ml. Transferrin interacts with specific cell surface 
receptors and has an intimate role in the facilitation of iron transport across the plasma 
membrane. There may also be additional in vitro functions such as the chelation of 
deleterious trace elements (Glassy et al., 1988). It thus appears that the role of 
transferrin in growth stimulation is mainly due to its ability to increase the uptake or 
utilisation of the existing iron in the medium. Some of the stimulatory activity may be 
related to its ability to bind metal ions which may be present in the medium at
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concentrations which are toxic (Barnes and Sato, 1980a; Iscove and Melchers, 1978). 
It is conceivable that the requirements of the MCF-7 and B 104 cell lines for unusually 
high transferrin concentrations (Barnes and Sato, 1979; Bottenstein and Sato, 1979) 
may relate to a particular sensitivity of these cell lines to trace amounts of toxic metals 
introduced into the medium as contaminants of other medium components.
Mather and Sato (1979) investigated the growth of the mouse melanoma cell line, MR2, 
in a serum-free medium containing varying concentrations of transferrin from 0- 
50fig/ml. They found that the observed growth stimulatory effects were dependant on 
the presence or absence of FeS04 in the medium. In the absence of added iron, there 
was found to be a fifteen-fold increase in the cell growth at a transferrin concentration 
of l|ig/ml. However, at the same transferrin concentration in the presence of added 
FeS04, only a two-fold stimulation of growth was observed. They also carried out 
dose-response curves to both iron-free transferrin and iron-saturated transferrin (2 
molecules of Fe/ molecule of transferrin) in Ham's F12 medium. They found no 
difference in the stimulation of growth between these two forms of transferrin most 
likely due to the iron-free transferrin binding sufficient contaminant iron from the 
medium during the course of the experiment over six days.
Transferrin is considered to be one of the essential growth promoting supplements in 
serum-free media for hybridomas (Glassy et a l ,  1988). Transferrin at a concentration 
of 35]Hg/ml was used in the serum-free growth of the hybridoma cell line, MPC11-BL 
(Murakami et a l, 1982a). They found that transferrin at a concentration of 2(ig/ml was 
required for the growth of the myeloma cell line, MPC-11.
Dai et al. (1992) showed that leukaemic stem cells require transferrin at a concentration 
of l|xg/ml. Murakami and Masui (1980) found that the human colon carcinoma cell 
line, HC84S, required transferrin at a concentration of 2fig/ml for optimal growth. 
Transferrin at a concentration of 5|ig/ml was required for optimal growth of the SV40 
transformed Balb/c-3T3 cell line. Iron, which is an essential component of the electron 
transport system and of several enzymes concerned with oxidation-reduction reactions 
within the cell, has been shown to be a critical nutrient for the successful proliferation 
of SV40 transformed cells (Rockwell et al., 1980). BHK-21 cells require transferrin at 
a concentration of Ijlg/ml (Bradshaw et a l,  1983). Deletion of transferrin from the 
SFM developed for C6, rat glioma cells, greatly reduced the growth response of this 
cell line (Wolfe et al., 1980). HeLa cells require transferrin at a concentration of 
5|ug/ml (Hutchings and Sato, 1978). Mendiaz et al. (1986) developed a serum-free 
media for the growth of CHO-K1 cells. Transferrin was found not to be an essential 
requirement as FeS04 substituted equally well for it. Optimal transferrin concentration
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for growth and long-term survival of neonatal rat cardiac muscle cells was found to be 
l^g/ml (Suzuki et al., 1989).
A different function of transferrin was noted when it was found to counteract the effect 
of LDL in its action on specific mitogen stimulation of lymphocytes. Another example 
of the diverse effects of transferrin is the interplay of LDL and transferrin in oxidative 
enzyme stimulated lymphocytes. The presence of LDL blocked the cell cycle but the 
block was relieved by the addition of transferrin (Scupham et al., 1987; Bjare, 1992).
1.1.2.4 Lipids
Serum is a rich source for the various lipids cultured cells generally need for their 
survival and particularly for their growth. Cell lines tend to differ in their requirements 
for essential fatty acids, phospholipids, lipoproteins, lecithins and cholesterol. Many 
cell lines have an obligatory lipid requirement, while other cell lines can grow perfectly 
well in media without any lipids present. The specific lipid demands have to be tested 
for each particular cell line (Bjare, 1992).
Lipids may be present in culture medium as components of added serum or they can be 
supplemented in the form of isolated lipoprotein fractions, free fatty acids complexed to 
serum albumin, or microemulsions composed of various fatty acids, phospholipids and 
cholesteryl esters. Incorporated lipids are utilised within the cell either as a source of 
cellular energy or as building blocks for cell growth especially in the formation of 
cellular membranes. Often the fatty acid composition of cellular storage lipids as well 
as of membrane phospholipids resembles that of lipids present in the medium. 
Modification of membrane phospholipid fatty acyl groups have been shown to lead to 
differences in cell function such as membrane enzymatic activity and membrane 
transport properties. This could lead to changes in the specific growth rate of cultured 
cells (Schmid et al., 1991). Thus, care must be taken in supplementing basal media 
with various lipids.
Fatty acids and cholesterol are the basic building blocks for cells. The more complex 
lipids can be synthesised by the cell provided that these two basic precursors are 
available. Many cell lines are also able to synthesise de novo both cholesterol and many 
of the fatty acids that they require from Acetyl Co A (King and Spector, 1981). If lipids 
are available in the medium, cells take them up and de novo synthesis of fatty acids and 
cholesterol is supressed. When the medium lipids are in the form of serum, the lipid 
content of the membrane resembles that of the serum (Geyer et al., 1962). Thus, most 
cell lines are capable of making fatty acid and cholesterol from non-lipid precursors but
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supression of de novo lipid synthesis occurs when adequate supplies of these lipids are 
available in the culture medium.
1.1.2.4.1 Fatty acids
The majority of cell lines show requirements for either essential or non-essential 
unsaturated fatty acids as opposed to saturated ones. The mechanism by which fatty 
acids stimulate growth is still relatively unknown. Exogenous lipids may be 
incorporated into the cell membranes, thus affecting their fluidity, which could 
influence the shear sensitivity of cells in culture. Polyunsaturated fatty acids such as 
linoleic or arachidonic acids have been shown to reverse the uncoupling of oxidative 
phosphorylation and the loss of respiratory control of HeLa cells incubated in lipid-free 
medium (Rockwell etal., 1980; Gerschensen et al., 1967). Therefore, the stimulation 
of growth by these unsaturated fatty acids may be simply due to their ability to maintain 
the integrity of the mitochondrial membrane. Rockwell etal. (1980) found that the cis- 
unsaturated fatty acids, linoleic, linolenic, oleic and arachidonic acids, were equally 
effective in stimulating the growth of SV40 transformed Balb/c-3T3 cells. Saturated 
fatty acids at similar concentrations were either inhibitory in the case of palmitic, or 
inactive in the case of stearic acid. Oleic acid was also found to be stimulatory to the 
growth of BHK cells (Bradshaw et a l, 1983) and a number of other cell lines (Yamada 
et a l, 1990). The rat glioma cell line, C6BU-1, was found to have a requirement for 
linoleic acid. It is thought that the growth promoting effects of linoleic acid are related to 
its conversion to either prostaglandin F2tx or a related compound. Prostaglandin F2a is 
synthesised from arachidonic acid, a linoleate derivative, and has been found to initiate 
DNA synthesis in quiescent mouse 3T3 cells (King and Spector, 1981; Jimenez de 
Asua etal., 1975).
1.1.2.4.2 C holesterol
Cholesterol is the most abundant of the lipid species in the plasma membranes of animal 
cells. It has a two-fold function, as a structural component of the membrane to maintain 
the integrity of the cells and as the regulator of fluidity of the plasma membrane playing 
an important role in the control of many cellular functions. Dividing cells require 
cholesterol for the formation of new plasma membrane either through endogenous 
biosynthesis or from an exogenous source such as serum.
Ohmori and Takahama (1989) demonstrated a cholesterol requirement for antibody 
production in murine lymphocytes in SFM. Cholesterol or cholesterol precursors such 
as lathosterol, 7-dehydrocholesterol and desmosterol have been found to support the
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growth of NS-1 and X63 mouse myeloma cells in SFM (Sato et al., 1988). Some cell 
lines are cholesterol auxotrophs thus requiring an exogenous supply of cholesterol 
(Chen and Kandutsch, 1983). Cholesterol can also have a negative effect on cell 
growth (Buntemeyer et al., 1993). Darfler (1990b) found that cholesterol and 
desmosterol were growth inhibitory or had no positive effect on hybridoma cell growth. 
This suggests that cholesterol requirements are cell line specific.
1.1.2.4.3 L ip op rotein s
Lipoproteins, especially HDL and LDL, are often added to serum-free formulations. 
Nakama and Yamada (1993) found that the most effective factor on the growth of 
HepG2 cells was LDL and found that the growth requirement of HDL was ten times 
less than than for LDL for the same growth promoting activity.
HDL has been found to be a primary mitogen for the growth of ABAE (adult bovine 
aortic endothelial) and VSM (vascular smooth muscle cells) grown in serum-free media 
(Fugii and Gospodarowicz, 1983; Gospodarowicz et al., 1981b; Tauber et al., 1981; 
Giguere et al., 1982). The primary mitogenic component of HDL was found to be 
phosphatidyl choline (Fugii et al., 1983).
The optimal proliferation of both human EC (vascular endothelial cells) and SMC 
(smooth muscle cells) clearly requires LDL or HDL where the active concentrations 
range from 20-60fiM for both cell types (Chen et al., 1986). A simple conjugate of 
BSA-oleic acid could not substitute for the lipoproteins. Therefore a growth 
stimulatory feature for EC or SMC is encoded in the lipoprotein structure beyond the 
presence of a simple polyunsaturated fatty acid like oleic acid. These results suggest 
that both the protein and lipid component of lipoproteins contribute to the maximum 
support of the growth of human EC and SMC cells.
1.1.2.5 Trace elements
The role of various inorganic trace elements has only been partly elucidated. Defining 
the type and concentration of trace elements needed for optimal cell growth is a very 
difficult task because of the regular contamination of these elements in the other 
nutritional components of culture media. The list of essential or potentially beneficial 
trace elements includes; cobalt, copper, iron, manganese, molbydenum, zinc, selenium, 
nickel and vanadium.
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Many of these trace elements act as enzyme cofactors. Se032' is required to activate 
distinct enzymes essential for metabolic detoxification. Selenium is also thought to 
serve as an inactivator of free radicals. The primary effect of selenium on cultured cells 
has been suggested as protection against oxygen toxicity (Murakami et al., 1982a). 
Murakami et al. reported that selenium was required for the optimal growth of the 
myeloma cell line, MPC-11, in serum-free medium. Ham has suggested that the 
requirements of cells for selenium is related to its presence as a cofactor for glutathione 
peroxidase, which appears to protect the cells from the toxic effects of lipid peroxides 
(Barnes and Sato, 1980a; Ham and McKeehan, 1979). Hamilton and Ham (1977) 
demonstrated that selenium appears to be an absolute requirement for the clonal growth 
of CHO cells. However, Mendiaz et al. (1986), in trying to develop a serum-free 
medium for the growth of their CHO-K1 cell line, were only able to demonstrate a 
minor effect of selenium. McKeehan et al. (1976) have found that selenium is essential 
for the clonal growth of diploid fibroblasts from human fetal lung (WI-38) in media 
containing small amounts of serum protein. Selenium has also been found to be 
required for the growth of certain human hepatoma cell lines (Nakabayashi et al., 
1982), rat neuroblastoma cells (Bottenstein and Sato, 1979) and hybridomas 
(Murakami et al., 1982b; Glassey et al., 1988).
1.1.2.6 Vitamins
Information in the literature is quite scant on the role of vitamins in serum-free cell 
culture. It does appear, however, that the water soluble vitamins are of more 
importance than the fat soluble vitamins for optimal growth of cells in culture. The 
requirements do vary from one cell line to another but it appears that the ingredients in 
the common media formulations satisfy most cell lines. Eagle (1955) reported that 
mouse L cells and HeLa cells had a strict requirement for seven vitamins (choline, folic 
acid, nicotinimide, panthothenate, pyridoxal, riboflavin, and thiamine) and thus 
included them in his basal medium. If a single vitamin was omitted from the culture 
environment, the cells would undergo degenerative changes within 5 to 15 days, 
resulting in eventual cell death. Media for serum-free culture are often enriched with a 
few additional vitamins especially vitamin B12 and biotin. Biotin becomes increasingly 
important when serum is reduced or eliminated because of its function in lipid 
biosynthesis as the prosthetic group of acetyl CoA carboxylase. Matsuya and Yamane 
(1986) noted a vitamin B12 requirement at low cell densities for a number of mouse cell 
lines that disappeared at higher cell densities. Inositol is often referred to as a vitamin 
supplement in cell culture media. Lockart and Eagle (1959) showed that a requirement 
for inositol became apparent when cells were cultured at low cell densities. These 
authors were the first to recognise differences in the nutritional requirements of cells
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undergoing clonal growth at low cell densities and those of cells in higher density 
cultures. The main functions of the B vitamins included in culture media are as 
cofactors or coenzymes associated with the many enzyme systems involved in 
carbohydrate, lipid, protein and nucleic acid metabolism.
The lipid constituent choline is classically included with the vitamins but it is usually 
required in amounts that greatly exceed those for other vitamins. It is a constituent of 
phospholipids and a precursor of the putative neurotransmitter acetylcholine. Choline 
was demonstrated to have a strong stimulatory effect upon the growth of human 
epidermal keratinocytes in the presence of myo-inositol in a defined culture medium 
(Gordon et al., 1988). CHO cells have been found to respond to supplemented choline 
(Esko et al., 1983).
There are many conflicting reports about the role of ascorbic acid in cell culture media. 
It may be beneficial, particularly to cells that synthesise collagen in culture, but its 
instability to oxidation makes it difficult to work with (Ham and McKeehan, 1979). 
Ascorbic acid was found to be stimulatory to the growth of a human colon carcinoma 
cell line in SFM (Murakami and Masui, 1980). It can function as a water-soluble chain- 
breaking anti-oxidant and acts synergistically with vitamin E to protect both endo and 
plasma membranes from oxidative damage. Ascorbic acid can regenerate vitamin E by 
directly reducing tocopherol radicals generated when vitamin E scavenges free radicals 
(Constantinescu e ta l,  1993).
The fat soluble vitamins, A, E, D and K, are rarely found in culture media even though 
the requirements for these fat soluble vitamins has been well established for higher 
animal species. Vitamin E has been added to some serum-free formulations usually as 
an anti-oxidant to protect membrane lipids from peroxidation (Smith, 1981). Bettger et 
al. (1981) included vitamin E and vitamin E acetate in the serum-free cultivation of 
HDF. It has also been found to inhibit the stimulation of c-fos levels in MCF-7, 
mammary carcinoma cells, induced by IGF-1 (Li et al., 1994).
Vitamin A appears to have a more pronounced effect on cells in culture compared to the 
other fat-soluble vitamins. It has been shown to increase DNA synthesis in guinea pig 
epidermal cells (Christopher, 1974). Sporn et al. (1973) have reported significant 
increases in protein, RNA and DNA synthesis in mouse epidermal cultures exposed to 
retinyl acetate. Vitamin A also appears to have a role in the maintenance of 
differentiated function and inhibition of neoplastic transformation in vitro (Smith, 1981; 
Miyazaki et al., 1984). It has also been found to promote differentiation of 
neuroblastoma cells (Ueno etal., 1993).
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1.1.2.7 M iscellaneous com ponents
Many other components are often added to SFM. Ethanolamine has been shown to be 
an essential growth promoting compound for hybridomas in serum-free culture (Glassy 
et al., 1988; Murakami and Masui (1982b). The rat neuroblastoma cell line, B 104, has 
been shown to have a requirement for putrescine at a concentration of 100|iM 
(Bottenstein and Sato, 1979).
Polyethylene glycol (PEG), which is a well-known fusogen for mammalian cells and 
microbial or plant protoplasts, has been found to stimulate the growth of a number of 
mammalian cell lines including Namalwa and CHO-K1 in SFM (Shintani et al., 1988). 
It was suggested that it stimulated growth by lowering the surface tension of the 
medium and thus improving the transport of metabolites into the cells. Bertheussen 
(1993) found that Pluronic F68 at a concentration of 20|ig/ml was optimal for the 
growth of the cell lines tested. Pluronic F68 is a solid with a molecular weight of 8300 
Da. About 80% of the molecule (by weight) consists of hydrophilic polyoxyethylene 
groups and the remainder of hydrophobic polyoxypropylene groups. In serum 
supplemented culture, it is often added to prevent denaturation of serum proteins during 
agitation. In serum-free media, it may act as a solubilising agent to increase the 
solubility of sparingly water soluble components (Collett and Tobin, 1977). It also has 
the ability to form complexes with phenols and other small molecules (Marcus et al., 
1956). This may reflect a weak albumin-like property of detoxifying species in the 
medium.
Ohmori and Takahama (1989) have reported that p-cyclodextrin is effective as a serum 
substitute for inducing the primary antibody response to sheep erythrocytes in murine 
lymphocyte cultures, a-cyclodextrin has been used as a partial substitute for BSA in 
the serum-free culture of a human lymphoblastoid cell line (Yamane, 1982). (i-
mercaptoethanol has been proven to be an effective growth stimulatory supplement in 
hybridoma and lymphoma cultures (Glassy et al., 1988).
Conditioned media may be defined as media that have used by one cell culture and are 
reused by another. The 'conditioning' of the medium is non-specific and includes the 
release of growth stimulating substances and specific nutrients by the first culture. 
These types of media are thus not defined. However, they are often useful for very 
selective strains that do not grow well in SFM (Bjare, 1992). In the serum-free growth 
of a number of human hepatoma cell lines, it was found that a conditioned medium 
from the HuH-7 cell line of liver origin was able to support the growth of the hepatoma 
cells under serum-free conditions (Bagnarelli and Clementi, 1987). CCRF-CEM, a
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human T-cell line, was found to grow well in serum-free media at concentrations 
greater than 2xl05 cells/ml, while at lower cell densities the cultures rapidly underwent 
apoptosis or programmed cell death (Sandstrom and Buttke, 1993). The viability of 
low density CEM cells could be preserved by supplementing the medium with 
'conditioned' medium from high density CEM cultures. Analysis of the conditioned 
medium resulted in the isolation of a 60kDa protein capable of sustaining CEM growth 
in the absence of serum and was subsequently identified as human catalase. Bradshaw 
et al. (1983) showed that at low cell densities, the growth of BHK-21 cells in SFM was 
poor unless it was supplemented with ‘conditioned’ medium from BHK-21 cells 
themselves.
1.1.3 Industrial relevance for SFM
There is huge potential for the use of serum-free medium in the production of 
commercially valuable products for the veterinary and pharmaceutical industries. 
Mammalian cell products include vaccines, monoclonal antibodies, interferons, 
hormones and tissue plasminogen activator. There are two traditional methods of 
production, monoclonal antibodies from hybridoma technology and expression of 
recombinant proteins in genetically engineered cell lines.
One of the biggest successes for SFM has been in the production of monoclonal 
antibodies (mAbs). For most of the hybridomas used industrially, there is little 
variation in the medium composition with insulin, transferrin, and ethanolamine being 
the most important components of the SFM (reviewed Merten and Litwin, 1991; 
Glassey et al., 1988). It has also been possible to grow hybridomas in protein-free 
media (Schneider, 1989; Darfler, 1990; Zhou and Hu, 1995) with improved mAb 
secretion. Immobilisation of hybridoma cells using calcium alginate entrapment has 
been shown to increase mAb production in SFM (Lee and Palsson, 1990).
Bacterial and yeast expression systems have been traditionally used to produce a wide 
variety of recombinant proteins. However, post-translational modification especially 
glycosylation, is much more complex in animal cells compared to bacterial and yeast 
cells. Animal cells thus provide an ideal environment in which recombinant proteins 
can be properly transcribed and glycosylated. A wide variety of cell lines have been 
found to be suitable for transfection with various genes encoding particular therapeutic 
products including CHO-K1, BHK, MCDK, Vero and Namalwa. Various SFM have 
been used in the production of such therapeutics and viruses from these cells (reviewed 
Berg et al., 1993).
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BHK-21 cells have been adapted to suspension aggregate culture for the serum-free 
production of rabies vaccine in a perfusion-reactor system (Perrin et al., 1995). A ras- 
amplified BHK-21 cell line can hyper-produce a human recombinant mAb in protein- 
free medium (Inoue et al., 1996). Production of tPA has also been reported from BHK 
cells adapted to SFM (Wang et al., 1995). HeLa cell have been cultured in protein-free 
medium for the production of a number of viruses including poliovirus 2 and 3 and 
herpes simplex virus 1 and 2 (Cinatl Jr. et al., 1994). Namalwa cell adapted to growth 
in SFM have been used to produce (3-interferon (Miyaji et al., 1990a) and human 
lymphotoxin (Miyaji et al., 1990b). A Vero cell line derived from the parental cells by 
SV40 transformation was found to be a useful host for protein production, such as 
human growth hormone (GH), in SFM (Ohno et al., 1991).
Chinese hamster ovary cells (CHO) lacking the enzyme dhfr' are among the most 
frequently used recipient cells for stable transfection of genes encoding recombinant 
proteins (Kaufman, 1989; Zaworski and Gill, 1993). Often genetically engineered 
CHO cells are used for pharmaceutical or medical production of human glycoproteins 
because they can grow in suspension and can be adapted to grow in SFM which 
lightens down-stream processing and eliminates the potential for contaminating proteins 
with undefined FBS components. Recombinant CHO cell lines have been found to be 
capable of producing a wide range of products in SFM including human thyroid 
stimulating hormone (Cole et al., 1993), human soluble thrombomodulin (Ogata et al., 
1993a, 1993b), monoclonal antibodies (Keen and Rapson, 1995), plasminogen 
activator and IgG kappa light chain (Zang et al., 1995). Ito et al. (1996) successfully 
cultivated CHO cells over-expressing human insulin receptors on insulin immobilised to 
an artificial substrate in protein-free conditions.
Recent insights into cell cycle and cancer biology have allowed a clearer understanding 
of the basic mechanisms that control cell cycle progression. These can be manipulated 
to bypass growth factor and cytokine requirements for cultured cells when grown in 
serum- or protein- free media. It has been shown that transfection of CHO cells with a 
vector encoding cloned cyclin E resulted in the elimination of anchorage dependence 
and growth factor requirements in these cells (Renner et al., 1995). Manipulation of 
transcription factors may also allow growth in serum-free or protein-free media. De­
regulated E2F-1 transcription factor expression may have a predominant effect on 
cellular proliferation by bypassing the requirements for growth factor signalling. Lee et 
al. (1996) transfected CHO-K1 cells with an expression vector for E2F-1 with the 
resultant over-expression of the gene and growth in a protein-free medium.
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1.1.4 SFM and differentiated cell types
The expression of specialised functions in cell culture in vitro is controlled by the 
composition of the surrounding microenvironment. The presence of various nutrients, 
growth factors or hormones (with inducer or repressor functions) and the composition 
of the extracellular matrix (ECM) all play key roles in the proliferation and maintenance 
of the differentiated phenotype of the specific cell type. The design of the cell culture 
environment which will determine the proliferative capacity and the expression of 
function of tissue-specific cells is dependent on the type of tissues that are the object of 
the study.
Cells that are derived from constantly regenerating tissue such as skin or bone marrow 
cells can be maintained in culture for sustained periods of time before the occurrence of 
terminal differentiation. The use of defined culture conditions allows the growth and 
differentiation of a cell type to be controlled. For example, Rahemtulla et al. (1989) 
reported on two SFM for the growth of normal human keratinocytes, where good 
growth was achieved in a SFM composed of 10ng/ml EGF and 0.3mM calcium, 
whereas differentiation was enhanced by a combination of low EGF (0.1ng/ml) and a 
high calcium (2mM) concentration. Haematopoiesis is a tightly regulated process 
whereby mature cells in the circulating blood are constantly re-generated. This is vital 
for the sustainence of life because of the relatively short life-span of these blood cells. 
The process is regulated by a cascade of haematopoietic growth factors especially the 
interleukins and CSFs, with many of these cytokines having multiple and overlapping 
functions. Many SFM have been described in the literature for the cultivation of 
progenitor and mature haematopoietic cells (Lebkowski et al. 1995; Sandstrom et al. 
1994).
Epithelial cell types are often responsible for the recognised fuctions of an organ such 
as gas exchange in the lung. Many epithelial cell lines have been derived from liver, 
lung, pancreas, kidney, prostrate, mammaiy gland, etc. These can be maintained for 
months with limited cell divisions (Greunert et al., 1990; McCallum and Lowther, 
1996). B-estradiol (Peterson et al., 1990), prolactin and progesterone (Ethier, 1986) 
are often required in defined culture for the maintenance of the differentiated phenotype 
in mammary cell lines. Normal human bronchial cells (Lechner et al., 1982) and 
conducting airway cells (Robinson and Wu, 1991) which are important for research 
into the physiology of respiratory epithelia and the study of airway diseases have all 
been cultured in SFM. Type II pneumocytes have been successfully maintained in SFM 
(Borok et al., 1994; Kumar et al., 1995; Fraslon et al., 1991). By using serum-free 
defined conditions, a potential in vitro model exists to study regulation of alveolar
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epithelial cell function and differentiation. Serum has been found to accelerate loss of 
type II cell differentiated phenotype to type I cells and inhibit DNA synthesis in adult 
type II pneumocytes (Kumar et a l, 1995).
1.1.5 SFM and cancer
Tumour transformation is associated with a partial break-down of the normal regulatory 
systems governing cell proliferation and differentiation. As a consequence, malignant 
cells are often less dependent on external growth factors and may be refractory to 
differentiation signals. Autocrine stimulation of cellular proliferation may be an 
important element in the oncogenesis of various tumours including bladder carcinomas 
(Spom and Roberts, 1985; Ruck et a l, 1994) and hepatomas (Bagnarelli and Clementi,
1987). FGF has been found to play a role in the autocrine growth of human oral 
squamous cell carcinoma (Myoken et al., 1994). TGF-a overexpression causes 
autonomous cell proliferation and contributes to neoplasia in hepatocytes (Wu et al., 
1994) and in a gastric scirrhous carcinoma cell line (Yanagihara et al., 1993). 
Transferrin has been found to be an autocrine growth factor secreted by a rat hepatoma 
cell line (Shapiro and Wagner, 1989). Addition of anti-transferrin antibodies resulted in 
a decrease in growth. A number of polypeptide growth factors have been identified in 
the conditioned medium (CM) of various cancer cell lines including EGF, TGF-a, 
TGF-p, PDGF, CSF, IGF and IL-2 (Goustin et al., 1989).
A number of serum-free media have been described in the literature in the culture of 
lung cancer cells (Brower et al., 1986; Gazdar, 1994; Collodi et al., 1991). Over the 
last fifteen years many SCLC and NSCLC cell lines have been established by using 
serum-free, hormone and growth factor supplemented defined media, HITES and ACL- 
4 (Oie et al., 1996). Masusda et a l (1991) successfully established twenty human 
NSCLC cell lines in ACL-4 SFM.
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1.2 EXTRACELLULAR MATRIX
The interaction of normal cells with the extracellular matrix (ECM) components plays a 
crucial role in regulating many cellular processes such as anchorage, polarity, 
cytoskeletal organistation, state of differentiation and proliferation (Yamada, 1991). 
Mammalian organisms are divided into a series of tissue compartments separated by the 
ECM, which consists of the basement membrane (BM) and its underlying interstitial 
stroma (Yurchenco and Schittney, 1990).
The major components of the ECM include the cell adhesive or anti-adhesive molecules 
such as fibronectin, vitronectin, laminin and tenascin; the structural components such as 
collagens and elastin; and the proteoglycan family which is a complex array of proteins 
with glycosamino glycans side-chains. The ECM is an integral part of the machinery 
that regulates cell function, see Fig. 1.1. These processes are mediated by 
transmembrane receptors known as integrins, which will be discussed in greater detail 
in Section 1.4. Upon integrin ligation, changes in receptor triggered by ligand binding, 
in turn causes rearrangement of the cytoskeletal network and an intracellular cascade of 
signal transduction leading to changes in gene expression, and therefore the growth and 
differentiation status of the cells. The ECM can interact with hormones and growth 
factors to regulate growth and differentiation (Lin and Bissell, 1993; Lupetti et al., 
1996; Yao et al., 1995; Nugent and Newman, 1989).
Under normal conditions, the structural integrity of the BM is largely maintained. 
However, alterations in its structure and signalling pathways could lead to the ECM 
playing a major role in carcinogenesis. During the progression from in situ to invasive 
cancer, the tumour cells gain the ability to invade the basement membrane, through to 
the interstitial stroma (reviewed Liotta et al., 1991).
The major proteins of the extracellular matrix, fibronectin, collagen and laminin, will 
now be discussed in more detail.
1.2.1 Fibronectin
Fibronectin has been found to mediate cell adhesion, embryonic cell migration and 
wound healing (reviewed Hynes, 1990). It is encoded by one gene but exists in a 
number of variant forms that differ in sequence at three general regions of alternative 
splicing of its precursor mRNA. Fibronectin is produced by a wide variety of cell 
types, which secrete and organise themselves into extensive extracellular matrices. It is 
also found in blood as a soluble plasma glycoprotein. Fibronectin appears as a
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FIG. 1.1 Role of cell adhesion in basic multicellular processes
multimeric glycoprotein consisting of a dimer of a  and P chains of unequal length, 
linked together at the carboxyl end by disulphide bonds. Most of the cells adhere to 
fibronectin by binding to centrally located ‘cell-binding’ domain. The crucial sequence 
in this domain is the RGD (Arg-Gly-Asp) motif.
Fibronectin appears to have an important role in wound healing where it is found in 
large quantities associated with fibrin in the provisional matrix laid down during wound 
healing (Hynes, 1990). Keratinocytes then migrate over this fibronectin-rich matrix to 
initiate the healing process. It appears that fibronectin is capable of inhibiting terminal 
differentiation in human keratinocytes thus maintaining the cells in a continuous 
‘cycling’ proliferative state enabling growth of new tissue (Adams and Watt, 1989).
Fibronectin and its integrin receptors appear to play a role in tumour progression 
(reviewed Akiyama et al., 1995). Lupetti et al. (1996) found that interaction of 
metastatic melanoma cells with fibronectin can regulate cytokine gene expression with 
upregulation of IL-6 and IL-8. Interaction with fibronectin can upregulate GM-CSF 
expression in macrophages (Thorens et al., 1987). Many cell lines can synthesise 
fibronectin so the need for fibronectin supplementation in serum-free medium varies 
from one cell type to another. Some cell lines apparently have lost their ability to 
produce fibronectin which may explain their frequent loss of anchorage dependence 
(Butler, 1986). Addition of fibronectin to culture medium can alter the phenotype of 
transformed cells towards a more normal morphology (Junker and Heino, 1987).
In serum-free medium, the requirement for fibronectin to promote proliferation or 
maintenance of the differentiated state of a cell has been clearly demonstrated in a 
number of cases. Orly and Sato (1979) have shown that to inoculate the rat ovarian 
follicular cell line, RF-1, directly into serum-free media, it was necessary to add 
fibronectin at a concentration of 8|ig/ml to the culture medium. They found that in the 
absence of fibronectin, a high proportion of the cells became binucleated after the first 
cell cycle occurred. Fibronectin eliminates cell binucleation and considerably enhanced 
cell growth and thus facilitates cytokinesis of RF-1 cells so that their cell cycle is not 
disturbed and cell growth is enhanced. Grinnell (1976) has shown that fibronectin was 
found to promote cell attachment and spreading for a number of cell lines. Grinnell and 
Feld (1980) inhibited cellular synthesis of fibronectin in human fibroblasts by 
dithiothreitol. This adversely affected the initial spreading onto culture dish surfaces in 
serum-free medium. The addition of plasma fibronectin to these cells restored the 
ability of the cells to adhere to the substratum. Suzuki et al. (1989) found that their 
neonatal rat cardiac myocytes would not spread on plastic without serum being present. 
Fibronectin, at a concentration of 10|ng/ml, significantly improved cell attachment,
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spreading and maintenance of contractility of rat myocytes in serum-free medium. 
Rockwell et a l (1980) showed that fibronectin completely replaced serum preincubation 
of cells and serum precoating of tissue culture surfaces in allowing attachment, 
spreading and growth of SV40 transformed Balb/c-3T3 cells in serum-free medium. 
The proper attachment provided by fibronectin is an obligatory requirement for the 
growth of these cells.
1.2.2 Laminin
Laminin has been found to mediate cell adhesion, migration and differentiation 
(reviewed Timpl, 1989; Beck e ta l ,  1990). It is a large molecular weight glycoprotein 
which is found exclusively in the basement membrane. It consists of several different 
subunits linked together by disulphide bonds. The most extensively studied of these 
subunits are the 400kDa A chain, the 210kDa B, chain and the 200kDa B2 chain which 
are found ubiquitously in BM. This and other forms of laminin appear to be 
asssembled from closely related genes encoding isoforms of certain chains rather than 
undergoing alternative splicing controlled by one gene in the case of fibronectin.
Laminin can interact with cells by a host of mechanisms including a variety of adhesive 
recognition sequences and receptors. Heparin-binding domains are present which are 
important for interaction with the large heparin sulphate proteoglycans present in the 
BM in large quantities (Ott et a l,  1982). Laminin can also interact with type IV 
collagen (Rao e ta l ,  1982). Complexes of laminin, heparin sulphate proteoglycans and 
other molecules especially type IV collagen provide structural organisation to the BM. 
Laminin contains many EGF-like repeats which may explain the role of laminin in 
promoting the growth of certain cells (Darmon, 1982).
Laminin appears to play an extremely important role in tumour progression and 
metastasis. Topley e ta l  (1993) found that by injecting a number of cell lines with 
Matrigel (reconstituted basement membrane) or purified laminin the growth of 
subcutaneous xenografts in nude mice can be improved. Down-regulation of the 
laminin binding integrins also appears to play a role in tumour progression and 
metastasis (reviewed Ziober et a l, 1996).
Laminin has been found to modify gene expression in a number of cancer cell lines as a 
result of cell-matrix interactions. The over-expression of oncogenic ras and myc in 
SCLC cells resulted in the transition towards a more NSCLC classification when 
cultured on laminin. Myc-overexpressing SCLC cells which normally grow as 
aggregates adhered to laminin and exhibited an epithelial morphology and began to
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express markers of both SCLC and NSCLC (Barr et al., 1996). Laminin has also been 
found to induce attachment of a number of SCLC cell lines with the formation of 
neurite-like processes in the cells (Giaccone et a l, 1992). Interaction with laminin may 
be important for the malignant behaviour of lung cancer cells (Fridman et a l,  1990), as 
SCLC cells generally have a higher metastatic potential than NSCLC in patients (Minna 
etal., 1989).
1.2.3 Collagens
Collagens are the most abundant proteins found in the basement membrane. Collagens 
are glycoproteins present in five major forms (types I to V). The most widely 
distributed collagen chains are the a, (IV) and a 2 (IV) chains with a more restricted 
distribution of a 3 (IV), a 4(IV), a 5 (IV) and a6 (IV) (reviewed Yurchenco and O’Rear,
1994). Type IV collagen provides the scaffolding for laminin and the other components 
of the basement membrane. The basal lamina is composed of enmeshed collagen and 
laminin polymers in which nidogen (entactin) acts as a bridge between these molecules 
to provide anchorage for diverse matrix components and tissue integrity.
Type IV collagen has been found to be capable of binding epithelial carcinoma cells 
(Palm and Furcht, 1982). It has also been shown to provide extended proliferation for 
mammary epithelial cells growing in serum-free medium (Kidwell et a l,  1982). It can 
also be used in native or denatured form to form a gel which can act as a pre-coat for 
cells.
1.2.4 Other glycoproteins of the extracellular matrix
Vitronectin is found in human serum and in the ECM (reviewed Tomasini and Mosher,
1991). This protein was originally known as serum spreading factor. The main 
vitronectin receptors are the integrins, a vp3, a IlbP3 and a 5P3, and the attachment of cells 
to vitronectin is mediated through the ‘RGD’ binding motif. The protein contains 
heparin-binding sites and also binds plasminogen activator and stabilises its activity 
(Tomasini and Mosher, 1991). These functions may help regulate the localisation and 
activity of this important inhibitor of plasminogen activator which is implicated in a host 
of tissue remodelling events including implantation, cell migration and tumour cell 
invasion. Most of the cell adhesive activity of serum used for cell culture can be 
attributed to vitronectin.
Thrombospondin is a large glycoprotein released when platelets are activated and 
secreted continuously by a a variety of cell types (reviewed Mosher, 1990). It is
capable of mediating or inhibiting cell adhesion and regulating the growth of certain 
cells.
Tenascin (also known as cytotactin) is important in morphogenetic events including 
embryonic migration, wound healing and tumourigenesis. Increased levels are 
observed during wound healing (Mackie et al., 1988) and in association with certain 
tumours (Hoffman et a l,  1990).
Nidogen (also known as entactin) is distributed ubiquitously in basement membrane 
where is binds tightly to laminin. This entactin-laminin complex can then bind tightly to 
collagen to maintain structural integrity of the basement membrane (Yamada, 1991).
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1.3 CELLULAR ADHESION MOLECULES
Cell-cell and cell-matrix interactions are mediated to a large extent by families of 
adhesion molecules called cadherins and cellular adhesion molecules (CAMs) and also 
by cell surface receptors called integrins. Cadherins and CAMs (as part of the 
immunoglobulin superfamily of adhesion molecules) will be briefly discussed in this 
section. An extensive review of integrins will be presented in Section 1.4 because of 
their importance in normal cellular functioning and alterations in expression which may 
be associated with the pathogenesis of disease and the progression to a malignant 
phenotype.
1.3.1 Cadherins
Cadherins are calcium-dependent transmembrane cell-cell adhesion receptors. They 
bind cells by means of homophilic interactions and are mainly responsible for 
establishing and maintaining intercellular connections (reviewed Takeichi, 1991).
There at least twelve known members of the cadherin family which are subdivided into 
subclasses, sharing a common basic structure. The three main subclasses are well 
characterised at the molecular level, and are E-cadherin, found on many types of 
epithelial cells; P-cadherin, found in the placenta and epidermis; and N-cadherin, found 
on nerve, heart and lens cells (Takeichi, 1991; Buxton et a l, 1993). Cadherins connect 
cells to each other by selective binding to identical cadherin types (Nose et a l, 1990).
The presence of cadherins is important for the maintenance of epithelial and endothelial 
structure (Buck and Horwitz, 1987), and alterations in their expression may thus be 
expected to be associated with loss of normal cell-cell integrity. In tumour metastasis, 
the detachment of cells from the primary tumour is an initial step which is caused by a 
disruption of normal mutual cell connections (Van Roy and Mareel, 1992; Streit et al., 
1996). Malignant transformation appears to be associated with a supression in cadherin 
receptors (reviewed Birchmeier and Behrens, 1994).
Intercellular adhesion of epithelial tissues is mainly regulated by the E-cadherin 
molecule and its associated cytoplasmic protein a-catenin that forms a linkage to the 
cytoskeleton and regulates the function of E-cadherin. Down-regulation of the E- 
cadherin/ catenin complex has been implicated in oesophageal cancer (Kadowaki et al.,
1994), gastric cancer (Streit et a l, 1996) and colon cancer (Vermeulen et a l,  1995b). 
The tumour supressor function of this complex has been demonstrated in skin tumours 
(Cano et a l, 1996) and lung carcinomas (Bohm et a l,  1994). Retinoic acid has been
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found to upregulate the function of the invasion suppressor complex in human MCF-7 
breast cancer cells (Vermeulen et al., 1995a). The E-cadherin/catenin complex also 
plays an important role in embryonic development (Ranscht, 1994).
Thus a lot of experimental evidence exists to support the hypothesis that loss of 
cadherin expression or function is associated with increased invasiveness in 
transformed epithelial cells.
1.3.2 Immunoglobulin Family
The immunoglobulin (Ig) superfamily comprises a wide variety of cell adhesion 
molecules (CAMs) that share common structural features of antibody molecules 
(Springer, 1990). They mediate function via calcium-independent mechanisms. The 
most important members of the family are neural cell adhesion molecule (NCAM) 
(Montefort et al., 1993), intercellular adhesion molecule (ICAM) (Long, 1992) and 
vascular cell adhesion molecule (VCAM) (Rice et al., 1988). Most members of the Ig 
family are invoved in cell-cell recognition. Other members of the Ig family include 
molecules that function in cellular immunity, CD4 and CD8, and molecules associated 
with tumours, e.g. carcinombryonic antigen (CEA).
ICAM-1 may have a potential role in lymphocyte-carcinoma cell interactions. It 
mediates cell-cell adhesion by interacting with its counter-receptors a L(32 and a MP2, the 
leucocyte integrins. Increased expression of ICAM-1 has been correlated with 
melanoma tumour progression and an increased risk of metastasis (Johnson et al.,
1989).
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1.4 IN TEG RIN S
1.4.1 Introduction
Integrins are a large family of heterodimeric transmembrane glycoproteins that bind to 
components of the extracellular matrix and can bind to cell-cell adhesion molecules such 
as CAMs of the immunoglobulin family (reviewed Hynes, 1992; Newham and 
Humphries, 1996). Integrins consist of two protein chains; the a  chain is known to 
have 15 variants while the P chain has 8 identified variants at present. They can 
combine into at least 22 different integrins (see Fig. 1.2). The a  subunits are 
homologous to one another but not to the p subunits, which form their own 
homologous group. The extent of similarity at the amino acid sequence level within the 
a  and P subunit groups is 40-50%. During the mid to late 1980s, it became obvious 
from sequence data that a major glycoprotein complex on platelet cell surfaces (at that 
time, known as lib and Ha) and two groups of glycoprotein antigens on lymphoid and 
myeloid cells (one group contained LFA-1 and Mac-1 and a second set of antigens 
originally identified on T-lymphocytes termed VLA antigens) shared common structural 
features and considerable sequence homology (Hynes, 1987).
Integrins are the most ubiquitous and versatile adhesion receptors expressed by almost 
every cell type. In addition to mediating cell adhesion, integrins are now known to 
function as signalling receptors, participating in a diverse array of cellular events 
including spreading, migration, proliferation, differentiation, apoptosis, and gene 
expression. Epithelial cells, in vivo, perform a number of important functions that 
require unique interactions with the ECM. These include wound repair, modulation of 
inflammation and establishment of tissue polarity and morphogenesis. Integrins have 
been implicated in a number of diseases and in cancer (reviewed Pignatelli and Stamp, 
1995; Varner and Cheresh, 1996; Horwitz, 1997; Hillis and MacLeod, 1996). 
Neoplastic change seems to be associated with alterations in cellular integrin 
expression. Integrins play a role in a number of cellular processes that impact on 
development of tumours, including the regulation of proliferation and apoptosis, 
cellular motility and invasion, cell surface localisation of metalloproteinases, and 
angiogenesis.
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FIG. 1.2 Integrin subunit association
1.4.2 S tru c tu re
The a  subunits vary in size from 150 to 200kDa and are non-covalently associated with 
the |3 subunit which varies in size from 90 to 1 lOkDa, with the exception of P4 which is 
larger than 2 lOkDa. The integrin receptor is a transmembrane glycoprotein with two 
large globular amino terminal extracellular domains that together make up an ellipsoidal 
head (N-domain). Each subunit provides a relatively thin leg which traverses the 
plasma membrane and ends in a relatively short cytoplasmic tail of less than 60 amino 
acids (C domain). The only known integrin which does not fit this category is the p4 
integrin which has a cytoplasmic domain of close to 1000 amino acids (Akiyama et al.,
1995).
The P subunits all show considerable similarity at the amino acid level (Hemler, 1990). 
They all contain 56 conserved cysteine residues except for P4 which has 48. These 
cysteine residues are arranged in 4 repeating patterns which are thought to be linked 
internally by disulphide bonds. The a  subunits exhibit a lower degree of similarity than 
the p chains. The N-terminal region of all a  subunits contain a sevenfold tandem repeat 
of a homologous module composed of approximately 60 amino acids. The final 3 or 4 
of these repeats show sequence homology to functional subunits known as EF-hands, 
found in Ca++ binding proteins such as calmodulin. Seven a subunits including a! and 
a 2 chains of P, integrins plus the a L, a M and a x chains of P2 integrins possess a 200- 
residue insert between the second and third repeats which shares sequence homology 
with the A domain of von Willebrand factor and a number of ECM components. This 
may contribute to the binding function of these integrins (Hynes, 1992; Hemler, 1990).
Several divalent cations regulate integrin-ligand binding including Ca^, Mg^ and Mn4^ . 
The activity varies with the integrin. Integrins possess multiple cation binding sites and 
it is not clear whether occupancy of one or all of these sites is required for activation or 
ligand binding (Hillis and MacLeod, 1996). A characteristic feature of integrins is that 
they can exist in active or inactive states; they may be present at the cell surface but they 
are not necessarily active and capable of ligand binding. The transition from the 
inactive to active state appears to be accompanied by conformational changes and is 
regulated by divalent cation occupancy (Hillis and MacLeod, 1996). An understanding 
of the structural basis of integrin activation will be a major goal because it appears to be 
a critical step in initiating transmembrane signal transduction.
The a  and p subunits could in theory associate to give more than 100 integrins. 
However, the actual diversity is much more restricted. The Pj integrins primarily affect 
adhesion between cells and the ECM (Buck and Horwitz, 1987), the exception being a 4
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which mediates cell-cell adhesion via VCAM-1 (Elices et al., 1990). The majority of (3, 
integrins are receptors for ECM proteins such as collagens (a,, a 2, a 3), fibronectin (a 3, 
a4, a 5) or laminin (a 1? a 2, a 3, a 6). These integrins are also known as very late antigens 
(VLA) because they were originally identified as a series of cell membrane antigens 
expressed by T-lymphocytes after long-term stimulation with phytohaemagglutin 
(Hemler et al., 1987). The p2 integrins are composed of three closely related molecules 
which are also known as leucocyte integrins because their expression is limited to 
leucocytes (Springer, 1990). They participate in cell-cell interactions (Hynes, 1987). 
The P3 integrins consist of two members at the moment. The ocIIbP3 integrin is involved 
in platelet aggregation and has affinity for fibronectin, fibrinogen and von Willebrand 
factor (Ferrell and Martin, 1989). The a vP3 receptor binds to many adhesion molecules 
including vitronectin and thrombospondin and appears to have an important role in 
angiogenesis (Brooks e ta l,  1994). The binding specificity of a particular integrin may 
vary according to cell type which further adds to their complexity. a 2P, is a receptor for 
collagen on platelets but is a collagen and laminin receptor on endothelial cells 
(Kirchofer etal., 1990).
Integrins hold a cell in place by attaching at one end of the molecules of the ECM (or 
molecules on other cells) and at the other end to the cellular cytoskeleton. Binding is not 
very tight, but many relatively weak attachments form a stronger one. The most 
extensively studied site in the integrin ligands is the RGD sequence which refers to 
arginine, glycine and aspartate. This sequence is present in fibronectin, fibrinogen, 
thrombospondin, vitronectin, vWF, laminin and collagen type I (Rouslahti and 
Pierschbacher, 1987; Humphries, 1990)
Integrin ligands appear to use very short (3 or 4 amino acids) sequences as recognition 
motifs for receptor binding. An additional binding site in fibronectin and in some cell- 
surface Ig superfamily ligands have identified a second common motif ‘LDVP’ 
(Humphries, 1990). This binds to a 4P integrin. The ‘DGEA’ site in collagen type I was 
also recognised (Staatz et al., 1991) among others (reviewed in Newham and 
Humphries, 1996; Danen et al., 1996). All these sequences have been shown to 
possess a degree of cross-reactivity in their binding to a variety of integrins. However 
the exact mechanisms by which integrins bind different ligands are not yet fully 
understood.
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1.4.3 In teg rili Signalling
Integrins function as signalling receptors to direct cell adhesion and regulate other 
aspects of cell behaviour, including cell proliferation and differentiation, and to 
determine cell survival and cell cycle events (including apoptosis). The biochemical 
pathways initiated by integrin-ligand interactions are now being extensively elucidated. 
Integrins can mediate the bidirectional transfer of information from the outside to the 
inside of the cell, and also from the inside to the outside of the cell, which has been 
termed “outside-in” and “inside-out” signalling respectively. The pathways involved in 
integrin signalling have been extensively reviewed in the last few years (LaFlamme and 
Auer, 1996; Dedhar and Hannigan, 1996; Parsons, 1996; Yamada and Miyamoto, 
1995; Dedhar, 1995; Garratt and Humphries, 1995).
Although the cytoplasmic domains of both integrin subunits are required for binding, 
the P chain appears particularly important. Phosphorylation of this subunit may be a 
means by which the function of this integrin is regulated (Hibbs et al., 1991). P ,, P2, 
P3, P4, P5 and P6 chains all possess potential sites for phosphorylation due to the 
presence of tyrosine residues. Thus, the P subunit is primarily responsible for integrin 
clustering to focal adhesions (LaFlamme et al., 1992).
When integrins become complexed with a ligand they redistribute into clusters. This 
serves to increase avidity or strength of interaction between cell and ligand, and also 
sequesters integrin cytoplasmic domains into focal adhesions. These are sites of 
interaction between the ECM and signalling molecules. Integrins co-localise with a 
complex organisation of cytoskeletal components that serves both to link the 
cytoskeleton to the focal adhesions and as a site for the congregation of secondary 
messenger mediators, linker/adapter proteins, kinases and phosphatases.
1.4.3.1 “Outside-in” Signalling
Occupation of integrins at focal adhesions results in tyrosine phosphorylation of focal 
adhesion kinase (FAK) and regulates actin cytoskeleton reorganisation. p21rh0 is a 
member of the Ras superfamily of GTPases which regulates actin cytoskeleton 
rearrangement and assembly of focal adhesion plaques in response to growth factors 
and ligand binding to the ECM (Ridley and Hall, 1992). Assembly of focal adhesions 
requires the direct binding of the cytoplasmic domains of the p integrin subunit with the 
focal adhesion proteins, a-actinin, talin and FAK. FAK can bind to paxillin which is 
tyrosine phosphorylated in an adhesion-dependent fashion (Parsons, 1996). FAK has
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binding sites for the SH2 domain of Src and for phosphatidylinositol-3-kinase (Clark 
and Brugge, 1995).
The phosphorylation of FAK is believed to initiate a cascade of phosphorylation events 
and new protein interactions required for adhesion and formation of adhesion- 
dependent signalling complexes. The adhesion-dependent activation of MAP kinases 
appear to be important in the pathway by which integrins regulate cell proliferation. 
MAP-K can then be activated by Ras which can in turn activate a number of 
transcription factors including c-myc that can regulate growth and differentiation 
(Davis, 1993).
Another early event triggered by integrins is the activation of lipid secondary messenger 
pathways. Activation of tyrosine kinase dependent phospholipase C-y (PLC-y) has been 
demonstrated which in turn hydrolyses phosphatidylinositol (PIP2) to inositol 
triphosphate and diacylglycerol which are secondary messengers involved in the control 
of intracellular Ca2+ and the activation of protein kinase C (PKC) (Kanner et al., 1993; 
Daniel et al., 1992). PIP2 can also regulate other cell processes, such as modulating the 
function of several actin-binding proteins of the cytoskeleton.
Thus, regulation of adhesion is clearly a complex process under the control of several 
regulatory pathways. The (32 integrin cytoplasmic domains have been found to contain 
all the information required for its localisation to focal adhesion plaques and for the 
initiation of many of the integrin-mediated signalling events. By defining the pathways 
that are altered by integrin occupancy, it is conceivable that specific targets will be 
identified for therapeutic intervention.
1.4.3.2 “Inside-out” signalling
This refers to changes in the activation state of integrins via intracellular signalling. The 
ability of cells to regulate their adhesiveness is critical in many situations. Modulation 
of the ligand-binding activity of integrins plays a role in these responses and is critically 
dependent on the cytosolic environment with which the tails of the integrins are 
associated. There appear to be regions of the cytoplasmic tails which may be crucial for 
the mediation of this “inside-out” signalling. A highly conserved “GFFKR” motif 
exists in many a  subunits (O’Toole et al., 1994; Kassner et al., 1994).
The integrin a 6(34 is part of an epithelial adhesive structure that is distinct from focal 
adhesions - the hemi-desmosome complex. The extremely long cytoplasmic tail part of 
the p4 chain can reach to the actin cytoskeleton directly.
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1.4.4 Role of In tegrins
Ligation of integrins by their ECM protein ligands induces a cascade of intracellular 
signals, including an increase in intracellular pH and intracellular Ca++ levels (Schwartz,
1992), tyrosine phosphorylation of ppl25 FAK (Komberg et a l, 1993), activation of 
p34/cdc2 (Symington, 1993) and cyclin A (Guadagno et al., 1993), synthesis of 
protein kinase C (Vuori and Rouslahti, 1993), activation of MAPK (Morino et al., 
1995; Schlaepfer et a l, 1994; Chen et al., 1994a), p21 ras (Kapron-Bras et a l,  1993), 
and transcription factors such as NF-KB (Yebra et a l, 1995).
As well as signal transduction, integrins have many roles in mediating the expression of 
genes involved in proliferation, apoptosis, differentiation, invasion and metastasis.
1.4.4.1 Role of integrins in proliferation
Most adherent cells are incapable of proliferating without signals from the ECM, most 
of them being transmitted via integrins. Integrin signalling has been found to regulate 
cell-cycle progression. In fibroblasts, the requirements for adhesion maps to the G0/G, 
transition and to mid-to-late G, before the initiation of DNA synthesis (Guadagno et al.,
1993). Integrin-mediated signalling activates expression of MAP kinases, which have 
been implicated in cellular proliferation (Davis, 1993), as discussed previously. Cyclin 
A expression, which is required for entry into S phase of the cell cycle, is regulated by 
adhesion (Guadagno et a l, 1993).
There may be a possible tumour supressor role associated with the a 5 integrin. 
Fibronectin matrix assembled by this integrin is primarily responsible for the supression 
of malignant properties of cells expressing elevated levels of this integrin (Rouslahti, 
1996; Varner et al., 1995; Symington, 1990; Giancotti and Rouslahti, 1990).
Since the intracellular domain of the p integrin sub-unit signals FAK phosphorylation, it 
is thus likely that integrins play an important role in regulating cell proliferation. The p, 
cytoplasmic domain has been shown to cause a stimulation in cell proliferation 
(Pasqualini and Hemler, 1994). A spliced P, subunit (PIC) has been shown recently to 
be growth inhibitory, preventing cyclin A expression and DNA synthesis (Meredith et 
a l,  1995).
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1.4.4.2 Role of in tegrins in apoptosis
Programmed cell death or apoptosis is a normal part of development, homeostasis, and 
the pathogenesis of some diseases (Steller, 1995). Integrin ligation has been shown to 
regulate the expression of bcl-2, a key regulatory component in the supression of 
apoptosis (Zhang et a l,  1995). Expression of the P4 cytoplasmic domain in cells has 
been shown to activate p21 and induce growth arrest (Clarke et a l, 1995).
There is evidence that integrin occupancy can trigger signals that inhibit apoptosis. This 
inhibition of apoptosis by the ECM is dependent upon the expression and function of 
particular integrin heterodimers, and these requirements appear to be cell type specific. 
Inhibition of a v(3;1 function during angiogenesis with an anti-avP3 antibody both 
inhibited proliferation and induced apoptosis whereas treatment with anti-Pj antibodies 
did not (Brooks et a l, 1994). Howlett et a l (1995) reported that interruption of normal 
mammary morphogenesis by anti-integrin antibodies was associated with an inhibition 
of cell growth and induction of apoptosis. Engagement of specific p, integrins 
prevented apoptosis in mammary epithelial cells by inhibiting the expression of 
interleukin ip-converting enzyme (ICE), a known inducer of apoptosis in mammalian 
cells (Boudreau et a l,  1995).
1.4.4.3 Role of integrins in tissue morphogenesis and differentiation
Epithelial branching morphogenesis is a process by which a continuous epithelium, 
embedded in mesenchyme, forms tubules and branches into surrounding mesenchyme. 
This is responsible for the architecture of many organs, including the lung. Integrin 
receptors may mediate the interaction between the ECM molecules and the epithelium to 
allow normal branching to occur (reviewed by Gumbiner, 1996). There appear to be 
major changes in the expression of ECM molecules, such as laminins and integrins 
(during morphogenesis of the lung), which may be important for normal development 
(Virtanen et a l, 1996).
The a, integrin has been found to be expressed on developing smooth muscle and 
endothelium. The a 3 and a 6 integrins are expressed pericellularly in young epithelia, 
while as maturation progresses, these subunits become basally restricted. These 
integrins thus have roles in the maturation and polarisation of the epithelium (Wu and 
Santoro, 1996). The o  ^integrin is expressed at lung branch tips and may have a role in 
the formation of the basement membrane at growing tips or the extension of epithelia 
into surrounding mesenchyme (Wu and Santoro, 1996; Virtanen et a l, 1996). In vitro, 
a 2P, integrin has been found to play an important role in epithelial branching
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morphogenesis in mammary epithelial cells (Keely el al., 1995; Zutter et al., 1995; 
Howlett et al., 1995) and kidney epithelial cells (Saelman et al., 1995).
Integrins must be functional for development to proceed normally. As the cells of an 
embryo proliferate and differentiate to form tissues of the body, they add and subtract 
integrins from their surface. Cells of the embryo also require integrins to help them 
travel to their final destination. “Knocked-out” integrins often result in deformation or 
death during development (Horwitz, 1997).
Adhesion molecules generally vary with the epidermal stratification and differentiation 
states. Integrins appear to be extremely important in the regulation of events leading to 
terminal differentiation of keratinocytes (reviewed by Jensen and Wheeloch, 1996). 
Basal keratinocytes of the skin contain three populations based on proliferation capacity; 
stem cells, transit-amplifying cells and committed cells. Stem cells can be identified and 
sorted in vitro based on higher expression of [3, integrins (Jones and Watt, 1993; Jones 
et al., 1995). In committed cells, integrin function appears to be inhibited and they are 
lost from the cell surface. This allows keratinocytes to be free to move upwards 
through the epidermis from the basement membrane. There appears to be in vitro 
evidence that inhibition of integrin synthesis occurs only after the basal keratinocyte has 
begun to differentiate further and detach fom the ECM. Expression of integrin 
receptors, especially a2, Oj and a 5, is down-regulated by forced suspension culture of 
keratinocytes (Adams and Watt, 1989) and may represent detachment from the ECM in 
vitro.
Symington and Carter (1995) have provided evidence that a 3P, mediated adhesion to 
epiligrin (epidermal BM component) may be capable of regulating keratinocyte 
differentiation. They found that using anti-o^p, antibodies can inhibit keratinocyte 
adhesion to epiligrin and induce involucrin synthesis, a marker of terminal 
differentiation in keratinocytes.
The role of integrins in expression of markers of differentiation has been most 
extensively studied in mammary epithelial cells. When mammary cells are grown on 
plastic dishes, they cannot be induced to produce milk proteins. However in 3D 
culture, P, interaction with laminin results in activation of p-casein gene expression with 
resultant milk production (Streuli et al., 1991). An ECM response element has recently 
been identified in the P-caesin promoter (Schmidhauser et al., 1992).
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The effects of wounding on the local expression of integrins and their ligands has been 
most extensively studied in squamous epithelia of the skin. Cutaneous wounds contain 
a provisional matrix, rich in fibronectin, osteopontin and tenascin. Keratinocytes at the 
wound edge have been found to increase expression of several integrins, such as a 5P,, 
a vP6 and a vP5 (Sheppard, 1996).
Integrins have been found to be very important in processes that involve cell adhesion 
and motility, such as extravasation of circulating leucocytes into infected or damaged 
tissues, which results in inflammation (reviewed by Horwitz, 1997). At the site of 
infection, white blood cells of the immune system are plucked from the blood by 
endothelial cells. Migration of these leucocytes initially involves selectins, which 
causes the white blood cells to slow down and roll along the endothelial lining of the 
vessel wall. Inside-out signalling causes a4Pj and P2 subunit integrins of the leucocytes 
to gain affinity for molecules of the immunoglobulin family - ICAM’s - on the 
endothelial cells. These attachments help the leucocytes to stop, squeeze between 
endothelial cells thus allowing them to cross the blood vessel wall into the damaged or 
infected tissue.
1.4.5 Regulation of Integrin Expression
The up- and down- regulation of certain genes in various cancers appears to be 
manifested at the transcriptional level. However, mechanisms controlling integrin gene 
expression are quite poorly understood. A number of growth factors and cytokines 
have been found to regulate the expression of integrins (see Table 1.4.1 and Table 
1.4.2).
TGF-a has been shown to upregulate expression of a 2 and a 3 integrins, while 
downregulating a v and a 6 integrins (Lin et al., 1994). If tumour cells lose their ability 
to bind ECM proteins, growth factors such as TGF-a and FGF may exert growth 
stimulatory activities, due to loss of the normal regulatory control, mediated by ECM 
proteins, therefore inappropriate expression of growth factors seen in malignant tissue 
whose cell-matrix adhesion receptors are altered, may have deleterious effects on the 
maintenance of normal tissue architecture and growth (Pignatelli and Stamp, 1996).
Many tumours are heterogenous populations with ECM heterogeneity within these 
tumours, which results in differences in integrin expression. Growth factors and 
cytokines also vary with tumour type and may directly or indirectly affect integrin 
expression. TGF-P has also been found to upregulate certain integrins and
1.4.4.4 In tegrins in W ound Healing, Infection and Inflam m ation
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downregulate others. These changes promote synthesis of ECM, causing changes in 
integrin expression and hence influence gene expression (Heino and Massague, 1989). 
Integrin receptors on melanoma cells are subject to cytokine mediated modulation and 
type of response to each cytokine depends on the integrin considered.
Regulation of cytokine effects by specific integrins has also been recently demonstrated 
for the angiogenic effects of bFGF, TGF-a and VEGF. Friedlander et al. (1995) 
demonstrated that in vivo angiogenesis induced by bFGF was dependent on a vp3 
integrin, whereas that induced by VEGF or TGF-a depended on a vp5 integrin.
Adhesion of cancer cells to the vascular epithelium is an important step in the 
hematogenous metastasis of cancer. Heparin-binding EGF has been found to increase 
the expression of a 2 and a 3 integrins in human breast cancer cells (Narita et al., 1996) 
and oesophageal cancer cells (Sato et al., 1996) already expressing EGF-R. The 
interpretation from the findings of these groups is that cancer cells receive signals from 
the cytokines such as HB-EGF, produced by endothelial cells following initial adhesion 
of cancer cells via selectins. This causes a secondary increase in the expression of cell 
adhesion molecules and leads to augmentation in the adhesive activities of cancer cells at 
the vessel walls.
EGF-R has also been implicated in the upregulation of expression of the a 2P, integrin 
and enhance cell adhesion and migration on type I collagen (Fujii, 1996). Signals 
down-stream of EGF-R can modulate integrin-mediated adhesion to ECM proteins in 
both an inhibitory and stimulatory manner in mammary carcinoma cells (Genersch et 
al., 1996). EGF-R encodes the c-erbB proto-oncogene which has also been implicated 
in cancer metastasis as well as cellular proliferation.
ECM and growth factors are important in morphogenesis and wound repair. In an in 
vitro model designed to mimic wound healing, Xu and Clark (1996) cultured normal 
human dermal skin fibroblasts in relaxed collagen gels and fibronectin-rich cultures or 
stressed fibrin gels, and stressed collagen gels. Integrin subunit mRNA levels were 
measured before and after stimulation with PDGF-BB, a potent mitogen and 
chemoattractant for fibroblasts. The fibronectin-rich cultures and fibrin gel induced a 3 
and a 5 mRNA expression. The stressed and relaxed collagen gels attenuated these 
responses while promoting maximal integrin a 2 expression. ECM alterations during 
wound healing or any new tissue formation causes cells to respond differently to 
repeated growth factor stimuli. During cutaneous wound repair in vivo, the provisional 
matrix of fibronectin, fibrinogen, fibrin and vitronectin forms in the wound area (Gailit 
and Clark, 1994). In the fibrin network, platelets release PDGF that stimulates 
proliferation and chemoattraction of fibroblasts (Deuel et al., 1991). Activated
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fibroblasts must move from surrounding collagenous connective tissue into a fibrin/ 
fibronectin- filled wound and subsequently synthesise new collagenous matrix. Thus 
fibroblast response to these ECM molecules and growth factors is essential for the 
healing process (Xu and Clark, 1996).
TGF-P has been found to increase a 6 and P, mRNA expression in alveolar epithelial 
cells in a dose-dependant manner. It has also been found to increase the levels of the 
laminin P( chain mRNA (Kumar et al., 1995). The cytokine thus appears to be 
important in regulating embryonic formation and tissue moiphogenesis and remodelling 
(Sporn and Roberts, 1990; Border and Rouslahti, 1992).
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Table 1.4.1 U pregulation of in tegrin  expression by cytokines
C ytokine Integrin Cell type Reference
FGF a, rat PC 12 cells Zhang et al. (1993)
NGF «1 rat PC 12 cells Zhang et al. (1993)
EGF-R «2 cutaneous squamous 
carcoma
Fujii (1996)
IFN-y aiPj monocytes Rubio et al. (1995)
TGF-ß Pi osteocarcoma Cervella et al. (1993)
TNF-a a,,a2,a5
a 2
melanoma 
bladder cancer
Mortarini étal. (1991) 
Nista et al. (1996)
IL-l|j «i,0Î2,a5 melanoma Mortarini et al. (1991)
TGF-ßj
Pl«3
a,,02,03,0 ,^! 
LFA-1
melanoma 
WI-38 fibroblasts 
monocyte leukemia
Mortarini et ai. (1991) 
Heino et al. (1989) 
Ignotz et al. (1985)
Table 1.4.2 Downregulation of integrin expression by cytokines
C ytokine Integrin Cell type Reference
IFN-y a* a* |3, lung cancer Van Valen et al. (1996)
TNF-a lung cancer Van Valen et al. (1996)
«6 endothelial cells Delfilippi et al. (1994)
IL-ip a4 melanoma Mortarini et al. (1991)
IFN-a a 4 melanoma Mortarini et al. (1991)
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1.4.6 M olecular Biology of integrins
Many of the a  and p integrin subunits have been sequenced and many cDNA clones are 
available. Ignatius et al. (1990) reported on the rat a, clone which is homologous to the 
human form of the a, subunit. The human a! structure has since been elucidated 
(Briesewitz et al., 1993). Takada and Hemler (1989) cloned cDNA for the a2 integrin 
gene. The rat «, and human VLA-2 a2 subunit have been found to share greater than 
50% sequence homology that may underline some of their similar ligand properties. 
The promoter regions of a number of integrin a  subunits have been described and 
characterised (Birkenmeier etal., 1991; Rosen et al., 1991; Shelly and Amaout, 1991; 
Uzan etal., 1991). A common feature demonstrated by these promoters is the lack of 
TATA and CCAAT boxes and high G+C content, with the exception of the a 4 integrin 
promoter (Rosen etal., 1991). The promoter region of the a 5 integrin also lacks these 
TATA and CCAAT boxes (Birkenmeier et al., 1991).
The promoter region of integrin seems to be the most characterised and was found to 
lack TATA and CCAAT boxes, but contains an abbreviated initiator sequence and 6 
Spl binding sites. Consensus binding sequences for AP-1 and AP-2 complexes, a Pu-1 
box, a GAT A, and 2 palindromic motifs with potential to bind the oestrogen receptor 
are also present (Zutter et al., 1994). Characterisation of the a 2 promoter suggests a 
complex pattern of positive and negative regulatory elements which determine cell type 
and differentiation-specific expression (Zutter etal., 1994).
The regulatory region of the human P, gene consists of two promoters tandemly located 
which appear to be independently regulated. The two promoters drive the expression of 
the unique Pj-gene resulting in the synthesis of at least two mRNAs, that diverge only 
in the complete 5’-untranslated region and share the same coding sequence, as is 
indicated by the isolation of two cDNAs with this structure. The longer mRNA 
transcript is ubiquitously present in human tissues and is 20-fold more abundant than 
the shorter transcript, which is expressed only in a subset of tissues (Cervella et al.,
1993). All the characterised integrin gene promoters drive the expression of reporter 
genes in a tissue-specific manner, which corresponds to the tissue-specific expression 
pattern of the respective genes (Ziober et al., 1996).
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1.4.7 In tegrins and Disease
There have been many good recent reviews on the role of integrins in various diseases 
(Horwitz, 1997; Hills and MacLeod, 1996). Integrins have been associated with 
inflammation as already discussed. The expression of a 4P, on immune cells is 
associated with chronic inflammation such as autoimmune disease, multiple sclerosis, 
rheumatoid arthritis and asthma. The p2 integrins, aMP2 (Mac-1) and aLPL (LFA-1), are 
the main integrins on neutrophils. These cells are usually the first at the site of injury 
and infection and are responsible for many of the symptoms of acute inflammation. 
Compounds have been targetted against a4p, and P2 integrins to interfere with integrin- 
mediated adhesion of white blood cells to endothelial cells (Featherstone, 1996). 
Monoclonal antibodies against LFA-1 and Mac-1 (P2 integrins) have been successfully 
used to treat pulmonary fibrosis (Piguet et al., 1993). Antibodies against a 4P, integrin 
have been used to treat airway inflammation such as asthma (Albelda, 1993a).
A disease known as leucocyte adhesion deficiency (LAD) results in individuals lacking 
P2 integrin or producing a defective version of this integrin. These people suffer 
repeated life-threatening infections, as leucocytes cannot migrate to the sites of injury or 
trauma. People who lack OjIbP3 integrin which is involved in platelet aggregation suffer 
from a disease known as Glenzmann’s thrombasthemia. Platelets are incapable of 
aggregating properly causing excessive bleeding. On the other hand, excessive 
thrombus formation as a result of too much <Xjjbfi3 integrin production can lead to heart 
attacks or strokes if it obstructs a blood vessel. The first product of integrin research 
(ReoPro - Centocor, Leiden, The Netherlands) is an antibody against this integrin, to be 
used as a potent anti-thrombotic agent in patients with cardiovascular complications 
(Newham and Humphries, 1996).
Integrins have been implicated in other diseases such as osteoporosis (Horton and 
Roden, 1995), where overactivity of cells such as osteoclasts, which bind to and 
degrade bone, is a result of overexpression of a vP3 integrin. In skin diseases such as 
psoriasis, normal skin integrins such as pt and P4 are normally confined to the basal 
layer whereas in psoriatic lesions, both these integrins are found in suprabasal layers of 
lesional skin (Gailit and Clark, 1993; Andrew et al., 1992). Some microbes apparently 
enter cells at least in part by latching onto integrins, including influenza virus, 
meningitis and diarrheoa.
44
1.4.8 In tegrins and cancer
Integrins are required for tissue morphogenesis and disruption of expression or 
function may lead to loss of differentiation of malignant cells and their ability to invade 
normal tissue (Albelda, 1993b; Pignatelli and Vessey, 1994). It appears that there is no 
single integrin expression profile that correlates with malignancy. Rather, for different 
types of cancer, different stages in integrin expression seem to be associated with 
transformation and tumour progression (Pignatelli and Stamp, 1995). However, there 
appears to be a trend for the down-regulation of (3, integrins in epithelial carcinomas 
(reviewed Ziober et al., 1996).
The a.;Pj integrin is consistently lost or decreased in moderately and poorly 
differentiated colorectal tumours as described in Table 1.4.3. The potential tumour 
supressor function of this integrin has recently been shown in breast cancer where 
antisense mRNA reduction of a 2P, integrin induced a transformed phenotype (Keely et 
al., 1995). Zutter et al. (1995) transfected this integrin into a poorly-differentiated 
mammary carcinoma that lacked a 2 integrin expression, with a dramatic change in 
cellular phenotype. The cells changed from a fibroblastoid, spindle-shaped, not-contact 
inhibited, motile and invasive cell to an epitheloid, polygonal-shaped, contact-inhibited, 
less motile and invasive cell. Re-expression of the a 2P, integrin was found to restore 
the ability of the cells to differentiate into gland-like structures in 3D matrices 
(reconstituted Matrigel) and markedly reduced the in vivo tumourigenicity of the cells.
Table 1.4.3 Loss of a2 integrin in poorly differentiated carcinomas
Tumour type Reference
Colorectal Koukoulis et al. (1993) 
Nigam eia/. (1993) 
Pignatelli etal. (1990) 
Koretz et al. (1991)
Oral carcinoma Kosmehl et al. (1995)
NSCLC Damjanovich et al. (1992)
SCLC Pellegrini et al. ( 1994)
Breast cancer Zutter et al. (1995) 
Koukoulis etal. (1991) 
Pignatelli etal. (1991)
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In some cancers, high levels of the a 2Pn integrin has been associated with metastasis. 
Highly metastatic melanoma cells have been found to over-express this integrin (Klein 
et al., 1996; Albeda et al., 1990) which appears to have an important role in 
melanocytic tumour progression. Increased expression was shown in advanced stage 
carcinoma (Duncan et al., 1996). Transfection of this integrin into a 
rhabdomyosarcoma cell line resulted in a more metastatic cell type that showed 
increased adhesion to collagen and laminin (Chan etal., 1991). This integrin may play 
a dual role in poorly differentiated epithelial tumours by inhibiting early stages but 
facilitating late events in the metastatic process (Danen et al., 1995a). Chen et al. 
(1994b) looked at the integrin expression in various clones from a human NSCLC 
primary tumour. Parental cells expressed low amounts of a v a 2 and (3, integrins. 
However, one of the clones was found to express high amounts of the a! and a 2 
integrins. Different clonotypes from the same tumour may have different invasive and 
metastatic potentials. In primary anal carcinomas, no a 2 integrin expression was 
detected but cells from metastatic tissuse showed a 2 positivity (Anastassiou et al.,
1995).
Loss of a, integrin has been observed in lung adenocarcinomas, compared to high 
expression in normal lung pneumocytes (Roussel et al., 1994). Down-regulation of a 3 
integrin has been observed in NSCLC (Smythe et al., 1995; Chen et al., 1994b), breast 
carcinoma (Pignatelli etal., 1991) and colorectal carcinoma (Pignatelli et al., 1990). In 
CHO cells, a clone expressing low levels of a 3P, grew most rapidly in nude mice while 
cells with elevated levels of the integrin grew much more slowly (Schreiner et al., 
1991). Transfection of (Xjpj integrin into rhabdomyosarcoma also repressed the 
transformed phenotype (Weitzman et al., 1996). Elevated levels of a 5p, integrin in 
CHO resulted in a supression of the transformed phenotype (Giancotti and Rouslahti,
1990).
Up-regulation, down-regulation and loss of cc6 integrin has been implicated in tumour 
progression and metastasis in many cell types. This integrin plays a key role in 
anchoring cells to the basement membrane. The upregulation of this integrin appears in 
tumours where normal tissue express low or undetectable levels (see Table 1.4.4). A 
ribozyme that selectively degrades a 6 integrin mRNA was transfected into a human 
fibrosarcoma cell line and resulted in a change to a less adherent and less invasive cell 
type (Yamamoto et al., 1996). The down-regulation of a 6 has been implicated in 
epithelial tumours that normally express high levels of this integrin (see Table 1.4.4). 
In lung cancer, the results are somewhat variable but high a 6P4 expression has been 
shown in highly metastatic Lewis lung carcinoma (Perrotin et al., 1990) and SCLC 
(Feldman et al., 1991) while low levels of expression have been reported in NSCLC
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(Smythe et al., 1995). The difference in expression may be due to the fact that 
mesenchymal cells (e.g. fibroblasts) have no need to interact with BM and thus have no 
need to express a 6 integrin but when the cells become transformed they must interact 
with BM to invade tissue, hence increased expression. In epithelial cells which are 
associated with BM, for carcinomas to detach from the BM, a reduction in a 6 
expression may be necessary but on development of the secondary metastasis, 
expression of a6 may be required for attachment to the BM and to initiate invasion.
Table 1.4.4 Changes in a6 integrin expression in cancer
Tumour type R eference
Upregulation o f  a 6
Fibrosarcoma Lin etal. (1993) ,
Yamamoto et al. (1996)
Melanoma Danen et a l . (1995b)
Liver cancer Volpes etal. (1993)
Skin cancer Tennenbaum et al. (1993)
Downregulation o f  a 6
Breast D’Ardenne et al. (1991)
Colon Stallmachetal. (1992)
Prostate Knox etal. (1994)
Kidney Korkonen et al. (1992)
Pancreas W eineletal. (1995)
Integrins have been found to have a role in angiogenesis of tumours. The formation of 
blood vessels serve to nourish the cells and provide access routes into bloodstream for 
metastatic cells (Horwitz, 1997). To form new blood vessels, proliferating endothelial 
cells must form adhesive attachments to one another and to the matrix around them. 
There appears to be increasing evidence that the a v(33 integrin appears in quantity on 
these endothelial cells that are forming new blood vessels and this display keeps 
proliferating cells from dying. As a result there is often an upregulation of this integrin 
associated with invasive cancers. Increased expression has been observed in metastatic 
melanomas (Albeda et al., 1990; Danen et al., 1995a; Natali et al., 1997), colorectal 
carcinoma (Nigam et al., 1993), and breast carcinoma (Pignatelli et al., 1992a).
There appears to be an association of integrin expression with expression of 
metalloproteinases (MMPs) (reviewed Heino, 1996). MMPs appear to play an 
important role in cancer cell invasion and metastasis (Liotta, 1986; Ura et al., 1989). 
Collagenase MMP-2 has been shown to bind directly to a v(33 and is thus localised in
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proteolytically active form on the surface of invasive tumour or endothelial cells 
(Brooks et al., 1994; Seftor et al., 1993). Clarke et al. (1997) have shown that 
production of MMPs is associated with increased a v expression. There appears to be 
an association between a 2P, integrin expression and positive regulation of MMP-1 
(Riikonen et al., 1995). Using antibodies to a 3 integrin resulted in increased levels of 
MMP-2 and greater invasive capabilities in Matrigel assays of glioblastoma cells 
(Chintala et al., 1996).
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1.5 DIFFERENTIATION
Cellular differentiation can be defined as the process leading to the expression of the 
phenotype characteristic of the functionally mature cell in vivo. In other words, ‘a cell 
acquires or displays a new phenotype without changing its phenotype’ (Ham and 
Veomett, 1980). As differentiation progresses, cell division is reduced and eventually 
lost (reviewed Davila et al., 1990). The principle cells which differentiate are stem cells 
capable of rapid growth and division. These cells are multipotent and thus have the 
potential to differentiate into two or more different cell phenotypes. In general they 
possess unlimited proliferative potential but they can remain quiescent under certain 
microenvironment conditions (Davila et al., 1990). A progenitor cell represents the 
progeny of stem cells which possess more limited proliferation and differentiation 
potential. This cell is usually only involved in a single cell lineage.
The destiny of a cell during embryogenesis and development is regulated by genetic 
programs and restricts the number of lineages that stem cells have the potential to form. 
Ham and Veomott (1980) proposed that ‘determination’ is a process whereby a cell 
becomes committed to differentiate into a specific lineage. A determined or committed 
cell initially may not appear phenotypically different; this only occurs after its program 
has been expressed (MacLean and Hall, 1987).
A cell can differentiate in a manner that results in either the irreversible loss of its 
proliferative capacities (terminally differentiated) or some of its proliferative capacity 
has been retained while being fully differentiated (non-terminally differentiated). 
Dedifferentiation is the process whereby a cell loses its differentiated phenotype and 
transdifferentiation occurs when a cell dedifferentiates and then redifferentiates into a 
new distinct phenotype (Davila et al., 1990).
In vivo and in vitro studies support the role for differentiation defects early in the 
process of carcinogenesis. This may be due to uncoupling of the integrated control of 
differentiation and proliferation in cancer cells, where such developments can result in a 
relative insensitivity to differentiation signals and increased sensitivity to proliferation 
signals. Two scenarios thus exist for the possible origins of cancer; from 
dedifferentiation of mature cells which retain the capacity to divide or from maturation 
arrest of immature cells. With increasing tumour progression, the histology of the 
tumour often indicates poorer differentiation and from a prognostic standpoint, patients 
with poorly differentiated tumours will generally have a lower survival rate than those 
with differentiated tumours.
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FIG. 1.3 Stem cell theory of the origin of lung epithelial cells
The pathways involved in the haematopoietic system and their disruption leading to 
leukaemia have been extensively studied (reviewed in Sawyers et al., 1991). 
Leukaemia may be defined as the uncontrolled proliferation of haematopoietic cells that 
do not retain the capacity to divide into normal mature blood cells. In the adult, the 
pluripotent stem cells of the haematopoietic system are located in the bone marrow in a 
quiescent state. The proliferation, differentiation and survival of haematopoietic stem 
cells depend on a number of different growth factors and cytokines produced by the 
bone marrow and stroma of other cell types (reviewed Metcalf, 1989). HL60 
promyelocytic cell line can be chemically induced to differentiate into a variety of cell 
types that functionally and morphologically resemble their normal counterparts 
(reviewed Collins, 1987). HL60 can differentiate into four types of myeloid cells 
depending on the inducing agent. DMSO and retinoic acid induce granulocytic 
differentation. Vitamin D3 can induce differentiation into monocytes, phorbol esters 
induce macrophage-like colonies to develop, while GM-CSF can promote eosinophil 
differentiation in these cells.
In the respiratory system, a single stem cell type may be a precursor of different cell 
types such as Clara cells, alveolar type II cells and pulmonary neuroendocrine cells 
depending on specialised culture conditions (Emura, 1996). Fetal syrian hamster cells 
appear to have the potential to differentiate into Clara cells by cultivating the cells in a 
collagen-gel supplemented with retinoic acid, into type II pneumocytes by using 
hormone-supplemented medium containing an agar overlay supplemented with insulin 
and hydrocortisone, and into neuroendocrine cells by reducing the oxygen pressure in 
the air to 5% concentration. McDowell (1987) and Emura (1997) have discussed the 
possible existence of a common stem cell for the lung epithelium, as outlined in Fig.
1.3.
The presence of common overlapping features between lung cancer cell types supports 
the theory of a common stem cell origin for lung epithelial cancers. Gazdar et al. 
(1981) outlined how all the cells of the bronchial epithelium and the tumours which 
arise from them could have a common stem cell origin. The transforming events which 
lead to carcinogenesis affect undifferentiated or partially-differentiated cells. There are 
many reports in the literature of evidence for the presence of stem cell populations in 
tumour cell lines (Khan et al., 1991). Gazdar et al. (1988) suggested that the 
overlapping expression of markers between different tumour types is indicative of a 
common stem cell origin of lung epithelial cancers.
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Induction of differentiation has been considered as a possible component of therapy for 
cancer (Waxman et a l ,  1988). Natural retinoids have been found to play an important 
role in the maintenance of the normal differentiated state of the adult lung (Chytil, 1992; 
Zachman, 1995; Chytil, 1996). Retinoids thus play an important role in cancer 
differentiation and chemoprevention (Lotan, 1996).
1.5.1 Differentiation specific markers - Keratins
The proteins of the keratin family, which is composed of at least 20 different proteins 
(not including hair keratins) are expressed in a very cell-specific manner in epithelial 
tissue (Moll et al., 1982; Coulombe, 1993). A particular epithelium may be 
characterised by its specific pattern of keratin expression. The keratin family can be 
generally subdivided into acidic type I keratins (keratins 9-20) and neutral to basic type 
II keratins (keratins 1-8) (Schaafsma and Raemakers, 1994; Moll et al., 1982). Type I 
and type II keratins are always co-ordinately and pair-wise expressed, in approximately 
equal amounts, which is due to the fact that the keratin filament is a heterotetramer of 
two type I and two type II polypeptides (Steinart and Roop, 1988). Keratins 5 and 14 
are generally co-expressed in the undifferentiated basal cell layer of stratified squamous 
epithelia while keratins 8 and 18 are constituitively expressed in essentially all simple 
epithelia.
The 20 cytokeratins can be grossly subdivided into stratified epithelium-type (keratins 
1-6, 9-17) and simple epithelium-type (keratins 7, 8, 18, 19, 20) according to 
predominant occurrence (Moll, 1992). Many epithelial tumours retain a profile of 
keratin expression characteristic of their differentiation state (Broers and Raemaekers,
1994). However, alterations in keratin expression during malignancy has been 
observed (Trask et al., 1990; Moll, 1992; van der Gaast et al., 1994). SCLC-V cells in 
particular, despite being of epithelial origin, often express no detectable amounts of 
keratin filaments (Broers et al., 1985) and can instead express neurofilaments or 
vimentin intermediate filaments.
Epithelial cells possess specific keratin profiles characteristic of their cell type, stage of 
development, disease status and degree of differentiation. Keratins appear to be the 
first intermediate filament proteins detectable during foetal development, with 
appearance of keratins 8 and 18 first (Franke et a l ,  1982). It appears that the more 
specialised keratins which are expressed at later stages of development have probably 
evolved from K8 and K18 (Blumenberg, 1988). Co-expression of cytokeratins with 
other intermediate filaments (vimentin, neurofilaments, glial filaments) are characteristic 
of certain epithelial differentiation lineages (Moll, 1992). Blobel et al. (1984) showed
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that the keratin pattern clearly distinguishes different domains of the normal respiratory 
tract as well as different types of lung carcinomas.
In general, in vivo, poorly-differentiated tumours exhibit increased invasiveness and 
have a worse prognosis compared to well differentiated tumours (Behrens, 1994). The 
loss or alteration of epithelial features such as keratins and cell adhesion molecules such 
as beta-1 integrins and cadherins involved in cell-cell and cell-matrix interactions 
appears to facilitate cell migration and metastasis.
1.5.1.1 The simple epithelial keratins
Keratins 8 and 18 are the first to appear during embryogenesis (Franke et al., 1982) and 
they have also been shown to occur in early mesenchymal tissues and developing 
organs such as the heart (van Muijen et al., 1987). In foetal skin maturation, keratins 
8, 18 and 19 appear first (van Muijen et al., 1987; Moll et al., 1982). All 
adenocarcinomas express K8 and K18 and frequently express K19. Neuroendocrine 
carcinoma has been shown to express K8 and K18 consistently with K19 expressed in 
a more restricted fashion (Moll et al., 1982; Broers et al., 1988; Wetzels et al., 1991). 
Trask et al. (1990) showed that breast cancer cells produce K8, K18 and K19 whereas 
normal breast cells produce K5, K6, K14 and K17. Keratin 8 expression may be a 
prognostic marker in invasive breast carcinomas (Takei et al., 1995).
The particular localisation of keratin 19 in various epithelia has led to the hypothesis that 
it could be a marker for epithelial progenitors (Bartek et al., 1986), including stem cells 
of the skin (Michel et al., 1996). In human adult skin, K19 is restricted to the inner 
root sheath of the hair follicle and has not been detected in the epidermis (Stasiak et al. 
1989), while in human foetal skin, K19 is observed in cells of the basal layer (Dale et 
a l,  1985; Oliver et al., 1990). Increased expression of a , (3, integrin on the surface of 
these K19 positive cells was shown by double-labelling immunofluorescence. This is 
consistent with previous reports where stem cells of the skin express increased amounts 
of (3, integrin than differentiated keratinocytes (Jones and Watt, 1993; Jones et al.,
1995). Keratin 19 is an informative sub-type specific marker because the basal cells of 
non-keratininising epithelia express keratin 19 in vivo and in culture. However, 
epidermal keratinocytes normally do not express keratin 19 (Schon and Rheinwald,
1996).
Keratin 19 also appears to be associated with the fully differentiated type II cell 
phenotype (Paine et al., 1995). In freshly isolated type II cells there is abundant 
synthesis of K19 and low-level synthesis of K18. As the cells differentiate to the type I
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phenotype, K18 synthesis is increased and that of K19 is virtually lost (Paine et al., 
1988). Keratin 19 expression is frequently associated with the less differentiated 
proliferating cell in epithelial tissue (Stasiak et a l ,  1989). Cyfra-21 is a K19 fragment 
that is soluble in serum and may be useful as a circulating tumour marker, e.g. in 
gynecologic malignancies (Inaba et al., 1995). A high level of Cyfra-21 may correlate 
with advanced disease stage in NSCLC (Wieskopf et a l ,  1995). Diffuse staining of 
K19 may be a potential marker of poorly-differentiated oesophageal squamous 
carcinomas (Lam etal., 1995). The detection of K19 gene expression by RT-PCR has 
been reported as a sensitive tool for detecting occult metastasis to the lymph nodes and 
bone marrow of patients with primary epithelial tumours of the bowel and breast 
(Burchill et a l ,  1995; Gunn et a l ,  1996; Kruger et a l ,  1996). The presence of 
micrometastases in bone marrow worsens the outcome of breast cancer treatment 
significantly.
Keratin mRNA appears to be expressed more widely than its protein (Tyner and Fuchs, 
1986; Stoler et a l ,  1988). In normal stratified oral epithelia, post-transcriptional 
control of K7, K8 and K18 has been reported (Su et al. , 1994). Protein expression of 
these keratins was observed in dysplastic and malignant epithelia suggesting a release 
from a post-transcriptional block on K8 and K18 translation (Su et a l ,  1994). 
Alternatively rapid degradation of K8 and K18 protein may be occuring in normal 
epithelia but may be supressed in dysplasia and malignancy. A retinoic acid-dependent 
post-transcriptional mechanism modulates K19 intermediate filament expression in 
stratified squamous epithelia (Crowe, 1993).
1.5.2 Differentiating inducing agent - Bromodeoxyuridine
Bromodeoxyuridine (BrdU) has been used for 20 years as a tool for measuring DNA 
synthesis in isolated chromosomes and in cells and tissues (extensively reviewed 
Dolbeare, 1995a; Dolbeare 1995b; Dolbeare 1996). BrdU is a thymidine (Td) analogue 
which can compete with Td for incorporation into DNA. It appears to be capable of 
modulating differentiation in a number of different cell lineages. Its activity is 
reversible if removed from the culture medium or if thymidine is added to the growth 
medium in equimolar concentrations (Ashman and Davidson, 1980). This indicates that 
BrdU is not acting as a mutagen, but is reversibly blocking specific differentiation 
pathways. The ability of BrdU to modulate differentiation may be related to its 
incorporation into DNA, which may implicate the involvement of inhibition of 
expression of differentiation-specific genes (Harding etal., 1978).
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Induction or inhibition of differentiation depends on the particular cell type and the 
target genes. Decreased c-myc expression as a result of BrdU treatment has been 
demonstrated in terminally differentiated leukaemic cells (Yen and Forbes, 1990) and in 
differentiating melanoma cells (Valyi-Nagi etal., 1993).
BrdU has been found to supress differentiation and promote invasiveness of melanoma 
cells (Thomas et a l ,  1993). The integrin repertoire expressed by melanoma cells is 
relevant to their invasive phenotype. Expression of a 2P,, a 5P, and integrins and 
metalloproteinases were found to be increased, while induction of a3 and a vP3 integrins 
was shown in these cells. The production of melanin was repressed by BrdU. BrdU- 
treated cells were found to cause extensive invasion of Matrigel (Thomas et a l ,  1993). 
However BrdU has been found to induce differentiation of melanoma cells, with a 
resultant change in morphology. Flattening of the cells, with a 20-fold increase in cell 
surface area and a 17-fold increase in nuclear area was observed (Valyi-Nagy et al.,
1993). Tumourigenicity of these cells in nude mice was supressed when the cells lines 
were treated with BrdU. Colony formation in soft agar of these BrdU-treated cells was 
also decreased by more than 10% at a 10|xM concentration compared to untreated cells 
(Valyi-Nagy etal., 1993). BrdU has been shown to upregulate expression of the actin 
gene and increase cell adhesiveness in B16 melanoma cells (Gomez et al., 1995). Actin 
may be an important gene in melanoma growth where actin expression appears to be 
inversely correlated with melanoma metastatic potential (Shimokawa-Kuroki et al.,
1994).
BrdU has been found to block myogenesis and differentiation through a myogenic 
regulatory gene, M yoDl, in a mouse myoblast cell line (Tapscott et al., 1989). It 
appears that although BrdU was incorporated into the muscle structural genes, these 
genes were apparently transcribed normally.
BrdU has been shown to induce terminal differentiation in HL60 leukemic cells (Yen 
and Forbes, 1990). BrdU induces the early events, leading to precommitment to the 
onset of terminal differentiation along the myeloid or monocytic pathways. BrdU has 
also been found to induce differentiation in human myeloid leukemia cells (Koeffler et 
al., 1983).
Neuroblastoma have the potential to undergo three major differentiation pathways 
(neuronal, Schwannian or melanocytic) (Tsokos et a l ,  1987). BrdU has been found to 
induce Schwannian differentiation in neuroblastoma (Sugimoto et al., 1988; Emsui et 
al., 1989; Reynolds and Maples, 1985). BrdU treatment of neuroblastoma cells has
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been shown to upregulate expression of human melanoma-associated antigen (Feyles et 
al., 1991a).
Feyles et al. (199 lb) examined the effects of BrdU on a SCLC cell line with features of 
neuroendocrine differentiation. Treatment resulted in induction of substrate-adherant 
growth, along with an epithloid morphology and increased expression of 
neuroendocrine markers.
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1.6 AIMS OF THESIS
In this thesis, SFM was used to develop models to grow various cultured cell lines in 
totally defined conditions. As outlined in Section 1.1.1.1, there are many 
disadvantages to the use of serum in supporting growth, differentiation status and 
metabolic activities of cells in culture.
The aims of the thesis were as follows:
1. CHO-K1 is a commercially important cell line that has been successfully used to 
produce a number of recombinant human therapeutic proteins. Investigations were 
carried out to develop a system to grow CHO-K1 in SF suspension culture. 
Experiments were carried out to improve suspension culture growth using shear 
protective agents such as Pluronic F68 and also to use microcarriers to try to alleviate 
cellular aggregation of the cells by using low calcium SFM.
2. The SFM developed by Mendiaz et al. (1986) was found not to support the long­
term growth of CHO-K1. In this SFM, the cells can only be maintained for up to one 
month at most. Experiments were carried out to try to extend the subcultivation period 
of this cell line in SFM using inexpensive compounds to try to avoid using expensive 
growth factors or hormones. The low calcium SFM used in suspension culture 
experiments was also tried in long-term subcultivation experiments.
3. Transformation of normal to malignant cells is associated with a partial break-down 
of the normal regulatory systems governing cell proliferation and differentiation. SFM 
was developed for the growth of the poorly-differentiated lung carcinoma cell line, 
DLKP. A model would then be available to investigate response of these epithelial 
cancer cells to cytotoxic, chemotherapeutic drugs and to growth stimuli, in SFM 
without interference from ill-defined serum. The availability of a SFM then allowed 
experiments to be carried out using attachment factors, which are important in mediating 
many processes within the cell including proliferation and differentiation. DLKP 
appears to have three clonal populations that interconvert with each other and may be a 
model for the in vivo phenomenon of tumour heterogeneity. It is possible that these 
DLKP morphologies represent distinct phenotypes of the lung and the interconverting 
clones could be used as a model to examine cellular heterogeneity in lung cancer. SFM 
was also studied for the growth of the individual clones and DLKPA, the multiple drug 
resistant variant of DLKP. This would be of particular use to study mechanisms 
involved in MDR and drug transport in a completely defined system. The effects of 
different chemotherapeutic drugs on the cells could be tested without risk of masking 
effects that can be associated with the use of serum.
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At this point in the project, a new system, also based on DLKP, became available in our 
laboratoiy through the research of Dr. Shirley McBride. Treatment of DLKP with 
BrdU was shown to induce the expression of epithelial-specific proteins including 
keratins 8 and 18.
4. It was decided to investigate the possibility that similar treatment could induce the 
expression of other epithelial-specific proteins including adhesion molecules such as 
integrins. Growth of DLKP in SFM influenced the morphology of the cells especially 
when attachment factors such as laminin or fibronectin were added to the SFM. The 
differentiation-inducing agent, bromodeoxyuridine, also influenced morphology with 
the cells appearing more flattened and spread compared to untreated DLKP cells. 
Experiments were carried out to investigate changes in the expression of integrins and 
the adhesive properties of the cells themselves, by investigating the interactions of the 
cells with various extracellular matrix proteins. This may have important implications 
for the study of tumour progression and metastasis.
5. Induction of keratins 8 and 18 was previously observed in DLKP cells by treating 
them with bromodeoxyuridine. Further studies were carried out on these cells to 
determine if similar induction could be demonstrated in DLKPA cells. Studies were 
also performed to determine if keratin induction was a result of cytotoxic stress rather 
than a differentiating effect of BrdU. There appears to be strong evidence that K8 and 
K18 expression is regulated at a post-transcriptional level. Studies were carried out 
using protein synthesis inhibitors to try to determine if a protein may be causing de- 
stabilisation or rapid degradation of translational products.
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2.0 MATERIALS AND METHODS
2.1 WATER
Ultrapure water was used in the preparation of all media and solutions. This water was 
purified by a reverse osmosis system (Millipore Milli-RO 10 Plus, Elgastat UHP) to a 
standard of 12 -18  MQ/crn resistance.
2.2 GLASSWARE
Solutions pertaining to cell culture and maintenance were prepared and stored in sterile 
glass bottles. Bottles (and lids) and all other glassware used for any cell-related work 
were prepared as follows:- all glassware and lids were soaked in a 2% (v/v) solution of 
RBS-25 (AGB Scientific) for at least 1 hour. This is a deproteinising agent which 
removes proteinaceous material from the bottles. Following scrubbing and several 
rinses in tap water, the bottles were then washed by machine using Neodisher 
detergent, an organic, phosphate-based acid detergent. The bottles were then rinsed 
twice with distilled water, once with ultrapure water and sterilised by autoclaving.
2.3 STERILISATION
Water, glassware and all thermostable solutions were sterilised by autoclaving at 121°C 
for 20 minutes (min) under pressure of lbar. Thermolabile solutions were filtered 
through a 0.22|im sterile filter (Millipore, millex-gv, SLGV-025BS). Low protein- 
binding filters were used for all protein-containing solutions.
2.4 MEDIA PREPARATION
Medium was routinely prepared and sterility checked by Joe Carey. The basal media 
used during routine cell culture were prepared according to the formulations shown in 
Table 2.4.1. lOx media were added to sterile ultrapure water, buffered with HEPES 
and NaHC03 and adjusted to a pH of 7.45 - 7.55 using sterile 1.5M NaOH and 1.5M 
HC1. The media were then filtered through sterile 0.22\im bell filters (Gelman, 121-58) 
and stored in 500ml sterile bottles at 4°C. Sterility checks were carried out on each 
500ml bottle of medium as described in Section 2.5.5.
The basal media were stored at 4°C up to their expiry dates as specified on each 
individual lOx medium container. Prior to use, 100ml aliquots of basal media were
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supplemented with 2mM L-glutamine (Gibco, 25030-024) and 5% foetal calf serum 
(Sigma, F-7524 Batch # 122H3363; Biowhittaker, 14-601F Batch # 53B0007) and this 
was used as routine culture medium. This was stored for up to 2 weeks at 4°C, after 
which time, fresh culture medium was prepared.
T able 2.4.1 Preparation o f basal m edia
D M E M
(Gibco, 12501-029)
Ham s F12
(Gibco, 21700-109)
M E M
(Gibco, 21430-020)
10X M edium 500m l Powder 500m l
U ltrapure H 20 4300m l 4700m l 4300m l
1M HEPES*
Sigm a , H -9136
100ml 100ml 100ml
7.5% NaHCOj 
BD H, 30151
45m l 45m l 45m l
* HEPES =  N-(2-Hydroxyethyl)piperazine-N '-(2-ethancsulfonic acid)
Ham’s F12 medium was supplemented with 5% FCS. MEM was supplemented with 
5% FCS, 2mM L-glutamine, lx  NEAA (Gibco, 11140-035) and lx  sodium pyruvate 
(Gibco, 11360-039). For most cell lines, ATCC (Ham’s F12/ DMEM (1:1)) 
supplemented with 5% FCS and 2mM L-glutamine was routinely used.
2.5 CELL LINES
All cell culture work was carried out in a class II down-flow re-circulating laminar flow 
cabinet (Nuaire Biological Cabinet) and any work which involved toxic compounds 
was carried out in a cytoguard (Gelman). Strict aseptic techniques were adhered to at 
all times. The laminar flow cabinet was swabbed with 70% industrial methylated spirits 
(IMS) before and after use, as were all items used in the cabinet. Each cell line was 
assigned specific mpdia and waste bottles and only one cell line was worked with at a 
time in the cabinet which was allowed to clear for 15min between different cell lines. 
The cabinet itself was cleaned each week with industrial detergents (Virkon, Antec. 
International; TEGO, TH.Goldschmidt Ltd.), as were the incubators.
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The cell lines used during the course of this study, their sources and their basal media 
requirements are listed in Table 2.5.1. Lines were maintained in 25cm2 flasks (Costar; 
3050) or 75cm2 flasks (Costar; 3075) at 37°C and fed every two to three days.
2.5.1 Subculture of Adherent Lines
During routine subculturing or harvesting of adherent lines, cells were removed from 
their flasks by enzymatic detachment.
Waste medium was removed from the flasks and rinsed with a pre-warmed (37°C) 
trypsin/EDTA (TV) solution (0.25% trypsin (Gibco, 25090-028), 0.01% EDTA 
(Sigma, EDS) solution in PBS A (Oxoid, BR14a)). The purpose of this was to inhibit 
any naturally occurring trypsin inhibitor which would be present in residual serum. 
Fresh TV was then placed on the cells (2ml/25cm2 flask or 4ml/75cm2 flask) and the 
flasks incubated at 37°C until the cells were seen to have detached (5-10 min). The 
trypsin was deactivated by addition of a equal volume of growth medium (i.e. 
containing 5% serum). The entire solution was transferred to a 30ml sterile universal 
tube (Sterilin; 128a) and centrifuged at 1,000 rpm for 5 min. The resulting cell pellet 
was resuspended in pre-warmed (37°C) fresh growth medium, counted (Section 2.5.3) 
and used to re-seed a flask at the required cell density or to set up an assay.
2.5.2 Subculture of suspension cells
Cell lines growing in suspension did not require enzymatic detachment. Sometimes it 
was necessary to detach some of the cells which had become loosely adhered to the 
flask surface by gently tapping the flask. This was often the case for H82 cells. The 
cell suspension was then removed to a sterile universal, centrifuged at lOOOrpm for 5 
min and used to re-seed fresh flasks or set up assays.
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Table 2.5.1 Cell lines used during the course of this study
Cell line Basal medium Cell type Source
DLKP
(and all its derivatives)
A TC C Human poorly-differentiated 
lung carcinoma
Dr. Geraldine 
Grant, N CTCC
SKLU-1 M EM H um an lung adenocarcinoma A T C C 2
HL60* R PM I-16401 H um an leukaem ic line A TCC
H82* RPM I-1640 H um an SCLC-V A TCC
M C F-7 A TCC Hum an breast carcinoma A TC C
A549 A TCC H um an lung adenocarcinoma A TCC
CHO-K1 H am ’s F12 Chinese H am ster Ovary - 
fibroblastic-like
A TC C
* These cells grow  in suspension
1 RPM I-1640 (Gibco, 52400-025) supplem ented w ith 10% FCS and 2m M  L-glutam ine
2 A TCC = A m erican  Type C ulture Collection
2 .5 .3  Cell Counting
Cell counting and viability determinations were carried out using a trypan blue (Gibco, 
15250-012) dye exclusion technique.
An aliquot of trypan blue was added to a sample from a single cell suspension in a ratio 
of 1:5. After 3 min incubation at room temperature, a sample of this mixture was 
applied to the chamber of a haemocytometer over which a glass coverslip had been 
placed. Cells in the 16 squares of the four outer comer grids of the chamber were 
counted microscopically, an average per comer grid was calculated with the dilution 
factor being taken into account and final cell numbers were multiplied by 104 to 
determine the number of cells per ml (volume occupied by sample in chamber is 0 .1cm 
x 0.1cm x 0.01cm i.e. 0.0001cm3 therefore cell number x 104 is equivalent to cells per 
ml). Non-viable cells were those which stained blue while viable cells excluded the 
trypan blue dye and remained unstained.
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2 . 5 . 4  Cell Freezing
To allow long term storage of cell stocks, cells were frozen and cryo-preserved in liquid 
nitrogen at temperatures below -180°C. Once frozen properly, such stocks should last 
indefinitely.
Cells to be frozen were harvested in the log phase of growth (i.e. actively growing and 
approximately 50 - 70% confluent) and counted as described in Sections 2.5.3. 
Pelleted cells were re-suspended in serum and an equal volume of a DMSO/serum (1:9, 
v/v). This solution was slowly added dropwise to the cell suspension to give a final 
concentration of at least 5xl06 cells/ml. This step was very important as DMSO is toxic 
to cells. When added slowly the cells had a period of time to adapt to the presence of 
the DMSO, otherwise cells may have lysed. The suspension was then aliquoted into 
cryovials (Greiner, 122 278) which were then quickly placed in the vapour phase of 
liquid nitrogen containers (approximately-80°C). After 2.5 to 3.5 hours, the cryovials 
were lowered down into the liquid nitrogen where they were stored until required.
2.5.5 Cell Thawing
Immediately prior to the removal of a cryovial from the liquid nitrogen stores for 
thawing, a sterile universal tube containing growth medium was prepared for the rapid 
transfer and dilution of thawed cells to reduce their exposure time to the DMSO freezing 
solution which is toxic at room temperature. The suspension was centrifuged at 1,000 
rpm. for 5 min, the DMSO-containing supernatant removed and the pellet re-suspended 
in fresh growth medium. A viability count was carried out (Section 2.5.3) to determine 
the efficacy of the freezing/ thawing procedures. Thawed cells were placed into tissue 
culture flasks with the appropriate volume of medium (10ml/25cm2 flask and 
15ml/75cm2 flask) and allowed to attach overnight. After 24 hours, the cells were re­
fed with fresh medium to remove any residual traces of DMSO.
2.5.6 Sterility Checks
Sterility checks were routinely carried out on all media, supplements and trypsin used 
for cell culture. Samples of basal media were inoculated into Columbia (Oxoid, 
CM331) blood agar plates, Sabauraud (Oxoid, CM217) dextrose and Thioglycollate 
(Oxoid, CM 173) broths which should between them detect most contaminants 
including bacteria, fungus and yeast. Growth media (i.e. supplemented with serum and 
L-glutamine) were sterility checked at least 2 days prior to use by incubating samples at
63
37°C which were subsequently examined for turbidity and other indications of 
contamination.
2.6 MYCOPLASMA  ANALYSIS
Mycoplasma examinations were carried out routinely (at least every 3 months) on all 
cell lines used in this study. These analyses were performed by Mary Heenan and 
William Nugent.
2 . 6 . 1  Indirect Staining Procedure
In this procedure, Mycoplasma-negative NRK cells (a normal rat kidney fibroblast line) 
were used as indicator cells. As such, these cells were incubated with supernatant from 
test cell lines and then examined for Mycoplasma contamination. NRK cells were used 
for this procedure because cell integrity is well maintained during fixation. A 
fluorescent Hoechst stain was utilised which binds specifically to DNA and so will stain 
the nucleus of the cell in addition to any Mycoplasma DNA present. A Mycoplasma 
infection would thus be seen as small fluorescent bodies in the cytoplasm of the NRK 
cells and sometimes outside the cells.
NRK cells were seeded onto sterile coverslips in sterile Petri dishes at a cell density of 
2 x l0 3 cells per ml and allowed to attach over night at 37°C in a 5% C 0 2, humidified 
incubator. 1ml of cell-free (cleared by centrifugation at 1,000 rpm for 5 min) 
supernatant from each test cell line was then inoculated onto a NRK Petri dish and 
incubated as before until the cells reached 20 - 50% confluency ( 4 - 5  days). After this 
time, the waste medium was removed from the Petri dishes, the coverslips washed 
twice with sterile PBS A, once with a cold PBS/Camoys (50/50) solution and fixed 
with 2ml of Carnoys solution (acetic acid:methanol-l:3)for 10 min. The fixative was 
then removed and after air drying, the coverslips were washed twice in deionised water 
and stained with 2ml of Hoechst 33258 stain (BDH)(50ng/ml) for 10 min.
From this point on, work proceeded in the dark to limit quenching of the fluorescent 
stain.
The coverslips were rinsed three times in PBS. They were then mounted in 50% (v/v) 
glycerol in 0.05M citric acid and 0.1M disodium phosphate and examined using a 
fluorescent microscope with a UV filter.
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2 . 6 . 2  Direct Staining
The direct stain for Mycoplasma involved a culture method where test samples were 
inoculated onto an enriched Mycoplasma culture broth (Oxoid, CM403) - supplemented 
with 16% serum. 0.002% DNA (BDH; 42026), 2mg/ml fungizone (Gibco, 15290- 
026), 2x l0 3 units penicillin (Sigma, Pen-3) and 10ml of a 25% (w/v) yeast extract 
solution - to optimise growth of any contaminants and incubated at 37°C for 48 hours. 
Sample of this broth were then streaked onto plates of Mycoplasma agar base (Oxoid, 
CM401) which had also been supplemented as above and the plates were incubated for 
3 weeks at 37°C in a CO, environment. The plates were viewed microscopically at least 
every 7 days and the appearance of small, “fried egg” -shaped colonies would be 
indicative of a mycoplasma infection.
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2.7 SERUM-FREE MEDIA ASSAYS
2.7.1 Preparation of SFM
Serum-free medium was prepared for routine work using Ham’s F12 basal medium 
supplemented with the components listed in Table 2.7.1. All serum-free media were 
made up in sterile plastic 150ml containers (Sterilin, 165C) and stored for up to 2 
weeks at 4°C in the dark.
Table 2.7.1 Supplements to serum-free medium
Supplement Final concentration (jlM)
F eS 0 4 5.0
H2S e0 3 3.0xl0"2
C u S 0 4.5H20 l.OxlO'3
M n S 0 4.5H20 l.OxlO'3
Na2S i0 3 5 .0x l0 '2
n h 4v o 3 5 .0x l0 '3
(NH4)6M o70 24.4H20 l.OxlO'3
NiCl2.6H20 5.0x10“*
Z n S 0 4.7H20 5 .0x l0 '2
SnCl2.H 20 5 .0x l0 '4
I CaCl2 6 .0x l0 '2
Linoleic acid 3.0x1 O'2
NEAA l.OxlO'2
Transferrin 5.0ug/m l
Insulin 10.0flg/ml
L-glutamine 2mM
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The reconstitution of the reagents required for SFM and growth assays are described in 
Table 2.7.2
Table 2.7.2 Reconstitution of reagents required for SFM
PRODUCT SIZE CAT. NO. RECONSTITUTION
Bovine insulin lOOmg Sigma, 1-882 Add 9.9ml of sterile H2U  
plus 100(il glacial acetic 
acid. Stock = 10mg/ml
Sodium selenite lm g Sigma, S-9133 Add 20ml sterile medium or 
PBS A. Stock = 20|ig/mJ
holo-transferrin (iron 
saturated)
lOOmg Sigma, T-2158 Add 10ml sterile medium or 
PBS A. Stock = 10mg/ml
Trypsin Inhibitor 500mg Sigma, T-6522 Add 36ml of PBS A or sterile 
medium. Stock = lOx.
Type IV Collagen 5m g Sigma, C-5533 Add lOm iofPBSA . Stock = 
500fig/ml
Fibronectin 5mg Sigma, F-2006 Add 10ml of PBS A. Stock = 
500|xg/ml
Laminin lm g Sigma, L-2020 Dilute to 500jig/ml in 2ml 
PBS A.
2.7.2 Subculture of cells in SFM
Routinely growing cells were harvested by trypsinisation. An equal volume of 
prewarmed soybean trypsin inhibitor (Sigma T-6522) was used to inhibit the activity of 
trypsin. A volume of trypsin inhibitor at 1.388mg/ml was sufficient to inactivate an 
equal volume of the 0.25% trypsin solution used. The cell solution was then removed 
to a universal and centrifuged at 1500rpm for 7 minutes. The pellet was then 
resuspended in 8ml of basal medium. The centrifugation step was repeated a second 
time to remove as much residual serum proteins as possible. The supernatant was 
gently decanted off and the pellet was resuspended in fresh, pre-warmed SFM and 
inoculated in 25cm2 vented flasks (Costar 3056). Cells were incubated in an 
atmosphere of 5% COz at 37°C.
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2.7.3 Cell freezing in SFM
Cryopreservation studies were carried out using Methylcellose 4000cp (Fluka AG, 18- 
5844-37) and Polyvinylpyrollidone (Sigma, PVP-360) to replace serum. Stock 
solutions of 1% methylcellulose (lOx) and 30% polyvinylpyrrolidone (PVP) (lOx) 
were made up in PBS-A and autoclaved. The cryopreservative solutions were then 
made up at 2x concentrations from these stocks. These 2x stock solutions were 0.2% 
MC or 6% PVP supplemented to 20% DMSO in SFM previously filter-sterilised. 
lOmls volumes were made up at a time and stored at -20°C until use.
Cells to be frozen were usually in the log phase of growth and fed with fresh SFM 24 
hours prior to freezing. The procedure is as described in Section 2.5.4 except that no 
serum was used in the procedure. Before addition of the cryopreservative solutions, 
the cells were resuspended in SFM rather than serum.
2.7.4 Cell thawing in SFM
Cells were thawed after removal from the liquid nitrogen tanks, as described in Section 
2.5.5, and immediately transferred to a universal containing 9ml of SFM. The cell 
suspension was then centrifuged at 800rpm, the supernatant carefully removed and the 
cells resuspended in 8ml of SFM. Viability was assessed using haemocytometer 
counting as outlined in Section 2.5.3. The cells were then inoculated into 25cm2 vented 
flasks and allowed to attach. The cells were then re-fed with fresh SFM 24 hours after 
thawing.
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2.8 SUSPENSION CULTURE
500ml glass spinner flasks from Techne (Cambridge, UK) were used for the majority 
of the serum-free suspension culture experiments. 500ml spinner flasks from Bellco 
(New Jersey, USA) were used for the fluorescence anistropy experiments. Before 
glass spinner flasks could be used for any cell work they needed to be treated to prevent 
cells adhering to the glass.
2.8.1 Siliconisation of spinner flasks
A small amount (approximately 10-15ml) of 2% dimethyldichlorosilane in 1,1,1 
trichloroethane (BDH, 33164) was added to the flasks which were then rotated by hand 
to ensure even coating of all surfaces (including the agitator). This procedure was 
carried out with care in a fume hood. The flasks were allowed to air-dry for 
approximately one hour, after which time they were rinsed three times in ultrapure 
water. A small amount of UHP water was left in the flask after the final rinse and the 
two side arm caps left a little open to allow steam ventilation during antoclaving. Flasks 
were then loosely covered with tin-foil and sterilised at 121°C at lbar absolute pressure 
for 20 minutes.
2.8.2 Culturing in spinner flasks
After sterilisation, flasks were rinsed with pre-warmed medium and incubated at 37°C 
ready for use. Cells in the exponential phase of growth were trypsinised in the normal 
manner as in 2.5.1 for serum-supplemented cells and in 2.7.2 for serum-free cells. 
Counts were carried out and 100ml of medium containing cells diluted to the required 
density were inoculated into the spinner. Flasks were incubated at 37°C on a special 
magnetic spinner unit (Techne) at an average speed of 40rpm for most experiments.
2.8.3 Sampling from spinner flasks
Sampling was carried out in the laminar flow cabinet making sure to keep the agitator 
rotating to ensure a representative sample from the spinner flask was being obtained. 
Usually a 1ml sample was taken and centrifuged at lOOOrpm for 5 minutes. The 
supernatant was then carefully removed and 1ml of pre-warmed trypsin was added to 
the cells and incubated at 37°C for 5-10 minutes. The cells were then pipetted gently to 
obtain a single cell suspension and counted as described in Section 2.5.3. Trypsin was 
added to try to break up cell aggregates which is a common phenomenon of suspension 
culture CHO-K1 cells.
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2.8.4 Subculture of suspension culture cells
Every 8-9 days, the cells were decanted into 50ml centrifuge tubes and an aliquot was 
removed for counting using trypsin to break up the cell aggregates. Cells were then re­
seeded at the original inoculation density using fresh SFM.
2.8.5 Preparation of microcarriers
0.3g/l of microcarrier beads (Cytodex 3; Pharmacia, 17-0485-01) were added to a 
siliconised glass bottle containing 30ml of PBS A. The bottle was left at 37°C for 2-3 
hours with occasional agitation. The supernatant was then removed after allowing the 
beads to settle and replaced with fresh PBS A. The beads were then allowed to settle 
again, the PBS A removed and replaced with another 10ml of fresh PBS A. The beads 
were then autoclaved. After sterilisation, the bottle was then placed in a laminar flow 
cabinet and the PBS A was carefully removed and replaced with pre-warmed SFM. 
The microcarriers were agitated and allowed to settle before the supernatant was 
removed and replaced with 10ml of fresh pre-warmed SFM. The beads were then 
transferred to a sterile siliconised spinner flask.
2.8.6 Culturing in microcarrier culture
Cells were diluted to the required volume and added to 90ml of pre-warmed SFM. The 
cells were then transferred to the sterile spinner flask containing 10ml of microcarrier 
beads. The spinner flasks were placed on the spinner unit and agitated at 40rpm.
2.8.7 Sampling from microcarrier culture
Sampling was carried out while ensuring that the beads and cells were well mixed in 
order to obtain á representative sample from the flask. This was very important as the 
microcarrier beads tend to settle very quickly. 1ml samples were removed from the 
well mixed spinner and centrifuged at 1500rpm for 5 minutes. The supernatant was 
carefully removed using a pasteur pipette and the pellet was resuspended in 200|_il of 
0.1%(w/v) crystal violet in 0.1M citric acid (Sigma, C-3029). The samples were 
incubated at 37°C for 1-2 hours to allow the hypertonic solution to burst the cells and 
release the nuclei which the crystal violet stained. The beads were then pipetted gently 
up and down to dislodge the nuclei from the beads. Samples were loaded onto a 
haemocytometer and the nuclei were counted as for whole cells. The microcarrier beads 
are too large to enter the counting chamber and do not interfere with cell counts.
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2.9 PLASMA MEMBRANE FLUIDITY MEASUREMENTS
Steady state fluorescence polarisation was used to determine the plasma membrane 
fluidity (PMF) of the cells. This technique involves labelling the membrane with a 
fluorescent probe (TMA-DPH) and then exciting the membrane with polarised 
monochromatic light. The movement of the probe depends on the fluidity of the 
membrane.
A stock solution of 5xlO'4M TMA-DPH (Sigma, T-0775) was prepared by adding 
1.15mg of TMA-DPH to 5ml of dimethylformamide (DMF) (Sigma, 27,054-7) and 
stored in the dark at 4°C for up to one month.
The method involved washing cell monolayers or suspension culture samples (in 
pelleted form) three times in PBS A. The monolayer cells were trypsinised in 2.5% 
trypsin at 10°C for approximately 1 minute and then transferred to a sterile universal 
and centrifuged at lOOOrpm for 5 minutes. The resultant pellet was resuspended in 
PBS A and the viability was checked. Cells were diluted to lxlO6 cells per ml. To 1ml 
of cell suspension, 5(xl of TMA-DPH solution was added to give a final concentration 
of probe of 1x10 6M. The fluorescence anistropy value of the cell suspension/ probe 
mixture was immediately read on a Perkin-Elmer fluorimeter.
2.10 GROWTH ASSAYS IN SFM
2.10.1 Miniaturised growth assays
Miniaturised assays were of two types, depending on plate size (24-well (Greiner, 
662160) and 96-well (Costar; 3599) plates). For 24-well plate assays, results were 
determined by haemocytometer counts. For 96-well plates, results were determined 
using a combination of the Suforhodamine B and Crystal Violet Dye Elution assays.
Cells in the exponential growth phase were fed 24 hours prior to harvesting for all 
assays. Trypsin inhibitor was used to inhibit the trypsin. The cells were then 
centrifuged at lOOOrpm for 5 minutes and the pellet resuspended in basal medium. If 
the cells were being used directly from serum-supplemented flasks, a second 
centrifugation step was required to remove as much residual serum as possible before 
inoculating into SFM. The pellet was then resuspended in the required volume of 
SFM.
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For growth curve assays, DLKP and DLKPA were seeded at lxlO 4 per well while 
CHO-K1 cells were seeded at 0.5xl04 per well in triplicate in 24 well plates. One plate 
was taken down for analysis each day over a 7-10 day growth period and cells were 
counted using a haemocytometer.
For 96-well growth stimulatory assays, DLKP and DLKPA cells were both seeded at 
3xl03 cells per well in SFM. Cells were added in 100(il aliquots per well using 8-well 
multichannel pipettes. The plates were divided so that each variable was set up with 8 
repeats and 12 variables per plate. Two controls were set up per plate, a positive 
control with medium supplemented with 5% FCS and a negative control with basal or 
SFM. The variables to be tested were made up at a 2x final concentration required. 
100|xl aliquots were then added to the respective wells on the 96-well plate already 
containing cells plus medium. The concentration of the variables to be tested was thus 
diluted to the required lx  concentration. When all variables were plated out, the plates 
were placed in a C 02 incubator and incubated for the required amount of time for the 
assay. At the end of the assay, plates were taken down as described in section 2.10.2.
2.10.2 End-point for SFM 96-well assays
The end-point assay used was a combination of the Suforhodamine B (SRB) and 
Crystal Violet (CV) Dye Elution assays extensively studied by Dr. Angela Martin (PhD, 
1992).
At the end of the cell growth period, cells were first fixed by layering 50|j1 of 50% TCA 
(Sigma, T-9159) directly on top of the incubation medium, and the plates were 
incubated at 4°C for 2 hours. The wells were then rinsed 5 times with tap water to 
remove solutes, flicked to remove liquid and then allowed to air-dry thoroughly. Cells 
were then stained with 200(il1/ well of sulforhodamine B (0.4% in 1% acetic acid) 
(Sigma, S-9012) for 30 minutes and then rinsed four times in 1% glacial acetic acid and 
allowed to dry. When dry, 200|il/ well of lOmM Tris buffer, pH 10.5 was added. 
Alternatively, it was found to be possible to stain the fixed cells with crystal violet 
(BDH, 42555) (0.25% solution in UHP water). In this case, 200(il of crystal violet 
solution was added to each well and left to stain for 5-10 minutes. The plates were then 
left to dry before being eluted from the plates by adding 100(il of 33% glacial acetic acid 
to each well. The absorbance of both dyes (SRB and CV) was read on an ELISA plate 
reader at dual wavelengths of 570nm and 620nm. (570nm is the wavelength for
maximum absorbance of the dye and 620nm is specific for the absorbance from the 
plastic in the plates themselves).
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For most assays, crystal violet was used because of the shorter incubation times 
required for staining the cells with this dye compared to using SRB.
2.10.3 Subculture assays in SFM
To study the long-term growth of cells in SFM, subculture experiments were required. 
For all cell lines, cells were inoculated into 25cm2 vented flasks at a density of 2 .5x l05 
per flask using 8ml of pre-warmed test medium. CHO-K1 cells were incubated for 4 
days while DLKP and DLKPA were incubated for 7 days. The medium was replaced 
every 2-3 days when required. Cells were then trypsinised as described in Section 
2.7.2. When the cell number was determined, fresh flasks were inoculated with 
2.5x105 cells per flask. This was continued for the length of time required in the assay.
For all subculture assays, cells were inoculated at a density of 2 .5 x l0 5 per flask. Cell 
counts were carried out once a week for DLKP and all its derivatives (DLKP-I, DLKP- 
M, DLKP-SQ, DLKPA) with feeding every 3-4 days when necessary. CHO-K1 were 
passaged every 4 days. The extent of proliferation of these cells under SFM conditions 
was determined by haemocytometer counting (Section 2.5.3).
2.10.4 Subculture ‘crisis’ assays
Cells were grown for three passages in serum-free medium as described in Section
2.10.3. Cells were reseeded in the fourth subculture at 2.5x10s cells per flask with 
medium supplemented with one of the factors described in Table 2.10.1. Cells were 
trypsinised every 4 days and counted to determine the extent of proliferation achieved 
with supplemented factors.
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Table 2.10.1 Compounds tested in ‘crisis assays’
Component tested Concentration used Source
SF Briclone 5% v/v NCTCC
CM CHO-K1 5% v/v Section 2.11.1
LDL 100|lg/ml Sigma, L-2139
BME vitamins (lOOx) lx Gibco, 21040-035
Pluronic F68 20fig/ml Sigma, P-1300
DNase I 100^g/ml Boehringer Mannheim, 1284932
Fibronectin 10|i.g/ml Sigma, F-2006
2.10.5 Subculture Calcium assays
The low calcium medium used in these subculture assays was composed of Ham’s F12: 
MEM.S (Gibco, 31380-025) (1:1) supplemented with the components listed in Table
2.7.1. A ‘home-made’ calcium-free was made using commercially available 
supplements listed in Table 2.10.2. This medium was then supplemented with CaCl2 to 
required concentrations for subculture assays.
Table 2.10.2 ‘Hom e-m ade’ basal medium formulation
Component of medium Volume required for 100ml 
of medium
Source
Earle’s balanced salts solution* 
(lOx)
10ml Gibco, 14165-021
MEM vitamins (lOOx) 1ml Gibco, 11120-037
MEM amino acids (50x) 2m 1 Gibco, 11130-036
Phenol red (0.5%) 0.2ml Sigma, P-0290
N aH C 03(2.2g/100ml) 10ml
M gCl2 (2g/100ml) 1ml
ultrapure water 75ml
* Earle’s salts without Ca, Mg and phenol red
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Subculture assays were carried out using these media supplemented with SF 
supplements as outlined in Table 2.7.1.
2.11 TOXICITY ASSAY
Due to the nature of the compounds tested in the assays, precautions were taken to limit 
the risks involved in their handling and disposal. All work involving toxic compounds 
was carried out in a Gelman “Cytoguard” laminar air flow cabinet (CG Series). All 
chemotherapeutic drugs were stored and disposed of as described in table 2.11.1.
Table 2.11.1 Chemotherapeutic drugs used in study
Cytotoxic drug Supplier Inactivation Storage
Adriamycin Farmitalia Hyperchlorite inactivation 
followed by autoclaving
Store at 4°C
Vincristine David Bull Laboratories 
Ltd.
Autoclave Store at 4°C
V P-16 Bristol Myers 
Pharmaceuticals
Incineration Store at RT
Cells were harvested from a flask in the exponential phase of growth. A cell 
suspension of 3x1 O' cells/ml was made up in growth medium and lOOfxl added into 96- 
well plates and allowed to attach overnight at 37 ^ , 5% C 02. Drug dilutions (including 
a control with no drug) were prepared at 2x their final concentration in growth medium 
and 100|il added to each well in replicas of eight, giving final a concentration of lx  
drug. The plates were incubated for 7 days at 37"C and 5% COz or until the control 
wells reached 80% confluency.
Cell survival was determined using the end-point assay developed for SF culture of 
DLKP and DLKPA as described in Section 2.10.2. The concentration of drug which 
causes 50% cell kill (the IC50 value) was calculated.
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2.12 CONDITIONED MEDIUM COLLECTION AND FRACTIONATION
Medium in which cells have been growing can be termed ‘conditioned medium’ (CM). 
This medium contains waste products of metabolism as well as many growth factors 
and other secretory products. CM may be growth stimulatory to cell lines. The CM 
collected were SF Briclone and from CHO-K1 cells.
2.12.1 Collection of Conditioned Medium
Cells were harvested from 75cm2 flasks and seeded into tissue culture roller bottles 
(Falcon, 3027) at seeded at a concentration of 2xl06 per 100ml of serum-supplemented 
growth medium. The roller bottles were incubated at 37°C on a roller bottle apparatus 
which rotated the bottles at approximately 0.25rpm for the first 24 hours to allow cell 
attachment and at 0.75rpm after this time. The medium was replenished every 2-3 days 
until the cells were approximately 50% confluent. The spent medium was then 
removed, the cells rinsed twice with 100ml of sterile PBS A and then incubated for 1 
hour with PBS A to remove as much of residual serum components as possible. The 
PBS A was then removed and replaced with basal medium supplemented with 2mM L- 
glutamine. The roller bottles were incubated overnight.
This medium was then removed and replaced with fresh basal medium supplemented 
with L-glutamine and the cells were allowed to condition this medium for 48 hours. 
This medium was collected, centrifuged at lOOOrpm for 10 minutes to remove any cell 
debris and stored at 4°C. A fresh 100ml volume of basal medium was added to the 
cells and incubated for a further 48 hours. After this time, the medium was harvested 
as described before. The two fractions were combined and stored at -20°C until 
assayed.
2.12.2 Ultrafiltration of SF Briclone
The Diafflo membrane used in the study was a YM3 36mm (AN 06177A) which had a 
molecular weight cut-off of 3kDa. The membrane was pre-treated by soaking for 
approximately 1 hour in about 250ml of UHP water, with 3 changes of water in that 
time, to remove residual sodium azide which was used as a preservative. The 
membrane was then placed in an ultrafiltration cell (Amicon) and rinsed again by 
running 100ml of PBS A or UHP water through the system three times. 150ml of SF 
Briclone was run through the system. Pressure of 40psi was provided by N2 gas and a 
flowrate of 17ml per 15 minutes was used. When 135ml of fíltrate was collected, the
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gas was turned off and the retentate was poured into a universal (15ml of lOx retentate). 
The fractions were stored at 4°C until required.
At the end of the procedure, the membrane was rinsed with UHP water or PBS A, 
removed form the cell and soaked in water for a further 30 minutes. The membranes 
were then stored in a solution of 1.5M NaCl at 4°C until required again.
2.13 DIFFERENTIATION STUDIES
Differentiation studies were carried out using 5-bromodeoxyuridine (BrdU) (Sigma, 
B5002). BrdU powder was reconstituted in UHP water to a stock concentration of 
lOmM and the resultant solution was filter sterilised through a sterile 0.22frm filter, 
aliquoted into sterile Eppendorfs and stored at -20°C for up to 1 year.
2.13.1 Differentiation assays - Adherent cells
In all experiments, cells were plated onto 6-well plates (Costar, 3516) at densities of 
5xl03 per well for DLKP, DLKPA, A549 and lxlO 4 per well for SKLU-1. 1.5ml of 
medium was sufficient for each well. The cells were allowed to attach and form 
colonies by incubating at 37°C, 5% C 02 for 48 hours. The plates were covered with 
parafilm to prevent contamination. The medium was then removed and replaced with 
BrdU-containing medium at the required concentrations, usually from O-IO^M BrdU. 
Plates were wrapped in aluminium foil because of the light-sensitive nature of BrdU 
and incubated for up to 7 days. Medium was replaced every 2-3 days over the course 
of the assay. All waste medium was retained for disposal by incineration.
At the end of the assay, medium was removed from the cells, the plates were rinsed 3 
times with PBS A and the cells were fixed with methanol as described in Section
2.14.1. Immunocytochemistry was the carried out using a range of antibodies as 
described in Section 2.14.4.
2.13.2 Differentiation assays - Suspension cells
Suspension culture cells, HL60 and H82, were plated into 6-well plates at densities of 
5x l03 per well. In order to change the medium in these plates, it was necessary to 
transfer the cells plus medium to sterile universals and centrifuge at lOOOrpm for 5 
minutes to pellet the cells. The cells were then resuspended in 1.5ml of BrdU- 
containing medium and returned to the wells.
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At the end of the assay, the cells in suspension were used to prepare cytospins as 
described in Section 2.14.2. Any cells which had adhered during the course of the 7 
day treatment (H82 cells) were fixed as described in Section 2.14.1.
2.14 IMMUNOCYTOCHEMISTRY
2.14.1 Fixation of cells
This procedure was used for all cells whether they were grown on 6-well plates, 
multiwell slides, or cytospins had been prepared from them. For fixation, cells were 
rinsed 3 times with PBS A and then incubated at -20°C for 7 minutes using ice-cold 
methanol. The methanol was the removed from the cells and the cells were allowed to 
air-dry for a number of hours or overnight and then stored at -20°C until required. This 
method appeared to be successful for all antibodies investigated during the course of the 
study.
2.14.2 Preparation of cytospins
Suspension culture cells were harvested, centrifuged at lOOOrpm for 5 minutes and 
resuspended in PBS A. The cells were rinsed a further 2 times in PBS A and then were 
resuspended in cytospin buffer (components described in Table 2.13.1) to a final 
density of lx l0 6 cells/ml. The cell were spun onto clean glass slides at 400rpm for 4 
minutes using a cytocentrifuge. The cells were then allowed to air-dry before being 
fixed as described in Section 2.14.1.
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Table 2.14.1 Components of cytospin buffer
Component g/1
NaCl 8.00
KC1 0.40
CaCl2 0.14
M gCl2 0.10
M gSO, 0.10
Na2H P 04 0.06
k h 2p o 4 0.06
N aH C 03 0.35
Glucose 1.00
Ultrapure water 1000ml
2.14.3 Preparation of multiwell slides
Multiwell glass slides (Lennox, L10C7E) were used when the cells to be examined 
were adherent and they were used in non-differentiation assays. These slides were 
used because they enabled cells to be cultured on the slides in situ, allowing cell 
morphology and antigen localisation to be examined after the immunocytochemical 
procedure. This can sometimes be lost during the harsh preparation of cytospins, 
where some cell surface antigens may be lost during trypsinisation. These slides 
contained 10 wells, each of which could be analysed with a separate antibody.
The slides were prepared by soaking in RBS detergent for 1 hour. They were then 
scrubbed and rinsed thoroughly with UHP water and wrapped in aluminium foil. The 
slides were then sterilised by baking for at least 2 hours at 180°C.
Cells were harvested and seeded onto the sterilised slides at a density of lxlO 4 per 50|il 
per well. Each slide was then placed in a sterile Petri dish which was sealed with 
parafilm and incubated in the C 02 incubator for 24-48 hours until the confluency 
required was achieved. The cells were then fixed in methanol as described in Section
2.14.1.
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2.14.4 Immunocytochemical procedure
The avidin-biotin complex (ABC) immunoperoxidase technique combined with the 
diaminobenzidine (DAB) visualisation procedure was used in all immunocytochemistry 
experiments. The ABC method involves application of a biotin-labelled secondary 
antibody to cells probed with a primary antibody, followed by the addition of avidin- 
biotin-peroxidase complex which results in a high staining intensity due to the 
formation of an avidin-biotin lattice which contains peroxidase molecules. The 
peroxidase enzyme then reacts with a DAB solution to give an insoluble, brown- 
coloured precipitate. The formation of this brown precipitate-coloured precipitate is 
indicative of primary antibody reactivity.
The procedure used is as follows:
Cell preparations (cytospins, multiwell slides, 6-well tissue culture plates) which had 
been previously fixed in methanol and frozen at -20°C were allowed to thaw and 
equilibrate at room temperature. A grease pen (DAKO, S2002) was used to encircle 
cells on cytospins, multiwell slides and in tissue culture plates to contain the various 
solutions involved. The cells were incubated for 5 minutes with a 3% H20 2 solution to 
quench any endogenous peroxidase activity that may be present in the cells and could 
lead to false positive results. The cells were then rinsed with UHP water and placed in 
Tris-buffered saline (TBS) (0.05M Tris/HCl, 0.15M NaCl, pH 7.6) for 5 minutes. 
The slides were then incubated for 20 minutes at room temperature (RT) with normal 
rabbit serum (DAKO, X092) diluted 1:5 in TBS to block non-specific binding. This 
was then removed and 25-30|il of optimally-diluted primary antibody was placed on the 
cells. The slides and tissue-culture plates were placed on a tray containing moistened 
tissue paper and incubated at 37°C for 2 hours. The primary antibodies used in the 
study are listed in Table 2.14.2. The slides were then rinsed in TBS/ 0.1% Tween 
(Sigma, P-1379), x3 in 15 min, and then incubated for 30 min with biotinylated rabbit 
anti-mouse immunoglobulins (DAKO, E354) diluted 1:300 in TBS. The slides were 
rinsed as before and incubated with strepAB Complex/ Horse Radish Peroxidase (HRP) 
(DAKO, K377) for 30 min at RT, after they were rinsed x3 in TBS/ 0.1% Tween in 15 
min. The cells were then incubated with a DAB solution (DAKO, S3000) for 10-15 
min. Excess DAB solution was then rinsed off with UHP water and the slides were 
counterstained with a 3% methyl green (Sigma, M-5015). Slides were then mounted 
using a commercial mounting solution (DAKO, S3023).
80
Table 2.14.2 Primary antibodies used in immunocytochemical studies
Antibody Dilution/
Concentration
Supplier Catalogue no.
pan-keratin 1/100 Sigma C-2562
Keratin 8 1/200 Sigma C-5301
Keratin 18 1/800 Sigma C8541
Keratin 19 1/50 Sigma C-6930
ESA 1/300 Sigma E-6011
Desmosomal protein 1/400 Sigma D-1286
a-transglutaminase 1/20 Biogenesis 5560-6006
Neurofilaments 1/20 Immunotech 0168
NCAM 1/10 DAKO M799
5-HT serotonin 1/5 DAKO M758
EGF-R 1/5 DAKO M886
a ( integrin 1/3 Serotec MCA1133
a 2 integrin 1/50 Serotec MCA1186
a 3 integrin 1/100 Serotec MCA794
a 4 integrin 1/50 Serotec MCA697
a 5 integrin 1/100 Serotec MCA 1187
a 6 integrin 1/100 Serotec MCA956
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2.15 PROTEIN INHIBITOR EXPERIMENTS
Cycloheximide (Sigma, C-7698) and Actinomycin D (Boehringer Mannheim, 102 008) 
protein synthesis inhibitors were used in these assays. A lOmg/ml stock solution of 
cycloheximide was prepared in PBS A, filter-sterilised, aliquoted and stored at -20°C 
until required. A 5mg/ml stock solution of actinomycin D was prepared by dissolving 
the powder in cold, ultrapure water and leaving it to dissolve on ice for 30 minutes. 
The solution was then filter-sterilised and stored in the dark at -20°C because of its 
light-sensitive nature.
Cells were seeded into 6-well plates as described in Section 2.12.1. Cycloheximide 
and actinomycin D was added to the cells at a number of different concentrations for 
various time periods as outlined in more detail in Section 3.4.4. After treatment, cells 
were fixed with methanol before immunocytochemical analysis was performed.
2.16 WESTERN BLOT ANALYSIS
Proteins for western blot analysis were separated by SDS-polyacylamide gel 
electrophoresis (SDS-PAGE).
2.16.1 Sample preparation
Cells were inoculated into 75cm2 flasks at a density of lxlO5 cells per flask and allowed 
to attach and form colonies. BrdU-containing medium, at concentrations from O-IOjiM, 
was then added to the cells after 48 hours. Cells were treated with BrdU for up to 7 
days, with the medium replaced every 2-3 days. The cells were then harvested by 
trypsinisation, washed three times in cold, sterile PBS A, pelleted and stored at -80°C 
until required.
Cells were then lysed in buffer containing 62.5mM Tris-HCl pH 6.8, 12.5% glycerol, 
2% Nonidet P40 (Sigma, N6507), 2.5mM phenylmethylsulphonyl fluoride (PMSF) 
(Sigma, P7626), 1.25mM EDTA, 12.5p,g/ml leupeptin (Sigma, L2884), 116(jg/ml 
aprotinin (Sigma, A1153) for 30 min on ice. The extracts were used immediately for 
western blot analysis.
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2.16.2 Gel electrophoresis
Resolving and stacking gels were prepared as outlined in Table 2.16.1 and poured into 
clean 10cm x 8cm gel cassettes which consisted of 1 glass and 1 aluminium plate, 
separated by 0.75cm plastic spacers. The resolving gel was poured first and allowed to 
set. The stacking gel was then poured and a comb was placed into the stacking gel in 
order to create wells for sample loading. Once set, the gels could be used immediately 
or wrapped in aluminium foil and stored at 4°C for 24 hours.
Before samples were loaded onto the stacking gels, equal cell numbers (usually 2x l04 
cells per lane) were further lysed in 2x loading buffer (2.5ml 1.25M-Tris/HCl, l.Og 
SDS, 5.8ml glycerol and 0.1% bromophenol blue (Sigma, B8026) made up to 25ml 
with distilled water). The samples were then loaded including 6(il of molecular weight 
colour protein markers (Sigma, C-3437). The gels were run at 250V, 45mA for 
approximately 1.5 hours. When the bromophenol blue dye front was seen to have 
reached the end of the gels, electrophoresis was stopped.
Table 2.16.1 Preparation of electrophoresis gels
Components Resolving gel 
(7.5%)
Resolving gel
(12%)
Stacking gel
Acrylamide stock* 3.8ml 5.25ml 0.8ml
Ultrapure water 8.0ml 6.45ml 3.6ml
1.875M-Tris/HCl, pH 8.8 3.0ml 3.0ml -
1.25M-Tris/HCl, pH 6.8 - - 0.5m l
10% SDS (Sigma, L-4509) 150|ol 150(0.1 50(0.1
10% Ammonium persulphate 
(Sigma, A-1433)
60(xl 60(0,1 17(01
TEMED 
(Sigma, T-8133)
1 Opl 10(0.1 6(il
* Aciylamide stock = 2 9 .lg  acrylamide (Sigma, A-8887) and 0.9g NN’-methylene bis-acrylamide 
(Sigma, N-7256) made up to 100ml with distilled water
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2.16.3 Western blotting
Following electrophoresis, the acrylamide gels were equilibrated in transfer buffer 
(25mM Tris, 192mM glycine (Sigma, G-7126) pH 8.3-8.5 without adjusting) for 20 
min. Protein in gels were transferred onto Hybond ECL nitrocellulose membranes 
(Amersham, RPN 2020D) by semi-dry electroblotting. Five sheets of Whatman 3mm 
filter paper (Whatman, 1001824) were soaked in transfer buffer and placed on the 
cathode plate of a semi-dry blotting apparatus. Excess air was removed from between 
the filters by moving a glass pipette over the filter paper. Nitrocellulose, cut to the same 
size of the gel, was soaked in transfer buffer and placed over the filter paper, making 
sure there were no air bubbles. The acrylamide gel was placed over the nitrocellulose 
and five more sheets of presoaked filter paper were placed on top of the gel. Excess air 
was again removed by rolling the pipette over the filter paper. The proteins were 
transferred from the gel to the nitrocellulose at a current of 34mA at 15 V for 23 min.
All incubation steps from now on, including the blocking step, were carried out on a 
revolving apparatus to ensure even exposure of the nitrocellulose blot to all reagents.
The nitrocellulose membranes were blocked for 2 hours at room temperature with fresh 
filtered 5% non-fat dried milk (Cadburys; Marvel skimmed milk) in TBS/ 0.1% Tween. 
pH 7.5.
After blocking, the membranes were rinsed with PBS A and incubated with primary 
antibody (keratin 19 diluted 1:150 in TBS or ESA diluted 1:300 in TBS) overnight at 
4°C. The primary antibody was removed and the membranes rinsed 3 times with TBS/ 
0.1% Tween. The membranes were then washed for 15 min, and then twice for 5 mins 
in TBS/ Tween. Bound antibody was detected using enhanced chemiluminescence 
(ECL).
2.16.4 Enhanced chemiluminescence detection
Protein bands were developed using the Enhanced Chemiluminescence Kit (ECL) 
(Amersham, RPN2109) according to the manufacturer’s instructions.
Secondary antibody (1/1,000 dilution of anti-mouse IgG peroxidase conjugate (Sigma, 
A-6782) in TBS) was added for 1 hour. The secondary antibody was removed and the 
membranes were washed as before. A sheet of parafilm was flattened over a smooth 
surface, e.g. a glass plate, making sure all air bubbles were removed. The membrane
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was then placed on the parafilm, and excess fluid removed. 1.5ml of ECL detection 
reagent 1 and 1.5ml of reagent 2 were mixed and covered over the membrane. Charges 
on the parafilm ensured the fluid stayed on the membrane. The reagent was removed 
after one minute and the membrane wrapped in cling film. The membrane was exposed 
to autoradiographic film (Kodak; X-OMAT S, 500 9907) in an autoradiographic 
cassette for various times, depending on the signal. The autoradiographic film was then 
developed.
The exposed film was developed for 5min in developer (Kodak, LX24), diluted 1:6.5 
in water. The film was briefly immersed in water and transferred to a Fixer solution 
(Kodak, FX-40) diluted 1:5 in water, for 5min. The film was transferred to water for 5 
min and then air-dried.
2.17 IMMUNOPRECIPITATION
Immunoprecipitation was carried out using a cellular labelling and immunoprecipitation 
kit (Boehringer Mannheim, 1647652) according to manufacturer’s instruction.
2.17.1 Sample preparation
Cells were treated with BrdU as described in Section 2.15.1 and harvested in a similar 
manner, pelleted and stored at -80°C until required.
Pre-cooled lysis buffer was added to the cells and the cells were sonicated (10 pulses) 
on ice and incubated at 4°C for 30min. The lysate was then centrifuged at 13000rpm 
for 10 min at 4°C. The supernatant was transferred to a fresh Eppendorf and labelled 
with 25|il of biotin-7-NHS stock solution for 15 min at RT, as described in the manual 
accompanying the kit. The reaction was stopped by adding 50(xl of stop solution 
(50mM NH4C1) and incubated for 15 min at 4°C.
2.17.2 Sample immunoprecipitation
The lysates were pre-cleared using 50(xl of Protein A or Protein B beads per ml of 
sample for 3 hours to completely remove proteins that may bind to the agarose beads 
and result in non-specific binding. The samples were then centrifuged at 13000rpm for 
20 seconds to pellet the beads. The supernatants were collected and divided into two 
aliquots. A control irrelevant monoclonal antibody (Ab to EGF-R) was added to one of 
the samples while the antibody to be tested was added to the second aliquot (see Table
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2.17.1 for volume of antibody added). Samples were then rocked at room temperature 
for 1 hour. 50|il of protein A (Boehringer Mannheim, 1719408) or protein G 
(Boehringer Mannheim, 1719416) agarose beads, depending on the binding specificity 
of the Ab to be tested (see Table 2.17.2), were then added to the samples. The 
precipitated protein was then allowed to bind to the beads by incubating the mixture on 
a belly-dancer overnight at 4°C.
The complexes were then collected by brief centrifugation at 13000rpm for 20 seconds. 
The supernatant was carefully removed. The protein-bead complexes were washed 
with a number of different stringency buffers. 1ml of wash buffer 1 (50mM Tris-HCl 
pH 7.5, 150mM NaCl, 0.1% NP-40, 100|ig/ml PMSF, l^g/ml each of leupeptin and 
aprotonin) was added to the samples and rocked for 20 min. The complex was then 
pelleted by centrifugation as before and washed with 1ml of wash buffer 2 (50mM Tris- 
HCl pH 7.5, 150mM NaCl, 0.1% NP-40) in a similar manner to the first wash. A 
third wash was carried out using a buffer containing 50mM Tris-HCl, 500mM NaCl 
and 0.1% NP40.
Table 2.17.1 Volume of antibody required to precipitate proteins
Antibody tested Volume of antibody used
Keratin 19 10|il per ml of sample
0^ integrin 50(0.1 per ml of sample
a 2 integrin' 20pl per ml of sample
'N ote: Antibodies used were the same as those used for immunocytochemistry except for the a 2 
integrin where a separate antibody had to be used (Serotec, MCA2026) because of the unsuitability of 
the first antibody for immunoblotting and immunoprécipitation techniques
Table 2.17.2 Agarose beads chosen to precipitate the required proteins
Antibody used Isotype of Ab Avidity to 
Protein-A
Avidity to 
Protein-G
Beads chosen
Keratin 19 mouse IgG2a ++++ ++++ Protein-A
a , integrin mouse IgG l + ++++ Protein-G
a! integrin mouse IgG l + ++++ Protein-G
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After the final wash, 2x loading buffer was added to the pellets to give a final cell 
concentration of 2x105 cells per lOjxl. The proteins were then denatured by heating to 
100°C for 3 min. The agarose beads were removed by centrifugation at 13000rpm for 
20 seconds at room temperature in a microfuge and the supernatant was transferred to a 
fresh Eppendorf. Equal cell numbers were loaded on the gels, i.e 2 x l0 5 cells per lane. 
The keratin 19 precipitaed proteins were run on 12.5% polyacrylamide gels while the a, 
and a2 precipitated proteins were run on 7.5% gels as described in Section 2.16.2.
The proteins were then transferred to nitrocellulose membrane as described previously 
in Section 2.16.3 and were blocked for 3-4 hours at room temperature in 5% Marvel in 
TBS/ 0.1% Tween. The membranes were then rinsed briefly with PBS A and 
incubated for 1 hour in anti-biotin secondary antibody (monoclonal anti-biotin mouse 
IgG (Sigma, A0185) diluted 1:4000 in TBS). The precipitated proteins were then 
detected using ECL as described in Section 2.16.4.
2.18 EXTRACELLULAR MATRIX ADHERENCE ASSAYS
2.18.1 Reconstitution of ECM proteins
Collagen Type IV (Sigma, C-5533), fibronectin (Sigma, F-2006) and laminin (Sigma, 
L-2020) were reconstituted in PBS A to a stock concentration of 500fig/ml. Stocks 
were aliquoted into sterile Eppendorf s. Fibronectin and collagen stocks were stored at - 
20°C while laminin stocks were stored at -80°C. ECM gel (Sigma, E1270) was 
aliquoted and stored at -20°C until use. This gel undergoes thermally activated 
polymerisation when brought to 20-40°C to form a reconstituted basement membrane.
2.18.2 Coating of plates
Each of the ECM proteins, collagen, fibronectin and laminin, was diluted to 25(ig/ml 
with PBS A and 250|al aliquots were placed into wells of a 24-well plate. The plates 
were tapped gently to ensure that the base of each well was completely covered with 
solution. The plates were then incubated at 4°C overnight. The ECM solutions were 
then removed from the wells, rinsed twice with sterile PBS A and 0.5ml of a sterile 
0.1% BSA/ PBS A solution was dispensed into each well to reduce non-specific 
binding. The plates were incubated at 37°C for 20 min and then rinsed twice again with 
PBS A.
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EHS is a liquid between 2-8°C so aliquots of the gel were allowed to thaw in the fridge 
overnight before use. The EHS was then diluted 1:2 with cold DMEM and 250(il 
aliquots were quickly added to the wells of a 24-well plate. The gel was allowed to set 
atRT for 5-10 minutes. When the gel was completely set, the wells were rinsed twice 
with PBS A, blocked for 20 min with BSA as described above for the other ECM 
proteins.
2.18.3 Adherence assay
Cells were set up in 75cm2 flasks and treated with BrdU at 0 and 10(iM for 7 days as 
described in Section 2.16.1. The cells were harvested and resuspended in basal Ham’s 
FI2 medium. The cells were then plated at a concentration of 2 .5 x l0 4 per well in 
triplicate and incubated at 37°C for 15, 30 and 60 minutes. Control wells were those 
which had been coated but contained no cells. At each time point for the wells coated 
with fibronectin, collagen and laminin, the medium was removed from the wells and 
rinsed gently with PBS A. The cells were then stained with 0.5ml of 0.25% crystal 
violet dye for 10 min. The plates were then rinsed and allowed to dry. The dye was 
eluted with 200pl of 33% glacial acetic acid and LOOjj.1 aliquots were transferred to a 96- 
well plate and the absorbance was read on an ELISA reader at 570 and 620nm.
The extent of attachment of cells to EHS was determined using the MTT assay because 
of problems encountered with non-specific staining of the crystal violet dye to proteins 
of the EHS gel.
2.18.4 MTT assay
A Boehringer Mannheim cell proliferation kit (Cat no. I 465 007) was used in these 
experiments according to manufacturer’s instructions.
Unattached cells were carefully removed and discarded from the wells. 0.25ml of basal 
Ham’s F12 medium was then added to each well. 25fxl of MTT labelling reagent was 
added to each well in subdued light and incubated at 37°C for 4 hours. 250|il of 
solubilisation solution was then added to each well and left in incubator overnight at 
37°C. The samples were then read on the spectrophotometer at 575nm. Medium 
without cells and treated in this manner was used as the blank and negative control.
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2.19 ADHESION BLOCKADE ASSAY
Wells of a 24-well plate were precoated with 5|ig/ml of Type IV collagen for 1 hour at 
4°C. The wells were then washed twice with sterile PBS A and blocked with 0.1% 
BSA/ PBS A for 45 min at 37°C. Cells were treated with BrdU and harvested as 
described in Section 2.16.1. They were then resuspended in Ham’s F12 basal medium 
to a concentration of 4x l04 per ml. The cells were incubated with 10(ig/ml of an anti-a, 
integrin antibody (Upstate Biotech, 05246) for 30 min at 4°C. Control samples were 
cells incubated at 4°C without addition of antibody. The cells were then plated onto the 
wells at 2xl04 cells per well and incubated for 15 and 30 min at 37°C. The MTT assay 
was used to assess the attachment of the cells to collagen with and without Ab 
treatment, as outlined in Section 2.18.4.
2.20 RNA EXTRACTION
For all procedures using RNA, most glassware, solutions and plastics were treated with 
0.1% diethyl pyrocarbonate (DEPC) before use which is a strong inhibitor of RNases.
RNA was extracted from the cells as follows:
Cells were seeded into 175cm2 flasks (Nunc, I-56502A) at a density of approximately 
2xl06 per flask and allowed to attach and form colonies for 48-72 hours at 37°C. The 
flasks were then treated with BrdU for time periods of 0, 15min, lhr, 24hrs and 5 
days. The cells were trypsinised and the pellet was washed once with PBS A. The 
cells were pelletted and lysed using 1ml of TRI REAGENT™ (Sigma, T-9424). The 
samples were allowed to stand for 5 min at RT to allow complete dissociation of 
nucleoprotein complexes. 0.2ml of chlorofom was then added per ml of TRI 
REAGENT™ used and the sample was shaken vigorously for 15 sec and allowed to 
stand for 15 min at RT. The sample was then centrifuged at 13000rpm for 15 min at 
4°C. This step separated the mixture into 3 phases; the RNA was contained in the 
colourless upper aqueous layer. This layer was then transferred to a new Eppendorf 
and 0.5ml of isopropanol was added. The sample was mixed and allowed to stand at 
RT for 10 min before being centrifuged at 13000rpm for 10 min at 4°C. The RNA 
formed a precipitate at the bottom of the tube. The supernatant was removed and the 
pellet was washed with 1ml of 75% ethanol and centrifuged at 4°C for 5 min at 
13000rpm. The supernatant was removed and the pellet was briefly allowed to air-dry. 
20-30pl of DEP-C water was then added to the RNA to resuspend the pellet.
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RNA concentration was calculated by determining its OD at 260nm and 280nm and 
using the following formula:-
OD260nm x Dilution factor x 40 = (ig/ml RNA
The purity of the RNA extraction was calculated by determining its OD at 260nm and 
280nm. An A260nm : A280nm ratio of 2 is indicative of pure RNA. Only those samples 
with ratios between 1.7 and 2.1 were used.
2.21 REVERSE TRANSCRIPTASE REACTION
Reverse transcriptase (RT) reactions were carried out in laminar flow cabinets using 
micropipettes which were specifically allocated to this work.
cDNA was formed using the following procedure:- 
lp.1 oligo (dT)12"18 primers (1 ng/jrl) (Promega; Cl 101) 
l|ul total RNA (lfxg/jxl) (see 2.20)
3 1^ water
were mixed in a 0.5ml Eppendorf (Eppendorf, 0030 121.023), heated to 70°C for 10
min and then chilled on ice. To this, the following were added:-
4jil of a 5x buffer (250mM-Tris/HCl pH 8.3, 375mM-KCl and 15mM-MgCl2)
2\il DTT (lOOmM) (Gibco; 510-8025 SA) 
lfxl RNasin (40U/|xl) (Promega; N2511) 
lul dNTPs (lOmM of each dNTP)
6|il water
I |il Moloney murine leukaemia virus-reverse transcriptase (MMLV-RT) (40,000U/p,l) 
(Gibco; 510-8025 SA).
The solutions were mixed and the RT reaction was carried out by incubating the 
Eppendorfs at 37°C for 1 hour. The MMLV-RT enzyme was then inactivated by 
heating to 95°C for 2 min. The cDNA was stored at -20°C until required for use in PCR 
reactions as outlined in Section 2.20.
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2.22 POLYMERASE CHAIN REACTION
A standardised polymerase chain reaction (PCR) procedure was followed in this study. 
The Eppendorf tubes used (Eppendorf, 0030 121 023) and the sterile water were 
DEPC-treated. All reagents had been aliquoted and were stored at -20°C and all 
reactions were carried out in a laminar flow cabinet.
Each PCR tube contained the following:- 
24.5(xl water
5nl lOx buffer* (lOOmM-Tris/HCl, pH 9.0, 50mM-KCl, 1% Triton X-100)
3|xl 25mM-MgCl2*
8fil dNTPs (1.25mM each of dATP, dCTP, dGTP and dTTP) (Promega; U1240) 
l|xl each of first and second strand target primers (250ng/ml) (keratin 19 - Table 2.22.1) 
lp.1 each of first and second strand endogenous control primer (250ng/ml) (P-actin)
0.5pl of 5U/(il Taq DNA polymerase enzyme*
5pJ cDNA 
‘(Promega; N1862)
A drop of autoclaved mineral oil was placed in each reaction tube to prevent evaporation 
and the DNA was amplified by PCR as follows:
95°C for 1.5 min - to denature double-stranded DNA 
30 cycles: 95°C for 1.5 min. - denature
55°C for 1 min - anneal 
72°C for 3 min. - extend 
72°C for 7 min. - extend 
The reaction tubes were then stored at 4°C until analysed by gel electrophoresis as 
described in Section 2.23.
Table 2.22.1 Primer sequences for PCR amplification of keratin 19 mRNA
Keratin 19 Primer sequence
Sense primer 
Anti-sense primer
GCGGGACAAGATTCTTGGTG
CTTCAGGCCTTCGATCTGCAT
as published Burchill et al. (1995)
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2.23 ELECTROPHORESIS OF PCR PRODUCTS
A 3% agarose gel (NuSieve, GTG) was prepared in TBE buffer (5.4g Tris, 2.75g boric 
acid, 2ml 0.5M-EDTA pH 8.0 in 500ml water) and melted in a microwave oven. After 
allowing to cool, 0.003% of a lOmg/ml ethidium bromide solution was added to the gel 
which was then poured into an electrophoresis apparatus (BioRad). Combs were 
placed in the gel to form wells and the gel was allowed to set.
lOfil loading buffer (50% glycerol, lmg/ml xylene cyanol, lmg/ml bromophenol blue, 
ImM EDTA) was added to each 50|il PCR sample and 20|xl was run on the gel at 80- 
90mV for approximately 2 hours. When the dye front was seen to have migrated the 
required distance, the gel was removed from the apparatus and examined on a 
transilluminator and photographed.
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2.24 STATISTICAL ANALYSIS
All data was expressed as the mean of the number of replicates being analysed ± 
standard deviation (sd).
For all CHO-K1 suspension culture growth curves, see Section 3.1.1, all samples were 
taken in duplicate and the readings shown on the graphs are the average of two 
readings. The standard deviations, error bars, were not shown on the graphs. 
However, in all experiments the standard deviation was always less than 10%.
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3.0 RESULTS
3.1 GROWTH OF CHO-K1 CELLS IN SERUM-FREE MEDIUM
Many serum-free media have been cited in the literature that are capable of supporting 
the growth of CHO-K1 cells. Ham’s F12 medium was originally developed for the 
clonal growth of CHO cells in defined medium (Ham, 1965). In these studies, a 
modified Ham’s F12 serum-free medium developed by Mendiaz et al. (1986) was used. 
This SFM was extensively investigated (Keenan, 1994) for the growth of CHO-K1 
cells under various monolayer conditions.
In this thesis, the SFM was assessed for the growth of CHO-K1 cells in suspension 
culture. Investigations were also carried out to try and extend the subcultivation times 
of CHO-K1 cells. Keenan (1994) found that the modified SFM developed by Mendiaz 
et al. was not capable of supporting long-term growth of the cells, beyond on average 4 
to 6 passages.
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3.1.1 Growth in serum-free suspension culture
The serum-free medium used in these studies consisted of basal Ham’s F12 
supplemented with 5fig/ml transferrin, 10|ig/ml insulin, 0.3|iM linoleic acid, 6x10 2jxM  
CaCl2, lxlO'2|iM NEAA, 3x102[xM Na2S e 0 3, 5(xM FeS04 plus the trace elements 
outlined in Table 2.7.1. The medium was buffered with 1.176g/l NaHC03 and 
7.55mM HEPES. For all these experiments in spinner flasks, cell counts were taken 
every day and in duplicate where possible. The graphs for these suspension culture 
experiments are presented showing average cell counts without error bars (standard 
deviation was always less than 15%).
3.1.1.1 Growth response of CHO-K1 cells in SFM
A growth curve was set up to compare growth of the cell line in basal medium, serum- 
free and serum-supplemented medium over a 7 day period in monolayer culture. 
Assays were set up in 24-well plates with 4 wells per variable in two separate 
experiments. Cell counts were carried out using a haemocytometer every day for 7 
days where possible. The results are shown in Fig. 3.1.1. The basal medium, Ham's 
F12 was not capable of supporting proliferation of the cell line. The SFM was capable 
of growth of the cell line with an increase from 0.5 to 8 .16xl04 cells/well on day 6. 
Growth in the SSM resulted in an increase from 0.5 to 38 .9xl04 cells/well on day 5. 
These results show that the Ham’s FI2 based SFM is capable of supporting growth of 
CHO-K1 cells over a 7 day period in monolayer culture.
An experiment was then set up to assess the growth of CHO-K1 cells in this SFM in 
suspension culture. Cells in the exponential phase of growth were inoculated at a 
concentration of 2.5x10s cells/ml into 100ml of medium in spinner flasks, either SFM 
or SSM, and aliquots of suspension culture were assessed for cell number and viability 
each day, for 7 days where possible. The following growth curve was obtained, see 
Fig. 3.1.2
It is clearly evident from Fig. 3.1.2 that the SFM does not support growth in 
suspension culture even though the medium supports good growth in monolayer culture 
(see Fig. 3.1.1). As expected, good growth was seen in serum-supplemented culture.
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t ime in days
F i g .  3 . 1 . 1  Growth curve for CHO-K1 cells in basal medium (Basal), serum-supplemented medium 
(SSM) and serum-free medium (H SFM). Results are expressed as average cell number xlO5 per well.
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F i g .  3 . 1 . 2  Growth of CHO-K1 cells in Ham’s F12 serum-free medium (H SFM) and serum
supplemented medium (SSM) in suspension culture. Results are expressed as average cell number xlO5
per ml.
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3 . 1 . 1 . 2  E ffect o f  Pluronic F-68 on growth in SF culture
Pluronic F68 (PF68) is often used in industry as a shear protective agent and also to 
prevent dénaturation of serum proteins during agitation. Bertheussen (1993) suggested 
the use of PF68 for the SF growth of a number of different cell lines. It was then 
decided to use this compound in the H SFM (Ham's F 12 as basal medium) to see if cell 
growth was possible in suspension culture. Bertheussen (1993) used a concentration 
of 20/ig/ml PF68. Good growth of cells was achieved as seen in Fig. 3.1.3.
Addition of Pluronic F68 was found to substantially improve growth over 
unsupplemented SFM. Viability of these cells was also much higher over the course of 
the experiment (results not shown).
0 L 2 3 4 5 6 7 K 9
t ime in days
F i g .  3 . 1 . 3  Growth of CHO-K1 cells in SFM  with and without Pluronic F68 supplementation. 
Results are expressed as average cell number xlO5 per ml.
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Assays (24-well) were then carried out to try to determine a concentration of Pluronic 
F68 (PF68) in monolayer culture that may give maximum stimulation of growth, or at 
least to find a high enough concentration that does not result in growth inhibition. Thus 
maximum protection without growth inhibition could be afforded to the cells.
The first set of assays used concentrations of PF68 between 0 and 2500|ig/ml. In the 
monolayer cultures, 1000 and 2500flg/ml concentrations proved extremely toxic to the 
cells. Experiments were then carried out to determine the concentration between 0 and 
100(ig/ml that resulted in the greatest growth stimulation (Fig. 3.1.4). Growth 
stimulation was seen with a maximum response at 50|ig/ml and decreased growth or 
inhibition beyond this concentration.
F ig . 3 .1 .4  Growth of CHO-K1 cells in different concentrations of Pluronic F68 ranging from 0 to 
100|lg/ml. Results are expressed as average cell number x l0 4per well ±  standard deviation (n=3).
On the basis of these results, it was decided to compare the concentration of PF68 used 
up until now as recommended by Bertheussen, 20(ig/ml, with 50|lg/ml, to see if the 
higher concentration of PF68 affords greater protection to the cells from adverse shear 
forces or actually causes stimualtion of growth. The SFM used was H SFM (Fig. 
3.1.5).
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t ime in days
F i g .  3 . 1 . 5  Growth curve forC H O -K l cells in SFM supplemented with 2 different concentrations of 
Pluronic F68 (H SFM  + 20, supplemented with 20^tg/ml; H SFM  + 50, supplemented with 50ng/ml 
Pluronic F68). Results are expressed as average cell number xlO5 per ml.
It is clearly evident from the growth curve obtained that 50/*g/ml allows for better 
growth of the CHO-K1 cell line over a 7 day growth period. Viability was also higher 
in the 50/ig/ml culture over the 7 day period (results not shown).
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3.1.1.3 Subcultivation in suspension culture
Experiments were then carried out to determine if the SFM plus Pluronic F68 
supplementation was capable of supporting long-term subcultivation of the cell line 
under SF conditions. Fig. 3.1.6 (a-d) show that this was possible with good growth 
obtained for 4 passages over a period of about 5 weeks.
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Fig. 3.1.6(a) Long-term growth o f CHO-K1 cells in H SFM plus 50|J.g/ml pluronic F68. 
Growth curve for passage 1 cells. Results are expressed as average cell number x 10sper ml.
time in days
Fig. 3.1.6(b) Long-term growth of CHO-K1 cells in H SFM plus 50pg/ml pluronic F68.
Growth curve for passage 2 cells. Results are expressed as average cell number x l05per ml.
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Fig. 3.1.6(c) Long-term growth of CHO-K1 cells in H SFM plus 50|lg/m l pluronic F68. 
Growth curve for passage 3 cells. Results are expressed as average cell number xlO5 per ml.
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Fig. 3.1.6(d) Long-term growth of CHO-K1 cells in H SFM plus 50^lg/ml pluronic F68.
Growth curve for passage 4 cells. Results are expressed as average cell number xlO5 per ml.
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3.1.1.4 Plasma membrane fluidity measurements in CHO-K1 cells  
grown in serum-supplemented and serum-free medium
Experiments were undertaken to try and explain the poor growth of CHO-K1 cells in 
serum-free medium compared to serum-supplemented medium. Plasma membrane 
fluidity (PMF) appears to be a critical factor in determining the shear sensitivity of cells. 
An increase in PMF value appears to be associated with an increase in shear sensitivity. 
Studies were carried set up using the CHO-K1 cell line grown in both SFM and SSM 
conditions to determine the PMF values in both stationary and agitation culture so as to 
try and determine if a difference in PMF of the membrane of the SF cells may explain 
the poor growth of CHO-K1 cells in serum-free suspension culture.
3.1.1.4.1 Determination of PMF for CHO-K1 cells cultured in tissue
culture flasks
PMF measurements were carried out as in Section 2.9. The procedure involves 
labelling the cell membrane with a fluorescent probe (TMA-DPH) which is excited with 
a polarised monochromatic light. According to the movement of the probe (which 
depends on PMF) the emitted light will be partially depolarised with respect to the plane 
of polarisation of the excitation light. The resultant fluorescent anistropy is termed the 
rs value. Two parameters are being measured, the local micro viscosity and the 
molecular order which is related to the degree of rotational restriction of the probe in the 
membrane. Using the steady state fluorescence polarisation method the second 
parameter is mostly being measured. A change in molecular order is associated with the 
reciprocal of PMF. Thus an increase in the rs value is indicative of a decrease in PMF 
and a decrease in shear sensitivity.
PMF values for CHO-K1 cells growing in serum-supplemented medium and serum- 
free medium for 3 weeks and 6 months (see Section 3.1.3.3) in tissue culture flasks 
were determined (see Table 3.1.1).
Table 3.1.1 PMF values ±  standard deviation (n=5) for CHO-K1 growing in tissue culture flasks
Cell line Fluorescence Anistropy (rs value)
CHO-K1 SSM 0.219 ± 0.005
CHO-K1 (3 weeks SFM) 0.194 ± 0 .004
CHO-K1 (6 months SFM) 0.197 ±0 .007
SSM - serum-supplemented medium, SFM - serum-free medium
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There is a noted decrease in PMF values for the two serum-free cultures compared to 
the serum-supplemented control cells. If increased PMF correlates with increased shear 
sensitivity then these cells should have an increased PMF and thus a decreased rs value. 
Thus these cells should be more shear sensitive which has been demonstrated in Section
3.1.1.1.
3.1 .1 .4 .2  Fluorescence anistropy measurement of CHO-K1 cells in  
serum-free and serum-supplemented suspension culture
PMF values were then determined for CHO-K1 cells in suspension culture over a three 
day period to try and demonstrate a correlation between cell death in serum-free 
suspension culture and PMF. Serum-free medium was also supplemented with 
pluronic F68 at a concentation of 50(ig/ml to see if the rs value is increased, which may 
explain why cells can survive in serum-free suspension culture with this 
supplementation.
Cells were seeded into Bellco spinner flasks at a concentration of lx l0 5/ml and agitated 
at 50rpm over a 3 day period. Growth curves for viable CHO-K1 in SSM, SFM, SFM 
plus Pluronic F68 supplementation are shown in Fig. 3.1.7. CHO-K1 grew well at 
50rpm in serum-supplemented conditions. However, under serum-free conditions the 
cells began to die off almost immediately. When pluronic F68 was supplemented to the 
SFM the cells remained viable in the 3 day assay period. Fluorescence anistropy values 
were measured at these time points as shown in Fig. 3.1.8.
The rs value is seen to decrease gradually for CHO-K1 cells in serum supplemented 
culture. However, the rs values are significantly higher than for the CHO-K1 serum- 
free cultures possibly indicating that the cells are more shear sensitive in serum-free 
conditions. The rs values were found to be slightly higher for the cells in the PF68 
supplemented SFM which may indicate some sort of protective mechanism by this 
compound. PF68 results in an increase in PMF and a decrease in shear sensitivity.
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t ime in hours
F i g .  3 . 1 . 7  Viable cell number per ml for CHO-K1 cells in serum-supplemented medium (SSM), 
serum-free medium (SFM) and serum-free medium with pluronic F68 supplementation (SFM + PF68)
0 20 -W 60 80
t ime in hours
- O - CHOK1SSM
CHO-K1 SFM
CHO-K1 SFM 1- PF6S
F i g .  3 . 1 . 8  Fluorescence anistropy of CHO-K1 cells in serum-supplemented medium (SSM ), serum- 
free medium (SFM) and serum-free medium supplemented with pluronic F68 (SFM  + PF68)
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3 . 1 . 1 . 5  Growth in S F Microcarrier culture
Microcarriers were introduced into the SFM to see if they allowed for greater protection 
from shear forces than PF68. Using growth curves, microcarriers were compared to 
SSM and SFM plus PF68. Growth was compared over a 7 day period in SSM, SFM, 
SFM plus 50/ig/ml PF68 and SFM plus Cytodex 3 microcamers at a concentration of 
0.3g/100ml (see Section 2.8.5-2.8.7).
SSM
H SFM
— ■— Microcanicr
--o- SFM + PF68
t ime in days
F i g .  3 . 1 . 9  Growth of CHO-K1 cells in serum-free medium (H SFM ), H SFM  supplemented with 
Pluronic F68 (H SFM  + PF68), H SFM  supplemented with microcarriers (Microcarrier) and serum- 
supplemented medium (SSM). Results are expressed as average cell number x 10s per ml.
As can be seen from Fig. 3.1.9, the microcamers protected the cells to a certain extent 
but not as effectively as the serum-free culture plus PF68 supplementation. Again, SF 
culture without any protective compounds results in cell death.
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3.1.1.6 Suspension culture using low calcium SFM
Within 24 hours in SF suspension culture, it has been noted that the CHO-K1 cells 
clump extremely tightly compared to cells growing in serum-supplemented culture. 
This has also been observed by Renner et al. (1993) during the SF growth of another 
CHO cell line, CHO-SS3. This aggregation appears to affect cell growth with cells at 
the centre of the aggregate lacking 0 2 and nutrients, coupled with the adverse shear 
forces, to cause cell death. Ca2+ ions have been thought to play a role in the 
aggregation of cells which may account for the severe clumping. It was thus decided to 
try and reduce this clumping by using commercially available basal media that have low 
Ca2+ levels or that are Ca2+ free, instead of the basal Ham’s F12 being used up until 
now.
/
3.1.1.6.1 Growth in low calcium SFM
The first growth curve involved determining whether a low Ca2+ (113|_iM conc.) 
serum-free media, Ham's F12/ MEM.S (1:1) (H/M) SFM, was even capable of 
supporting the growth of the CHO-K1 cell line. Cells were grown over a 9 day period 
in H/M SFM with and without 50jig/ml Pluronic F68 supplementation. Fig. 3.1.10  
shows that the medium does support some growth of the cell line when supplemented 
with PF68.
The second growth curve involved comparing growth of the cell line in H SFM 
(226p,M conc.), Ham’s F12/ DMEM (1:1) (H/D) SFM (790^iM conc.) and H/M SFM 
(113|iM conc.) and all supplemented with 50|ig/ml PF68. Fig. 3.1.11 shows that 
good growth was obtained in the low Ca2+ culture, comparable to that of the high Ca2+ 
cultures, but it was not an improvement. Clumping from microscopic observations was 
still quite severe.
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F i g .  3 . 1 . 1 0  Growth of CHO-K1 in H/M SFM  with and without Pluronic F68 at 50ng/m l. Results 
are expressed as average cell number x 10s per m l.
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F i g .  3 . 1 . 1 1  Growth of CHO-K1 cells in SF media with different Ca2+ concentrations all
supplemented with Pluronic F68 at 50ng/ml. Results are expressed as average cell number xlO5 per ml.
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3 . 1 . 1 . 6 . 2  Growth in low  Ca** and Ca^-free SF suspension culture
The next experiment involved comparing growth in high Ca2+ (H SFM), low Ca2+ 
(H/M SFM) and Ca2+ free (M SFM) over a period of time, all with Pluronic F68 
supplementation. Again growth was quite comparable in the high and low Ca2+ media, 
H SFM and H/M SFM respectively (see Fig. 3.1.12). However no growth was 
observed in the Ca2+ free SFM (M SFM). Clumping was still found to be as severe in 
all serum-free media.
F i g .  3 . 1 . 1 2  Growth of CHO-K1 cells in high Ca2+ (H SFM), low Ca2+ (H/M SFM ), CaJ+-free 
medium (M SFM) all with Pluronic F68 supplementation. Results are expressed as average cell 
number xlO5 per ml.
H SFM
-----p— H/M SFM
— ■— M SFM
time in days
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3.1.2 Long-term growth of CHO-K1 cells in serum-free medium
Long-term subcultivation of a cell line is a good test for a true serum-free medium 
(SFM). Keenan (1994) found that the SFM developed by Mendiaz et al. (1986) for the 
growth of the CHO-K1 cell line did not support the growth of the cells over a long 
period of time. Continuous subcultivation was only possible up to 9 passages at most 
(or 36 days) under SF conditions. After this time, the cells began to detach off the flask 
surface and usually died.
The aim of this work was to try to extend the cultivation of the cell line over a longer 
period of time and hopefully determine which substances are being diluted out, or are 
lacking over long-term subcultivation.
3.1.2.1 Subcultivation of CHO-K1 cells in SFM
A number of subcultivation experiments were carried out on the CHO-K1 cell line. 
Table 3.1.2 shows the results of two of these experiments.
The results show that the SFM developed by Mendiaz et al. (1986) does not support the 
long-term growth of the cell line. No improvement on the 9 passages (36 days 
cultivation) achieved by Keenan (1994) was obtained. In the two sets of results shown 
below, the cells died off after passage number 8 and 7 respectively. Usually a fall off 
in growth occurred between passages 4 to 6 on average (results not shown).
Table 3.1 .2  Subcultivation  o f CHO-K1 in SFM
Passage no. Experiment 1 Experiment 2
1 1.281 ± 0.119 2.260 ±  0.109
2 1.688 ±  0 .450 1.050 ±  0.060
3 1.850 ± 0.000 2.050 ±  0 .800
4 1.569 ±  0.106 1.650 ±  0.101
5 0.657 ±  0.027 1.175 ± 0.027
6 1.448 ± 0 .1 2 8 1.748 ± 0.312
7 0.488 ± 0.050 0.145 ±  0.018
8 0.405 ± 0.070 -
Results are expressed as average cell number per flask xlO6 ± standard deviation (n=3).
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Long-term growth of the cell line often resulted in the cells forming aggregates which 
eventually caused the death of the CHO-K1 cell line after serial cultivation in SFM. 
Fig. 3.1.13 shows the growth of the CHO-K1 cells at P .l and P.4 in H SFM showing 
the formation of aggregates at P.4 in SFM.
Fig. 3.1.13(a) CHO-K1 P .l in H SFM Fig. 3.1.13(b) CHO-K1 P.4 in H SFM
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3 . 1 . 2 . 2  Extension o f  serum -free subcultivation
Experiments were then carried out to try to extend the subcultivation of CHO-K1 cells 
by supplementing the SFM with low cost compounds so as to try to avoid the use of 
expensive cytokines or growth factors.
3 . 1.2.2.1  Serum -free Briclone
It was decided use SF Briclone, derived from the NCTCC product Briclone, to try to 
extend the long-term growth of CHO-K1 cells. SF Briclone was used at a 5% 
concentration supplemented to the Ham's F12 SFM used up until now. Long-term 
subcultivation experiments were carried out to compare growth in SFM with and 
without SF Briclone supplementation. As can be seen from Fig. 3.1.14, the SF 
Briclone allowed extension of the the subcultivation period by approximately 2 
passages. Higher cell concentrations were generally achieved during the course of the 
subcultivations. However, a fall-off in growth in the unsupplemented culture was 
noted. Growth was really only extended by approximately one week.
p a ss a g e  no.
F i g .  3 . 1 . 1 4  Growth of CHO-K1 cells over a number of passages in H SFM with and without SF 
Briclone supplementation. Results are expressed as average cell concentration per flask xlO5 ± standard 
deviation (n=3)
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As the subcultivations were extended by a week compared to unsupplemented culture, it 
was decided to attempt to isolate the factors present in the SF Briclone that appeared to 
be stimulatory to growth and were lost after a number of passages in SFM.
150ml of SF Briclone was fractionated using a YM3 membrane to obtain 15ml of 
retentate (lOx conc.) containing all components with MW > 3000Da and 135ml of 
filtrate ( lx  conc.) containing all components with MW < 3000Da. A number of 24-well 
assays were carried out to compare growth of cells in SFM plus supplemented Briclone 
fractions - lx  filtrate, lx  retentate, lOx retentate, SF Briclone (unfractionated) - to 
growth in SFM without supplementation. All the fractions were used at a 5% 
concentration. Two of the assay results are shown in Fig. 3.1.15(a),(b).
From the two growth curves, it is clear that the lx  filtrate showed the greatest 
stimulation of growth over the other fractions tried. Generally lx  retentate showed 
better growth than lOx retentate. However, the SFM and SFM plus 5% SF Briclone 
results were quite variable between the two assays.
It was then decided to carry out a long-term subcultivation experiment using the various 
SF Briclone fractions. These assays were carried out in 25cm2 vented flasks and 
passaged every 4 days. The results are shown in Table 3.1.3.
The results in Table 3.1.3 show that again, 5% filtrate supplementation resulted in the 
greatest stimulation of growth over a four day period, as in passage 1. Cell number 
reached a total of 40 .69xl05 from an initial seeding density of 2 .5 x l0 5/flask. 
However, the lx  filtrate failed to extend the sub-cultures beyond three passages. The 
lx  and lOx retentate both failed to stimulate growth beyond 5 passages which is similar 
to SF Briclone results. It was noted that the lOx retentate showed lower cell number at 
passage 1 compared to the lx  retentate as was found in the 24-well assays above. 
However, growth in passages 2, 3 and 4 was much higher in the lOx retentate flasks.
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F i g .  3 . 1 . 1 5  (a) above and (b) below showing growth of CHO-K1 with SF Briclone fraction 
supplementation. Results are expressed as average cell number per well xlO 4 (standard deviation always 
less than 10%, not shown on graph).
time in days
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Table 3.1.3 Long-term subcultivation of CHO-K1 cells using the various SF Briclone fractions
P a s s a g e  no . S F M + S F  B ri + 5%  
F i l t r a t e
+ 5%  
R e t Ix
+  5%  
R e t !0 x
1 21.50 ± 2 .2 2 22.44 ±  3.72 40.69 ± 2 .1 0 34.52 ±  7.39 25.46 ±  1.75
2 11.14 ±  0.95 33.31 ± 4.90 20.31 ±  1.19 18.00 ± 0 .2 5 37.69 ±  3.94
3 7.65 ±  0.38 34.75 ±  4.40 1.58 ± 0 .3 0 20.75 ±  1.38 33.69 ±  0.94
4 <  2.5 17.06 ±  0.30 < 2.5 12.69 ± 1 .8 1 37.63 ±  6.00
5 - < 2.5 - <  2.5 < 2.5
Results are expressed as average cell number per flask xlO5 ±  standard deviation (n=3)
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3.1.3.2.2 Other components tested in passage number crisis assays
It was then decided to use defined components to try to extend the long-term 
subcultivation of CHO-K1 cells in SFM, because of the variability in the results 
associated with the use of the undefined SF Briclone.
The components tested in these assays were as follows - BME vitamins, Pluronic F68 
at 20p,g/ml, Fibronectin at 10fig/ml, LDL at 100|Hg/ml, DNase I at 100|ig/ml. 
Conditioned medium (CM) from CHO-K1 cells and SF Briclone were also tested in 
these assays.
These experiments involved growing CHO-K1 cells in Ham's F12 SFM for 3 passages 
in 25cm2 flasks. Cells were passaged every 4 days. The cells were then split into 
25cm2 flasks containing 8ml of H SFM plus the component to be tested. The positive 
control was H SFM plus 0.5% FCS and the negative control was H SFM only. The 
flasks were then passaged every 4 days and seeded at the initial seeding density of 
2.5xl05 cells per flask until such a time that the cells had all died or the cell number was 
less than the initial seeding density. The results of 3 experiments are shown below.
Table 3 . 1 . 4  E ffect o f  different com ponents on extending the subcultivation period for CHO-K1 in
SF M
Exp. no. BME
vitamins
CM
CHO-K1
SF
Briclone
Pluronic
F68
tibro-
nectin
LDL DNase 1 +ve
control
-ve
control
1 5 5 6 6 - - 6 6 + 5
2 4 4 5 5 7 - - 7 + 4
3 - - - 6 7 4 4 7 + 5
Results are expressed in number o f  subcultures achieved
Initial results show that fibronectin at a concentration of 10[ig/ml allowed the passage 
number to increase by 2-3 passages over the H FI2 SFM, negative control. From 
microscopic observations, the cells were much more spread out at the higher passages 
SFM supplemented with fibronectin compared to the H F12 SFM only, where the cells 
usually started to detach and grow in clumps before growth became inhibited.
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3.1.2.3 Low Calcium medium - Ham's F12/ MEM.S SFM
Due to the observation of clumping after a number of passages in SF monolayer 
culture, it was decided to see if the low Calcium medium, H/M SFM, could possibly 
reduce the clumping of the cells in monolayer culture and extend the long-term 
subcultivation of the cell line. Ca2+ ions have been thought to play a role in the 
aggregation of cells (Renner etal., 1993) which may explain the clumping noted at the 
higher passages in H SFM.
Ham’s F12/ MEM.S (1:1) SFM, with a Ca++ concentration of 113|U,M (compared to 
226jxM in H SFM), was used to set up a long-term subcultivation experiment using 
CHO-K1 cells. The highest number of subcultivations obtained for H SFM was 8 
passages (9 obtained by Dr. Joanne Keenan) or 32 days in culture. A subcultivation 
lasting 52 passages (approximately 11 months) has been successfully obtained using 
the low Calcium, H/M SFM.
The cells at this stage were frozen under completely serum-free conditions as described 
in 3.1.4. During the subcultivation experiments shown in Tables 3.1.5 and 3.1.6, the 
cells appeared to go through a crisis period which lasts between passages 6 and 12 in 
Experiment 1, between passages 10 and 11 in Experiment 2 and between passages 7 to 
10 in Experiment 3. After this crisis, the cells appeared to adapt to the SF conditions 
with cell counts greatly exceeding counts found initially at passages 1 or 2. Counts for 
the first 15 to 16 passages are shown for both experiments in Table 3.1.5 and 3.1.6.
From these passage number onwards, very high cell counts have been obtained, usually 
ranging from 4 to 6 xlO6 cells per flask from an initial seeding density of 0.25 xlO6 per 
flask (results not shown). The cells at the higher passages in SF culture appear smaller 
than earlier passage cells and are not as elongated or as fibroblastic-like. As a result, 
more space was available for the cell to grow, hence the higher cell number. It appears 
that the cells adapted to the SFM after going through a crisis period at passages 7 to 11.
The cells in the H/M SFM also appeared to be far less clumped at the higher passages in 
SFM compared to cells cultured in H SFM. Fig. 3.1.16 shows the morphology of 
CHO-K1 Passage 4 in serum-free conditions, demonstrating the clumping observed in 
H SFM.
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Fig. 3.1.16(a) CHO-Kl P.4 in H/M SFM Fig. 3.1 .16(b) CHO-Kl P.4 IN H SFM
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T a b le  3 .1 .5  L ong-term  subcultivation  o f  CH O -K 1 ce lls  in H am ’s F 1 2 / M E M .S (1:1) SFM  (results 
are expressed as cell number per flask  xlO 5 ±  standard deviation (n=2) for experim ent 1).________________
Passage no. Experiment 1 Experiment 2
l 16.71 ±  0 .7 1 0 25 .25
2 17.31 ±  0 .0 0 0 9 .4 5 0
3 2 0 .5 5  ±  4 .5 0 0 2 9 .69
4 14.18 ±  2 .9 3 0 18.70
5 14 .29  ±  1 .010 2 4 .23
6 4 .4 6 0  ±  0 .3 4 0 11.55
7 3 .4 8 0  ±  0 .5 3 0 14.93
8 5 .1 6 0  ±  0 .6 4 0 19.50
9 5 .4 4 0  ±  0 .7 6 0 17.95
10 5 .4 8 0  ±  1 .400 8 .210
11 4 .4 4 0  ±  1.390 8 .000
12 5 .1 6 0  ±  1.660 4 8 .8 6
13 11.05 ±  0 .3 3 0 4 2 .7 0
14 10 .30  ±  0 .4 8 0 65 .63
15 14.28 ±  1 .080 45 .88
Table 3.1.6 L ong-term  subcultivation  o f  CHO-K1 ce lls  in H  SFM  compared to H /M  SF M  (results 
are expressed as ce ll number per flask xlO 5 ±  standard deviation (n=2).
Passage no. H SFM (EXP. 3) H/M SFM (EXP. 3)
l 17.24  ±  1.925 17.81 ± 0 .4 8 1
2 6 .2 5 0  ±  1 .500 5 .906  ±  0 .344
3 10.38 ±  1.875 5 .938  ±  1.063
4 2 7 .0 9  ±  3 .844 13.75 ±  2 .375
5 10.41 ±  2 .400 8 .750  ±  1.625
6 5 .5 0 0  ±  2 .063 11.31 ±  2 .500
7 2 .685  ±  0 .465 5 .3 0 0  ±  1 .550
8 4 .0 5 0  ±  0 .000 9 .375  ±  0 .575
9 9 .688  ±  0 .000 7 .656  ±  1.594
10 1.312 ±  0 .000 4 .063  ±  0 .938
11 - 11.84 ±  0 .094
12 - 7 .375  ±  0 .188
13 - 7 .813  ±  1.813
14 - 12.34 ±  1.031
15 - 17.28 ±  9 .156
16 - 6 .063  ± 0 .1 8 8
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As a consequence of these results it was decided to determine if these cells had adapted 
to the SFM conditions. An assay was carried out to compare growth of Passage 1 SF 
to Passage 16 SF CHO-K1 cells over a 7 day period. The assay was carried out in 
25cm2 flasks containing 8ml of Ham’s F12 serum-free medium and seeded at 2.5X105 
cells per flask. Three flasks were taken down each day for a seven day period and 
counted.
As can be seen from the growth curve, Fig. 3.1.17, the cells P. 16 SF reached much 
higher cell numbers, with a maximum cell density of 5.67X106 per flask observed on 
day 7 compared to a maximum of 2 .42xl06 per flask for the P .l SF culture. That the 
P .l SF cells showed lower growth than the P. 16 cells was surprising as the P .l cells 
should still have contained small traces of serum proteins. This seems to suggest that 
the CHO-K1 P. 16 SF cells have adapted to the serum-free conditions in which they 
have been forced to grow.
t ime in days
F i g .  3 . 1 . 1 7  C om parison o f  growth o f  CHO-K1 serum-free ce lls  passage 1 and passage 16 in H /M  
SF M . R esu lts are expressed as average cell concentration per flask xlO 5 ±  standard deviation (n=3).
1 2 0
A growth curve was also set up to compare growth of CH0-K1 passage 1 serum-free 
cells in H SFM and H/M SFM, as a result of the observed differences between the two 
media types in supporting the long-term growth of the cell line. Assays were set up as 
previously described, i.e. 25cm2 flasks with an initial cell concentration of 2.5x105 per 
flask. Two flasks were taken down for the two serum-free media every day over an 8 
day period, and counted (Fig. 3.1.18).
time in days
F i g .  3 . 1 . 1 8  Growth com parison o f  passage 1 serum-free CHO-K1 ce lls  in H SF M  and H/M  SFM . 
R esults are expressed as average cell concentration per flask x 10s ±  standard deviation (n=2).
The growth curve clearly shows that the low calcium medium, H/M SFM, was capable 
of supporting better growth of CHO-K1 cells over a longer period of time compared to 
the high calcium medium, H SFM (greater than 8 days compared to the 4 days for H 
SFM with much higher cell counts achieved). The cells initially grew faster in the H 
SFM for the first 4 days. They then started rounding up and detaching from the surface 
of the flask.
1 2 1
3.1.2.4 Calcium addition to low calcium serum-free medium
Experiments were carried out to determine if by adding Ca++ to H/M SFM, to a 
concentration equivalent to H SFM, there is a restriction to the number of passages the 
cells can grow comparable to that usually obtained for H SFM, where the cells usually 
die off at passages 4-6 (on average).
Media supplements (Earle’s salts, MEM vitamins, amino acids, sodium bicarbonate, 
phenol red, Table 2.10.1) were bought in to attempt to produce a “home-made” basal 
medium, to which any concentration of CaCl2 could be added, see Section 2.10.5. 
When the medium was made up without calcium, the osmolarity was found to be 
0.299m0sm/kg and the pH was found to be 7.22 comparable to MEM.S and Ham’s 
F12 basal media.
Subcultivation experiments were carried out to compare growth of CHO-K1 cells in 
SFM with various concentrations of Ca4+ ions present.
Table 3.1.7 Subcultivation  experim ent for C H O -K 1 in SFM  with various concentrations o f  C aCl2 
present in addition to the lx l0" 5m g/m l concentration present in the serum -free m edium  supplem ents
P assage
n o .
H  S F M H /M  S F M M  SF M M SFM  + 
0 .0 4 4 m g /m l  
CaCI,
H/D SFM
Cone CaCl2 0 .044m g/m l 0 .022m g/m l 0 m g /m l 0 .0 4 4 m g /m l 0 .158m g/m l
1 9.72 ±  2.34 19.9 ± 1.13 1.80 ± 0 .23 12.3 ± 0 .1 6 18.1 ±  2.25
2 4.11 ± 0.58 14.6 ±  2.98 - 0.66 ±  0.02 8.91 ± 4 .09
3 9.49 ±  0.04 8.68 ± 2.11 - - 0.58 ±0 .13
4 4.29 ± 0.47 10.4 ±  3.90 - - -
5 9.97 ±  0.03 3.19 ± 0 .4 4 - - -
H SFM  (H am ’s F 12  SF M ), H/M  SFM  (H am ’s F 1 2 / M E M .S (1:1) SF M ), M  SFM  (M E M .S SF M ), 
H /D  SFM  (H am ’s F 12 / D M E M  SFM  (1:1) SFM . Results are expressed as ce ll counts per flask  x lO 5 
±  standard deviation (n=3).
From this experiment, it is clearly evident that MEM.S SFM medium is not capable of 
supporting growth of CHO-K1 cells at all. However, supplementation with CaCl2 at 
concentrations equivalent to HF12 allows good growth for one passage before the cells 
die off. The very high Ca++ SFM (H/D SFM) was capable of supporting growth for 
only 2 passages, after which time the cells were severely clumped, and then became 
detached and died off.
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Subcultivation experiments were carried out to compare growth of CHO-K1 cells in 
H/M SFM with CaCl2 supplementation, to that of H SFM (i.e. 0.044mg/l). Thus 
0.022mg/l of CaCl2 was added to the H/M SFM. If the cells die off at equivalent 
passage numbers to H SFM, poor growth of the cells at these passage number can 
possibly be attributed to the high calcium concentrations in the medium. Table 3.1.8 
shows the results for two separate experiments.
T a b le  3 .1 .8  Subcultivation o f  CHO-K1 cells in SFM  w ith different CaCl2 concentrations
E x p e r im e n t  1 E x p e r im e n t  2
P a s s a g e
N o .
H  S F M H /M
S F M
H /M  + 
0 . 0  2 2 m g / l  
C a C lj
H  S F M H /M
S F M
H /M  + 
0 . 0 2 2 m g /l  
C a C l2
1 7.65 ± 2 .1 0 23.48 ± 0.69 25.91 ± 1.31 9.95 + 0.00 21.26 ± 0 .2 6 15.88 ± 1.53
2 7.69 ± 0.39 15.75 ± 3.90 15.03 ± 0.22 3.945 ± 0.08 14.69 ±  2.43 7.200 ± 0.19
3 0.488 ±  0.10 6.13 ± 0.063 2.275 ± 0.03 3.450 ± 1.36 16.45 ± 0.88 8.288 ± 0.10
4 - 8.325 ± 0.79 - 7.144 ± 0.84 8.400 ± 1.35 8.700 ± 5.03
5 15.28 ± 1.21 5.775 ± 1.84 8.650 ± 0.15 6.675 ± 1.28
6 6.038 ± 0.75 8.638 ± 0.79 4.500 ± 0.60
7 1.279 ±  1.16 5.831 ± 1.11 6.413 ± 0.12
8 - 10.29 + 1.32 8.560 ± 0.99
9 - 12.29 ± 2.56
10 - 15.26 ±  1.85 -
11 - 14.29 ± 1.55 -
H am ’s F12 SFM  (H  SFM ), H am ’s F 12 / M EM .S SFM  (H/M  SFM ) w ith and w ithout C aC l2 
supplem entation. R esults are expressed in term s o f cell counts per flask x lO 5 ±  standard deviation 
(n=2)
* cells died o ff  at this passage
These results suggest that CaCl2 may be responsible, possibly among other factors, for 
the fall off in growth in H SFM after a number of passages in SFM. Experiment 1 
shows a fall off in growth at passage 3 for both H SFM and CaCl2 supplemented H/M 
SFM while experiment 2 shows a fall off in growth at P.7 for H SFM and P. 8 in H/M 
SFM supplemented with CaCl2.
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3.1.3 Cryopreservation of CHO-K1 cells under serum-free conditions
Serum-free cryopreservation of the CHO-K1 cells has been carried out using 
polyvinylpyrrolidone (PVP) and methylcellulose and comparing to the use of foetal calf 
serum. Concentrations used were those recommended by Merten et al. (1995).
Cells were frozen at concentrations of 5 x l0 6 per vial with 0.1% Methylcellulose plus 
10% DMSO in SFM, 3.0% PVP plus 10% DMSO in SFM and compared to cells 
frozen under serum conditions, using 90% FCS + 10% DMSO, as described in Section 
2.7.3. Cells were frozen for 7 days and then thawed to assess short term viability 
when using these compounds during the freezing process. Some vials were also frozen 
for approximately 300 days and then thawed to assess long term viability of the cells 
under these conditions.
The first two attempts at freezing using 10% (v/v) DMSO and 0.1% (w/v) MC were 
unsuccessful possibly due to a number of reasons. Perhaps the cells were not in the 
exponential phase when they were frozen or the cells were not very healthy when they 
were frozen. However, two separate attempts were successful and these results are 
presented in Table 3.1.9.
T ab le  3.1.9 V iability  and attachm ent ability o f  CHO-K1 cells frozen under SF conditions
7 DAYS 300 DAYS
Freezing
medium
% viability 
on thawing
Cells ability 
to adhere
% viability 
on thawing
Cells ability 
to adhere
MC + DMSO 78.21 ± 2.87 most attached 
< 1 hr
86.46 ± 1.87 most attached 
< 1 In­
PVP + DMSO 84.07 ± 1.38 most attached 
< 1 In­
93.14 ± 2 .8 5 most attached 
< 1 In­
FCS + DMSO 84.24 ±0 .91 most attached 
< 1 hr
86.01 ± 1.98 most attached 
< 1 hr
R esults are expressed as average percentage viability ±  standard deviation (n=6)
This experiment shows that methylcellulose or PVP in combination with DMSO are 
very effective compounds for serum-free cryopreservation. Thus serum-free conditions 
can be maintained when freezing cells.
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3.2 DLKP IN SERUM-FREE MEDIUM
DLKP is a human lung cell line derived in our laboratory from a lymph node biopsy 
and has been histologically diagnosed as a 'poorly differentiated squamous carcinoma'. 
Development of a serum-free system for this cell line allows a system that can be used 
in toxicity profiles and in growth factor and differentiation assays, without serum 
interference or the variability in results associated with the use of serum.
The serum-free medium developed by Mendiaz et al. (1986) and extensively 
investigated by Keenan (1994) was used as a starting base for the growth of this cell 
line in SFM. This medium was used because of its simplified nature and the presence 
of only one mitogen, insulin.
A
3.2.1 Growth of DLKP in H SFM
Initial experiments involved determining whether this simple serum-free medium 
actually supported growth of the cell line. Cells were set up in 24-well assay plates in 
SSM, SFM and Basal medium over a 5 day period with one plate taken down every day 
for five days and cell counts were determined. The following growth curve, Fig. 
3.2.1, shows that the serum-free medium is capable of supporting the growth of the cell 
line, reaching a cell density of 1.6xl04 per well from an initial seeding density of 
0 .5x l04 per well. The basal Ham's F12 showed only a very slight increase in cell 
number, while the SSM showed a high cell density of 6 .6x l04 per well on day 5. 
Thus, growth in the serum-free medium is higher than the basal medium but a lot lower 
than in SSM. However, these initial results looked very promising.
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F i g .  3 . 2 . 1  Growth curve for D L K P ce lls  in serum -supplemented medium (S S M ), serum-free 
medium  (SFM ) and Basal m edium  (B A SA L ) over a 5 day period. R esu lts are expressed as average cell 
number per w ell x lO 4 ±  standard deviation (n=3).
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3.2.2 Long-term sub-cultivation and adaptation in SFM
The true test of a serum-free medium, as stated before, is its capability of supporting the 
long-term sub-cultivation of a cell line. It has been found that the serum-free medium is 
capable of supporting the continuous cultivation of the DLKP cell line. The medium 
has been capable of supporting the growth of the cells for at least 2-years in a 
completely defined system. It has been observed that the cells appear to adapt to the 
serum-free conditions after a number of passages. Table 3.2.1 shows the growth of 
DLKP cells over a period of 8 passages in SFM, SSM and basal medium. The cells in 
basal Ham's FI2 die off after 3 passages. Table 3.2.2 shows 3 subcultivation 
experiments, up to 20 passages, for DLKP cells in SFM. Generally, there is an 
increase in cell number from about passage 10 onwards showing adaptation of these 
cells to their SF conditions.
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T a b le  3 . 2 . 1  Subcultivation o f  D L K P in serum-free m edium  (SF M ), basal m edium  (Basal) and 
serum -supplemented m edium  (SSM )
Experim ent 1
Passage no. SFM Basal SS M
1 4.850 ± 0.050 4 .200 ±  0.020 15.65 ± 0 .1 5
2 9.987 ± 0 .5 1 3 4.175 ±  0.085 17.40 ±  1.25
3 8.300 ±  0.800 1.750 ±  0.885 16.40 ±  1.85
4 4.263 ±  0.262 - 17.63 ±  0.57
5 4.850 ± 0.000 - 15.10 ± 0 .1 9
6 5.975 ±  0.775 - 16.05 ± 1.25
7 4 .950  ± 0.475 - 21.90 ± 0 .9 9
8 2.075 ±  0.000 - 18.20 ±  1.55
R esults expressed as average ce ll counts per flask xlO 5 ±  standard deviation (n=3).
T a b le  3 .2 .2  Subcultivation  o f  D L K P  in serum -free m edium  (SFM )
Passage no. Experiment 2 Experiment 3 Experiment 4
1 3.600 ±  0.050 4 .850 ±  0.000 4 .000
2 5 .800 ±  1.075 4.312 ±  0.487 4.481
3 4 .700 ±  0.425 4.338 ±  0.562 6.475
4 2.925 ± 0 .1 5 0 3.400 ±  0.300 1.388
5 4 .500 ±  0.000 3.263 ±  0.588 3.787
6 4.219 ±  0.431 6.562 ±  0.562 2.887
7 6.638 ±  0.000 5.213 ±  2.062 3.000
8 6 .750 ±  0.075 4 .500 ±  1.012 9.188
9 7 .312 ±  0.600 3.825 ±  0.825 8.438
1 0 6.253 ±  0.403 7.669 ±  0.281 11.363
1 1 8.288 ±  1.725 5.900 ± 0 .1 5 0 7.013
1 2 9.381 ±  2.751 10.43 ±  0.470 9 .450
13 9.485 ±  2.520 6.463 ±  1.113 6.225
14 5.250 ±  0.700 9.725 ± 0.575 13.25
15 11.275 ± 0.075 8.600 ± 0.200 8.325
16 13.675 ± 1.075 8.375 ± 1.725 12.25
17 11.400 ± 2 .4 5 0 10.975 ± 0.008 10.406
18 15.175 ±  2.475 11.488 ±  1.788 1 1 . 0 0
19 9.500 ± 0 .1 0 0 12.675 ±  0.000 8.125
2 0 9.475 ±  0.375 10.138 ±  0.138 17.125
Results expressed as average cell counts per flask xlO 5 ±  standard deviation (n=2) for experim ents 2  and
3
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Growth assays using high and low passage SF cells were carried out to try to determine 
whether adaptation has occurred. Assays were carried out in 24-well plates comparing 
growth of P. 1 SF cells to P. 13 SF cells over a 6 day period. The following growth 
curve was obtained.
t ime in days
F i g  3 . 2 . 2  Growth curve for passage 1 and passage 13 serum-free D L K P cells  in S F M  R esults are
expressed as average cell number per w ell xlO 4 ±  standard deviation (n=3).
As can be seen from Fig 3.2.2, the cells P. 13 in SFM showed much higher cell number
over the 6 day period compared to P. 1 cells in SFM.
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Experiments were then carried out to investigate changes in the growth properties of the 
DLKP cells growing for at least two years in this serum-free medium. Growth of the 
adapted (2-yr) serum-free cells were compared to the parental DLKP cells in serum-free 
medium, serum-supplemented medium and in basal medium. It was observed that the 
2-year SF cells showed much better growth in SFM, see Fig.3.2.3 and Table 3.2.3 
compared to the parental cells, suggesting that the cells have adapted well to the 
conditions in which they were forced to grow over the past two years. It was also 
observed that the 2-year SF cells showed a restrained growth pace under serum- 
supplemented conditions compared to the parental cells see Table 3.2.4 and Fig.3.2.4. 
The 2-year SF cells also showed better poliferation in basal medium compared to the 
parental cells, see Table 3.2.5 and Fig. 3.2.5.
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T a b le  3 . 2 . 3  Growth of DLKP over a 7 day period in serum-free medium
Experiment 1 Experiment 2
Time 
in days
parental
DLKP
2yr SF 
DLKP
parental
DLKP
2yr SF 
DLKP
I 1.350 1.275 0 .9 5 0 1.800
2 - - 1 .650 2 .4 7 5
3 3 .7 5 0 5 .3 2 5 2 .4 0 0 4 .6 8 8
4 4 .463 7 .5 0 0 3 .263 6 .9 7 5
5 0 .4 5 0 7 .2 0 0 3 .5 6 2 7 .1 2 5
6 0 .3 3 7 11.96 1.388 7 .613
7 0 .3 0 0 13.19 0 .563 7 .2 3 8
R esu lts are expressed as cell concentration per flask x 105,
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F i g .  3 . 2 . 3  Growth comparison in serum-free medium o f  D L K P parental ce lls  to ce lls  grown for 2- 
years in SF M . R esults expressed as cell concentration per flask xlO 5, experim ent 2 results show n from  
T able 3 .2 .3 .
131
T a b le  3 . 2 . 4  Growth of DLKP over a 7 day period in serum-supplemented medium
Experiment 1 Experiment 2
Time parental 2yr SF parental 2yr SF
in days DLKP DLKP DLKP DLKP
1 3.150 2.100 3.400 3.375
2 5.625 5.000 4.450 3.500
3 18.15 7.275 8.100 5.925
4 35.00 11.75 18.52 10.80
5 33.75 15.75 19.20 14.63
6 37.00 20.37 26.37 14.40
7 - - 22.63 11.50
Results are expressed as cell concentration per flask xlO5
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F i g .  3 . 2 . 4  Growth comparison in serum-supplemented medium of DLKP parental cells to cells 
grown for 2-years in SFM. Results expressed as cell concentration per flask xlO5, experiment 2 results 
shown from Table 3.2.4.
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T a b l e  3 . 2 . 5  Growth of DLKP over a 7 day period in basal medium
Time in days parental DLKP 2yr SF DLKP
1
2
3
4
5
6
0.713 ±0.128  
1.763 ± 0.152 
1.988 ±0.868
1.613+0.688
1.950 ±0.188 
4.425 ± 0.563 
6.000 ± 0.875
3.338 ± 0.868
R esults are expressed as cell concentration per 11 ask xlO 5,
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F i g .  3 . 2 . 5  Growth com parison in  basal m edium  o f D L K P parental ce lls  to ce lls  grown for 2-yeare in 
SF M . R esu lts expressed as cell concentration per fla.sk xlO 5.
133
The antigenic phenotype of the SF cells was also investigated using Abs to a variety of 
normal and tumour cell associated antigens. These 2-year SF cells were compared to 
the parental cells and SF cells (P20), growing for approximately 3 months under these 
conditions. The cells were grown on 10-well slides in both serum-free and serum- 
supplemented medium, and immunocytochemical analysis was carried out using Abs to 
various antigens as outlined in Table 3.2.6. The epithelial specific markers looked at 
included pan-cytokeratin, desmosomal protein and epithelial specific antigen; adhesion 
molecules included ocp a2, a3, a5, and a6 integrins. The NSCLC marker looked at was 
a-transglutaminase and SCLC markers included NCAM, neurofilaments and serotonin.
It was found that most of these antigens were expressed in similar amounts irrespective 
of whether the cells were grown in serum or had been kept in serum-free culture for 3 
months or 2-years. However, there appears to be an increase in expression of the a 2 
and a 3 integrins as in Fig. 3.2.6.
T ab le  3.2.6 Im m unocytochem ical analysis o f D L K P cells grown for periods o f tim e in SFM
Parental DLKP 3 month SF DLKP 2-year SF DLKP
Antigen SFM SSM SFM SSM SFM SSM
pan-CK -ve -ve -ve -ve -ve -ve
a t  integrin -ve -ve -ve -ve -ve -ve
a 2 integrin w eak +ve weak +ve w eak +ve w eak +ve strong +ve strong +ve
a 3 in tegrin +ve +ve strong +ve strong +ve strong +ve strong +ve
a 5 in tegrin -ve -ve -ve -ve -ve -ve
a 6 integrin -ve -ve -ve -ve -ve -ve
desm o. prot. -ve -ve nd nd -ve -ve
ESA -ve -ve nd nd -ve -ve
Neurofils. +ve +ve nd nd +ve +ve
EG F-R w eak +ve weak +ve weak -i-ve weak +ve weak +ve weak +ve
NCA M -ve -ve -ve -ve -ve -ve
a-transg lu t -ve -ve -ve -ve -ve -ve
5HT -ve -ve -ve -ve -ve -ve
pan-C K  = pan cytokeratin, desm o. prot. =  desm osom al protein, ESA = epithelial specific antigen, 
Neurofils. =  neurofilam ents, EG F-R = epiderm al grow th factor receptor, N C A M  = neural cell adhesion 
m olecule, a-tran sg lu t =  a-transg lu tam inase, 5H T =  serotonin, n.d. = not determ ined
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F ig . 3 .2 .6  Detection of a 2 integrin immunoreactivity in DLKP (a) P .l SF and (b) 2-year SF. 
Detection of a 3 integrin immunoreactivity in DLKP (c) P .l SF and (d) 2-year SF.
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3.2.3 Morphology of DLKP SF cells in culture
When DLKP cells were placed in SFM, usually all the cells were noted to have attached 
to the flask surface within one hour. However, the cells after 4 days growth were 
noted not to have spread but remained rounded. This was quite unlike the squamous 
morphology noted for the cell line in serum-supplemented culture. The cells were quite 
loosely attached compared to serum-supplemented culture and after 4 days growth 
many cells were noted to be present in suspension and appeared to be still viable. After 
long-term growth in serum-free medium (greater than 10 passages), it has been 
observed that the cells appear to adapt to the SF conditions and show increased growth 
rates over early passage cells. These cells also appear to be a more homogeneous 
population than the parental cells and also spread out and are more tightly attached than 
early passage SF cells, which may explain the increase in expression of a 2 and a 3 
integrins as observed by immunocytochemical analysis in Table 3.2.6. Samples of 
these high passage SF cells were put into serum-supplemented medium to compare 
morphology to parental serum-supplemented cultures. Changes in morphology were 
apparent, with the cells becoming squamous in appearance similar to the DLKP-SQ 
morphology. The cell population appeared to be almost totally homogeneous.
Fig. 3.2.7 shows morphology of DLKP in serum-free medium both short term SF 
(P.l) and long-term SF (P.30). The morphology of the long-term SF cells in serum- 
supplemented medium is also shown (DLKP SFS cells).
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Fig. 3.2.7(a) P .l SF DLKP cells Fig. 3.2.7(b) P.30 SF cells
V -
' ■ >’ -v s |. s i S. s . .  c  r- . . .  ,'v- o r » /  ■. v .
Fig. 3.2.7(c) DLKP SS cells Fig. 3.2.7(d) DLKP SFS cells (grown
25 passages in SFM and now P .l in SSM)
137
3.2.4 Cryopreservation of DLKP cells in SFM
To obtain a true serum-free system, it is essential that the cell line can be cryopreserved 
under serum-free conditions. The results of two simple experiments are shown in Table 
3.2.7. The cells were frozen for 2 weeks before being thawed and assessed for 
viability. Cells were frozen in a mixture of 10% DMSO and 0.1% Methylcellulose as 
outlined in Section 2.7.4.
Cells were noted to attach to the flasks within 30 minutes after thawing and successful 
serial cultivation of the cell was achieved there afterwards. Thus, cryopreservation of 
the cell line under SF conditions is possible.
/
T a b le  3.2.7 Serum -free freezing o f  D LK P serum -free cells, both long-term  and short term  serum -free
SF Cells used Viability on thawing (%)
Passage 1 SF 75.00 ±  5.20
Passage 22 SF 80.94 ± 7.22
Cell viability on thawing ±  standard deviation (n=6 )
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3.2.5 Development of miniaturised assay system for DLKP SF cells
A miniaturised assay system was developed for DLKP cells in SFM to aid in the 
investigations into the effects of different basal media and mitogenic components on the 
growth of the cell line under defined conditions. The assay system would also be 
beneficial for future toxicity and differentiation assays to be carried out under SF 
conditions.
5 miniaturised assay systems have extensively investigated for quantification o f growth 
and use in toxicity testing (Martin and Clynes, 1993). The CDVE assay which is 
routinely used in our laboratory was investigated under SF conditions. Cells were 
plated onto 96-well plates and left to grow for the required amount of time. The media 
was then removed and the cells rinsed with PBS but due to the loose attachment of SF 
DLKP cells most of the cells were lost during this stage of the assay even with applying 
the utmost care. It was then decided to use the Sulforhodamine B (SRB) assay (see 
Section 2.10.2) investigated by Martin (1992) which is an effective assay for cells that 
grow loosely attached or completely in suspension. Again the cells were plated onto 
96-well plates in SFM and allowed to grow for the required amount of time. In this 
assay, the cells were fixed before the waste medium was removed by layering 50|il of 
50% cold TCA onto the media in the wells and leaving the plates at 4°C for 1 hour. 
The media was then removed and the wells rinsed 5 times with tap water and allowed to 
dry completely. No significant amounts of cells were lost at this step. The wells were 
then stained with SRB stain for 30 minutes. Staining for 5 minutes with crystal violet 
was also found to be effective.
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3.2.5.1 Cell concentration optimisation for miniaturised SF assay 
system
To use crystal violet (CV) or sulforhodamine B (SRB) as an end point for experiments 
using DLKP cells in SFM, it was necessary to establish a linear relationship between 
cell number and absorbance at 620nm for CV and SRB.
A number of different cell concentrations were used ranging from 5 x l0 2 to lxlO 4 per 
well. Cells were seeded into 96-well plates at these concentrations and allowed to grow 
for 7 days. The plates were then fixed as described and stained with SRB or CV. 
From the graphs Fig. 3.2.8(a) and 3.2.8(b), it is clear that there is a linear relationship 
between SRB or CV and absorbance at 620nm and that a cell concentration of 3 x l0 3 
cells per well is ideal for setting up 96-well SF assays for the time period of 7 days for 
both end-points used.
Thus an assay system has been developed which allows DLKP cells to be used under 
complete SF conditions for a variety of different assays - toxicity, growth factor and 
differentiation.
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cell concentration per w ell (xlO3 )
F ig . 3 .3 .8(a) Cell concentra tion  assay fo r D LK P cells in 96-w ell assay system .
Crystal vio let staining. Results expressed as average absorbance at 620nm ±  standard deviation (n=8 )
cell concentration  per well (xlO3 )
Fig. 3 .3 .8 (b ) C ell concentra tion  assay for D LK P cells in 96-w ell assay system.
SRB staining. Results expressed as average absorbance at 620nm  ±  standard deviation (n=8 ).
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3.2.6 Improvements in the SFM for the growth of early passage DLKP
The majority of experimental assays that will usually be carried out on the DLKP cell 
line will be concerned with using cells that are grown for a short time only in SFM. 
The only mitogen present in the serum-free medium is insulin, so it appears that the 
DLKP cell line is capable of autocrine regulation in order for the cells to be able to grow 
in such a simple defined medium. A number of different experiments have been carried 
out to try and improve the SFM.
3.2.6.1 Optimisation of basal medium for SF growth of DLKP cells
The basal medium provides many soluble, low molecular weight nutrients to the cell 
such as ions, carbohydrates, vitamins, amino acids and nucleosides., Many cell lines 
have been grown in SFM using a 50/50 mix of DME/F12 as the basal medium. This 
was compared to the Ham's F12 SFM being used up until now. Growth performance 
of the DLKP cells was assessed after 4 days growth in 25cm2 flasks from an initial 
seeding density of 2 .5xl05cells/ flask in the two serum-free media. The results of three 
separate assays are shown in Table 3.2.8.
Overall, a slight increase in cell number was observed using Ham's FI2 as the basal 
medium in the serum-free medium formulation.
T a b le  3.2.8 O ptim isation  o f  basal m edium  for D LK P growth
Experiment no. Ham’s F12 SFM (H SFM) Ham’s F12/ DME SFM
1 5.220 ± 0.472 4.330 ± 0.437
2 4.317 ±0.591 3.883 ± 0.249
3 5.025 ± 0.801 4.375 ±  0.459
Results are expressed as average cell concentration per flask xlO 5 ±  standard deviation (n=3).
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3.2.6.2 Optimisation of insulin concentration in SFM
Insulin is a polypeptide of 5700 molecular weight that affects the metabolism of the cell 
in a number of different ways. It is thought that its principle effect is on glucose 
metabolism. Mendiaz et al. (1986) found that insulin is mitogenic for the growth of 
CHO-K1 cells in SFM but also exerts a mitogenic response from many cell lines most 
commonly through the IGF-1 receptor (Conover et al., 1989). Many other 
investigators use insulin at a concentration between 1 and 10|ig/ml in SF formulations. 
It was thus decided to try and determine if insulin is mitogenic to the growth of DLKP 
cells and to optimise this concentration.
96-well assays have been carried out using 9 different insulin concentrations ranging 
from 0 to 20|lg/ml in the defined SFM. This assay has been repeated twice with 3 
repeat plates and 8 repeat wells per plate per assay. The same result has been found in 
both cases with 2.5fig/ml insulin proving to give the greatest stimulation of growth. 
The concentration of insulin used up until now, lOfXg/ml, proved to be slightly 
inhibitory to growth. See Fig.3.2.9.
0  2 .5  5 7 .5  10 12.5 15 17.5 20
insulin  (|a,g/ml)
F ig . 3 .2 .9  E ffect o f  d ifferent insu lin  concentrations on the growth o f  D LK P cell in SFM . R esults  
are expressed as average absorbance at 620nm  ±  standard deviation (n=8).
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3.2.6.3 Optimisation of transferrin concentration in SFM
Transferrin is an iron-transport protein that is also capable of chelating toxic metals. 
These properties make it one of the most universally used components in serum-free 
media formulations and most cell lines show a positive response to its presence in 
SFM. Similar assays to those described for insulin optimisation were carried out. Fig. 
3.2.10 shows that over the range of concentrations used, holo-transferrin (iron 
saturated) was found to be slightly inhibitory to growth.
/I
0 2 4 5 7.5 10 12.5 15 20
transferrin (pg/ml)
F ig . 3 .2 .1 0  Effect o f  different concentrations o f transferrin on the grow th o f D LK P cells in  S F M . 
Results are expressed as average absorbance at 620nm ±  standard deviation (n=8 ).
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3.2.6.4 Optimisation of fibronectin concentration in SFM
A number of assays were carried out to assess the effect of fibronectin on cellular 
growth.
Assays were carried out in 6-well plates using two different concentrations of 
fibronectin commonly cited in the literature. Cells were seeded at a concentration of 
5X104 per well and counted four days later.
T a b le  3.2.9 E ffect o f d iffe ren t fibronectin concentrations on D L K P cell grow th
Fibronectin conc. (jig/ml) cell counts (xlOVwell) fold increase in cell nos.
0 6.680 ± 0.42 ' 1.34
5 10.50 ± 0.81 2.10
10 10.25 ± 2.05 2.05
Results are expressed as average cell concentration per flask ±  standard deviation (n=3). Fold increase in 
cell num ber refers to  the increase in num ber from  the initial seeding density o f  2 .5 x l0 5/flask  on D ay 1
From these results, it is clear that fibronectin has a definite stimulatory effect on cell 
growth, with an almost 2-fold increase in cell number over unsupplemented SFM. The 
cells are also much more spread out and tightly attached compared to unsupplemented 
SFM.
Fig. 3.2.13 shows the morphology of DLKP cells in fibronectin supplemented SFM 
compared to unsupplemented SFM.
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A growth assay was set up to compare growth of the DLKP cells in SFM with and 
without fibronectin supplementation. Again, when fibronectin was added at a 
concentration of 5[xg/ml, DLKP showed on average a 2-fold increase in cell number 
over a 4-5 day growth period.
Fig. 3.2.12 and Table 3.2.10 shows a growth curve for DLKP cells in SFM with and 
without fibronectin supplementation.
T a b l e  3 . 2 .1 0  Growth of D LK P in serum-free medium  (SFM ), serum-free medium  supplemented 
w ith fibronectin (SFM  + FBN), basal m edium  (Basal) and serum-supplemented medium  (SSM)
Tim e in days SFM SFM  + FBN B asal SSM
1 1.125 1.650 1.280 3.400
2 2.775 4.950 0.712 4.450
3 3.975 6.375 1.762 8.100
4 6.150 6.675 1.988 15.525
5 5.188 9.387 3.221 26.375
R esults are expressed as cell concentration per flask (xlO5).
F i g .  3 . 2 .1 1  Growth curve for D L K P in serum-free medium  (SFM ), serum-free medium 
supplem ented w ith fibronectin (SFM  + FBN), basal medium (Basal) and serum-supplemented medium 
(SSM ). R esults are expressed as cell num ber per flask  (xlO5).
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DLKP cells in SFM without fibronectin supplementation appear to adapt to the SF 
conditions over a long period of time with cell number much lower in early passage SF 
compared to Passage 10 SF onwards (see Table 3.2.11(b) and Fig. 3.2.12). Sub­
cultivation experiments were carried out with fibronectin supplementation to try to 
improve the growth of the cells in these early passages in the SFM.
Table 3.2.11 and Fig 3.2.12 show that fibronectin definitely improves the growth of 
early passage SF cells, but as the cells adapt to the SF conditions little difference in cell 
number was observed from about Passage 9 onwards. Table 3.2.11 shows this 
response to fibronectin up to 3 passages in Assay 1, and up to 4 passages in Assay 2.
Table 3.2.11(a) Subcultivation  o f  D LK P in SFM  w ith and w ithout fibronectin  supplem entation
Experim ent 1 Experim ent 2
Passage no. SFM SFM  + FBN SFM SFM  + FBN
1 5.188 ±0 .413 9.388 ±  0.688 4.200 ± 0 .1 0 0 6.775 ± 0.075
2 4.275 ± 0.400 3.787 ± 0 .012 2.625 ± 0.063 7.469 ± 0.219
3 2.762 ± 0.213 5.383 ±  0.018 1.950 ± 0 .1 5 0 4.031 ±  0.919
4 6.375 ± 0.638 8.231 ± 0 .994
Results are expressed as average cell concentration p er flask xlO 5 ±  standard deviation (n=2).
Table 3.2.11(b) S ubcultivation o f  D L K P  in SFM  w ith and w ithout fibronectin  supplem entation
Experim ent 3
Passage no. SFM SFM + FBN
1 4 .000 6.169
2 4.481 3.806
3 3.475 4.700
4 1.388 3.263
5 3.788 2.737
6 2 . 8 8 8 2.812
7 3.000 6.263
8 9.188 10.275
9 8.438 8.288
10 11.363 8.588
11 7.013 8.025
12 9.450 7.575
13 6.225 6.450
Results are expressed as average cell concentration per flask xlO 5
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F ig . 3 . 2 .1 3  Long-term  subcultivation o f  D LK P in SFM  with (SFM  + FBN ) and w ithout (SFM ) 
fibronectin supplem entation. Results are expressed as cell concentration per flask x lO s; experim ent 3 
results show n to dem onstrate the adaptation o f cells to serum -free m edium  over long-term  growth.
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3.2.6.5 Response of DLKP to Laminin
Laminin is found exclusively in the basement membrane in vivo (Timpl et al, 1989), 
and very little is actually found in serum.
However, DLKP growing in SFM were found to be extremely responsive to laminin, 
supplemented to the medium at 5(ig/ml, a concentration commonly used in the literature. 
Table 3.2.12 shows similar if not slightly higher cell number for laminin supplemented 
SFM compared to fibronectin supplemented SFM, with at least a 2 to 2.5 fold increase 
in cell number, over the control SFM flasks without supplementation. Subcultivation 
experiments have shown that laminin supplementation significantly improveD the cell 
number that can be obtained during early passages in SFM.
When laminin was added to the SFM, DLKP cells were noted to become more spread 
out, but there was also a very definite increase in “neurite-like” processes coming from 
the cells. Fig 3.2.13 shows growth of DLKP cells in laminin supplemented SFM.
T a b le  3 .2 .1 2  Subcultivation  o f  D LK P in SFM  w ith (SFM  + Ln) and w ithout lam inin 
supplem entation a t 5 |ig /m l
Passage no. SFM SFM + Ln 
( e x p .l )
SFM + Ln
(exp 2)
1 3.375 ± 0.025 9.9375 ± 0.300 9.275 ± 1.975
2 3.938 ± 0.225 12.063 ±2.125 7.050 ± 0.525
3 8.083 + 0.581 10.306 ± 0.413 8.281 ± 0 .098
4 5.285 ± 0.987 12.813 ±0.063 9.931 ± 1.006
5 7.875 ± 0.875 12.789 ± 1.275 10.50 ± 0.975
Results are expressed in term s o f  cell concentration per flask x l0 5±  standard deviation (n=2).
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3.2.6.6 Response of DLKP to Type IV Collagen
Collagen is the most abundant protein in the basement membrane of the cell. Type IV 
collagen has been found to be involved in the binding of epithelial carcinoma cells 
(Palm and Furcht, 1982). It is the most commonly used collagen in SFM.
Supplementing the SFM with type IV collagen at a concentration of 5|ig/ml was found 
not to improve the growth of the cells at all during early passages in SFM. Similar 
growth of cells was obtained for collagen supplemented SFM when compared to the 
control, unsupplemented SFM. See Table 3.2.13.
No apparent change in the morphology was observed when cultured in collagen
containing SFM (Fig. 3.2.13).
Table 3.2 .13  Subcultivation  o f  D L K P in SFM  w ith (SFM  + Coll) and w ithout T ype IV  Collagen 
supplem entation at 5(ig/rnl
Passage no. SFM SFM + Coll 
(exp .l)
SFM + Coll 
(exp .2)
1 3.375 ± 0.025 3.994 ±  0.019 4.450 ±  0.550
2 3.938 ±  0.225 3.969 ± 0.406 4.144 ± 0.206
3 8.013 ±  0.581 3.581 ±  0.356 3.713 ±  0.000
4 5.825 ± 0.987 4.639 ±  1.181 4.050 ±  0.975
5 7.875 ±  0.875 6.506 ±  0.281 5.287 ± 0.150
Results are expressed in term s o f cell concentration per flask xlO 5 ±  standard deviation (n=2)
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Fig . 3 .2 .13(a) Morphology of DLKP 
in fibronectin supplemented SFM
Fig. 3.2.14(c) Morphology of DLKP 
in Collagen supplemented SFM
Fig. 3.2.14(b) M orphology o f D LK P in 
laminin supplemented SFM
Fig. 3.2.14(d) M orphology o f DLKP in 
SFM
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3.2.7 Sensitivity of DLKP cells to chemotherapeutic drugs in SFM
The serum-free medium can be used as a tool to study the effects of chemotherapy 
drugs on the DLKP cell line without the variability in results associated with the use of 
serum. Serum proteins have been reported to possibly have a slight protective effect 
against cytotoxic drugs and other serum components, such as prostaglandins and 
cytokines, and thereby can also interfere with the performance of a drug. The objective 
of this study was to assess the effect of three structurally different chemotherapeutic 
drugs, Adriamycin, Vincristine and VP16, on the DLKP cells under serum-free 
conditions and to compare results obtained to serum-supplemented assays.
Chemotherapy drug profiles were obtained for early passage (P.l SF.DLKP) and late 
passage (P.22 SF DLKP) in both serum-supplemented and serum-free medium.
3.2.7.1 Sensitivity to Adriam ycin
DLKP P.l and P.22 SF cells were exposed to increasing concentrations of Adriamycin 
ranging from 1.25ng/ml to 80ng/ml in both serum-free and serum-supplemented media. 
The results in Table 3.2.14 show the mean results of 3 separate experiments with 8 
replicates per experiment.
T ab le . 3 .2 .14 Sensitiv ity  o f  D LK P P .l  and P .22 to A driam ycin  in  both  SFM  and SSM
DLKP cells used Adriam ycin (IC50  
ng/m l)
Adriam ycin (fold 
w.r.t. DLKP in SSM)
P.l SF 20.63 ± 3.40 1.5
SSM 13.74 ± 2.60 1.0
P.22 SF 39.90 ± 13.4 2.9
P.22 SF in SSM 21.10 ± 2.25 1.53
The fold difference in IC 50 value for each with respect to (wrt) D LK P SSM  is shown for the drug.
The IC50 value to Adriamycin was found to increase by almost 3-fold in long-term 
serum-free cells when the assay was performed in SFM, and by 1.5-fold when carried 
out in serum-supplemented medium.
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3.2.7.2 Sensitivity to Vincristine
DLKP P.l and P.22 SF cells were exposed to increasing concentrations of Vincristine 
in the range 0.094ng/ml to 6.0ng/ml in both serum-free and serum-supplemented 
media. The results in Table 3.2.15 show the mean results from 2 separate experiments 
with 8 replicates per experiment.
T ab le . 3 .2 .15  S ensitiv ity  o f  D LK P P .l  and P.22 to V incristine in both SFM  and SSM
DLKP cells used Vincristine ( I C 5 0  
ng/ml)
Vincristine (fold 
w.r.t. DLKP in SSM)
P .l SF 0.266 ± 0.093 1.06
SSM 0.251 + 0 .029 1.00
P.22 SF 0.453 ± 0.068 1.80
P.22 SF in SSM 0.317 + 0.073 1.26
The fold difference in IC 50 value for each w ith respect to (wrt) DLKP SSM  is shown for the drug.
No difference in IC50 value was observed whether assayed in SFM or SSM. However, 
P.22 SF cells showed a slight increase in IC50 in serum-free medium.
3.2.7.3 Sensitivity to VP16
DLKP P.l and P.22 SF cells were exposed to increasing concentrations of VP16 
ranging from 9.4ng/ml to 600ng/ml in both serum-free and serum-supplemented media. 
Again the results are the mean of three separate experiments with 8 replicates per 
experiment and are shown in Table 3.2.16.
T ab le . 3 .2 .16  S ensitiv ity  o f  D L K P P .l and P.22 to V P16 in both SFM  and SSM
DLKP cells used VP16 (IC50 ng/ml) VP16 (fold w.r.t. 
DLKP in SSM)
P.l SF 15.75 + 5.98 0.58
SSM 27.38 ± 9.09 1.00
P.22 SF 16.00 + 2.81 0.58
P.22 SF in SSM 21.95 ± 0.84 0.80
The fold difference in IC 5 0  value for each with respect to (wrt) DLKP SSM  is shown for the drug.
The cells were found to be extremely vulnerable to VP 16 when assayed in serum-free 
medium with a resultant decrease in IC50 value.
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3.3 DLKP CLONES AND MDR VARIANT IN SERUM-FREE MEDIUM
Cultivation of the DLKP cell line has been found to be possible in serum-free medium. 
This allows a system to be used so that experiments can be carried out in conditions free 
from serum interference and variability in results that can be associated with the 
presence of undefined components in the medium.
This SFM was applied to the growth of a number of variant DLKP cell lines. The 
parental DLKP cell line contains three morphologically distinct populations during 
normal cultivation in serum-supplemented conditions. These 3 clones have been 
established from the original parental population (McBride, 1995) and may represent 
tumour heterogeneity in vivo. The SFM was also used to try and develop a system for 
the growth of the MDR variant, DLKP A, in a totally defined environment. This would 
then allow a system to be in place that can be used for toxicity assays to be carried out 
in conditions where a totally defined environment is more beneficial than using serum- 
supplemented conditions.
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3.3.1 Growth of DLKP Clones in SFM
DLKP contains three morphologically distinct populations. Dr. Shirley McBride 
established three clones corresponding to these populations from the parental DLKP 
cells. These clones were designated -M (mesenchymal - like), -I (intermediate - like) 
and SQ (squamous - like). On prolonged subculture, -SQ and -M can each interconvert 
with -I, but -SQ and -M do not interconvert. This may represent tumour heterogeneity 
in vivo. The development of a SFM for the growth of these clonal cell lines would be 
an extremely useful tool to study this interconversion process.
Investigations were carried out into the growth of these clones in the SFM developed 
initially for DLKP. When cultured in SFM, the number of DLKP-SQ and -M cells 
always failed to increase above seeding density levels at any stage, regardless of 
frequency of media change or the length of time in culture. However, in contrast, 
DLKP-I grew very well under SF conditions, even better than the parental DLKP 
population and were capable of being cultured up to at least 10 passages at a time 
(McBride, 1995).
In this thesis, investigations were carried out to try to find a SFM that would allow the 
proliferation of each of the clones. Growth experiments were carried out using 
fibronectin supplementation to the SFM, to evaluate its effect on the growth of each of 
the clonal cell lines. DLKP has already been found to be extremely responsive to 
fibronectin at early passages in SFM.
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3.3.1.1 D L K P - S Q
The DLKP-SQ ‘squamous-like’ clone appears to make up the largest proportion of the 
DLKP heterogeneous parental population of cells. Approximately 65% of the parental 
population appear to have this morphology by microscopical observations. However, 
this clonal cell line does not proliferate in the SFM used for the growth of the parental 
cell line. The cells always failed to proliferate above the initial seeding density. 
However, addition o f fibronectin to the SFM at a concentration of 5|xg/ml permitted 
growth of DLKP-SQ.
3.3.1.1.1 M orphology o f DLKP-SQ in fibronectin supplem ented SFM
DLKP-SQ, when placed in SFM, failed to form colonies and remained rounded in 
appearance. However when fibronectin was added at a concentration of 5|Xg/ml, the 
cells began to spread and resemble the squamous-like phenotype of their serum- 
supplemented counterparts. Figure 3.3.1 shows morphology of DLKP-SQ in 
unsupplemented and fibronectin-supplemented SFM.
156
Fig. 3 .3 .1(a) M orphology of DLKP-SQ in SFM
Fig.3 .3 .1(b) M orphology of DLKP-SQ in SFM plus 5 |ig/m l fibronectin
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3.3.1.1.2 Growth curve for DLKP-SQ in fibronectin supplem ented SFM
Table 3.3.1 shows growth of DLKP-SQ over a 7 day growth period in SFM and 
fibronectin supplemented SFM (results for three separate experiments are shown). Fig.
3.3.2 shows a growth curve to compare growth of DLKP-SQ cells in fibronectin 
supplemented and unsupplemented SFM.
Table 3.3.1(a) G row th curves for D L K P -SQ  over a  7 day grow th period
Experim ent 1
Time in days SFM SFM + FBN Basal SSM
1
2
3
4
5
6 
7
0.600
0.525
1.725
0.9
1.65
1.462
3.375
5.025
8.325
6.338
0.975
0.975
1.125
1.763
0.938
5.00
8.600
15.13
18.37
25.75
Serum -free m edium  (SFM ), fibronectin supplem ented SFM  (SFM  + FBN), basal m edium  (Basal) and 
serum -supplem ented m edium  (SSM ). Results are expressed as cell concentration per flask xlO 5.
Table 3.3.1(b) G row th curves for D L K P-SQ  over 5 day grow th periods
E xperim ent 2 E xperim ent 3
Time in days SFM SFM  + FBN SFM SFM + FBN
1 1.088 2.213 - -
2 1.350 1.463 2.388 ±  0.238 6.388 ±0.113
3 1.725 3.263 2.525 ± 0.000 8.150 ± 0 .650
4 0.975 3.713 2.425 + 0.175 6.375 ± 1.175
5 1.950 3.488 1.513 ± 0 .038 6.038 ± 0.063
Serum -free m edium  (SFM ), fibronectin supplem ented SFM  (SFM  + FBN). Results are expressed as 
cell concentration per flask xlO 5 ±  standard deviation (n=3) for experim ent 3
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F ig .  3 .3 .2  Growth curve for DLKP-SQ  in serum-free m edium  (SFM ), fibronectin supplemented 
serum-free medium  (SF M  + FBN), basal medium (Basal) and serum-supplemented medium  (SSM ), 
R esults are expressed as cell concentration per flask xlO 5, results for experim ent 1 are shown.
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Subcultivation of DLKP-SQ was found to be possible once fibronectin was added to 
the SFM. Cells were passaged once every 5-7 days and counted before seeding new 
flasks at a density of 2.5x105 per flask.
Table 3.3.2 shows two separate subcultivation experiments up to 4 passages for 
DLKP-SQ.
3.3.1.1.3 Subcultivation of DLKP-SQ in fibronectin supplemented SFM
Table 3.3 .2  Subcultivation  o f  D L K P-SQ  in fibronectin  supplem ented SFM  (SFM  + FBN )
E xperim ent I Experim ent 2
Passage no. SFM SFM  + FBN SFM SFM  + FBN
1 1.313 ± 0 .038 7.625 ± 0 .175 0.575 ±  0.025 6.875 ± 0.312
2 - 5.125 ± 0 .5 0 0 - 6.338 ± 0.000
3 - 2.175 ± 0 .150 - 2.812 ±0 .188
4 - 3.169 ± 0 .094 - 3.150 ± 0.188
Results are expressed in  term s o f cell concentration per flask xlO 5 ±  standard deviation (n=3)
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3.3 .1 .2  D L K P - I
The DLKP-I clone appears in the parental population as small colonies with indistinct 
cell boundaries. They make up about 30% of the heterogeneous parental population. 
These cells have been found to grow very well in the SFM developed for the growth of 
the parental cell line, with cell counts often exceeding the parental population in SFM 
(McBride, 1995).
Addition of fibronectin to the SFM generally allows better growth of the cells, 
especially during earlier passages in SF conditions.
3.3.1.2.1 M orphology o f DLKP-I in serum -free medium
The morphology of DLKP-I in unsupplemented SFM resembles that of DLKP-I in 
serum-supplemented medium, where the cells form colonies with indistinct cell 
boundaries. Addition of fibronectin to the medium causes the cells to spread out a lot 
more, while the morphology appears to resemble the DLKP-M cells in fibronectin 
supplemented SFM. Fig. 3.3.3 shows morphology of DLKP-I in SFM and SFM 
supplemented with 5fig/ml fibronectin.
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Fig.3 .3 .3(b) Morphology of DLKP-I in SFM plus 5|Xg/ml fibronectin
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3.3.1.2.2 Growth curves for DLKP-I in serum-free medium
Growth assays were set up to compare growth of DLKP-I in unsupplemented and 
fibronectin-supplemented SFM over 5 to 7 day growth periods.
Table 3.3.3 shows the results for 3 separate experiments. Fig 3.3.4 shows the growth 
curves obtained in experiment 1.
Table 3.3.3(a) G row th curves for D LK P-I over a 7 day grow th period
Experim ent 1
Time in days SFM SFM + FBN Basal SSM
1 0.863 2.400 0.450 2.200
2 1.838 5.213 0.750 4.350
3 2.362 8.750 1.088 8.625
4 2.850 8.500 1.350 20.13
5 5.175 6.375 2.288 28.50
6 - - - -
7 2.438 3.038 1.463 32.63
Serum -free m edium  (SFM ), fibronectin supplemented SFM  (SFM  + FBN), basal m edium  (Basal) and 
serum -supplem ented m edium  (SSM ). Results are expressed as cell concentration per flask x lO 5.
Table 3.3.3(b) G row th curves for D L K P-I over 5 day grow th periods
E xperim ent 2 Experim ent 3
Time in days SFM SFM + FBN SFM SFM + FBN
1 0.413 1.238 - -
2 0.900 2.288 5.238 ±0.138 9.225 ±  0.050
3 1.688 4.575 5.525 ± 0 .100 7.037 ± 0.688
4 2.438 7.988 4.825 ± 0.425 6.850 ±  0.100
5 4.050 7.425 3.850 ±0 .325 4.713 ±  0.237
Serum -free m edium  (SFM ), fibronectin supplem ented SFM  (SFM  + FBN). Results are expressed as 
cell counts per flask xlO 5 ±  standard deviation (n=3) for experim ent 3.
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time in days
F i g .  3 . 3 . 4  Growth curve for DLKP-I in serum-free medium (SF M ), fibronectin supplemented  
serum-free medium (S F M  +  F B N ), basal m edium  (Basal) and serum -supplemented m edium  (SS M ). 
R esults are expressed as cell concentration per flask xlO 5, results for experim ent 1 are show n.
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3.3.1.2.3 Subcultivation of DLKP-I in serum-free medium
Subcultivation of DLKP-I was found to be possible in both supplemented and 
unsupplemented SFM. Generally fibronectin addition increased cell counts over 
unsupplemented SFM during the early passages in SF conditions. However, after this 
time (exp.l), cell counts were found to be quite similar irrespective of whether 
fibronectin was supplemented to the medium or not (Table 3.3.4).
T a b le  3 .3 .4  Subcultivation  o f  D L K P -I
Experim ent 1 E xperim ent 2
Passage no. SFM SFM +  FBN SFM SFM +  FBN
1 4.675 +  0.175 8.700 ±  0.000 3.075 ±  0.750 7.613 ±  0.450
2 7.250 +  2.625 5.590 ±  1.720 5.756 ± 0 .2 8 1 4.725 ±  0.600
3 7.439 ±  1.189 9.563 ±  1.313 4 .050 ±  7.425 6.150 ±  1.238
4 7.144 +  0.431 12.08 ±  1.538 4.825 ±  0.425 8.250 ±  0.250
5 15.79 ±  0.413 10.95 ±  0.000 5.525 ±  0 .100 6.219 ±  0.469
6 8.494 ±  0.244 7.238 ±  0.072
7 4.444 ±  0.581 4 .650 ±  0.510
8 8.981 ± 0 .9 5 6 9.600 ± 0 .1 8 5
9 11.00 ± 0 .9 3 8 *
10 11.34 ± 0 .0 1 9
11 5.688 ±  2.875
12 7.188 ±  1.313
13 12.75 ±  0.688
Serum -free m edium  (SFM ), fibronectin supplem ented SFM  (SFM  + FBN ). R esults are expressed in 
term s o f  average cell counts per flask  xlO 5 ±  standard deviation (n=2).
* fungal contam ination at this passage
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3.3.1.3 D L K P - M
The DLKP-M clone appears in the parental population as irregular, fibroblastoid cells 
that do not appear to form colonies. They make up approximately 5% of the parental 
population.
Like DLKP-SQ, this cell line fails to proliferate in the SFM investigated for DLKP. 
However, addition of fibronectin at a concentation of 5[ig/ml had a profound on the 
growth of the cell line under SF conditions.
3.3.1.3.1 M orphology o f DLKP-M  in serum -free m edium
The morphology of DLKP-M in unsupplemented SFM resembles their serum- 
supplemented counterparts. The cells appear elongated with neurite-like processes 
present in some of the cells. No colony formation occurred. However, on addition of 
fibronectin to the SFM, the cells became very spread out and appeared to grow to 
confluence (Fig. 3.3.5)
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Fig. 3 .3.5(a) M orphology of DLKP-M  in SFM
Fig .3 .3 .5(b) Morphology of DLKP-M in SFM plus 5 |ig/m l fibronectin
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3.3.1.3.2 Growth curves for DLKP-M in serum-free medium
Table 3.3.5 shows growth of DLKP-M over 4-5 day periods in SFM with and without 
fibronectin supplementation (results for 3 separate experiments shown). Fig. 3.3.6 
shows a growth curve to compare growth of DLKP-M in supplemented and 
unsupplemented SFM.
T a b le  3 .3 .5 (a) G row th curves for D L K P-M  over a 5 day growth period
Experim ent 1
Time in days SFM SFM + FBN Basal SSM
1 1.125 1.650 0.413 2.663
2 1.500 4.350 0.525 5.363
3 1.800 6.188 1.163 11.70
4 2.0625 10.24 1.575 14.85
5 2.0625 6.338 1.500 31.05
Serum -free m edium  (SFM ), fibronectin supplem ented SFM  (SFM  + FBN), basal m edium  (Basal) and 
serum -supplem ented m edium  (SSM ). Results are expressed as cell concentration per flask xlO 5.
T a b le  3 .3 .5 (b ) G row th curves fo r D L K P-M  over a 4 day growth period
Experim ent 2 E xperim ent 3
Time in days SFM SFM  + FBN SFM SFM  + FBN
1 0.275 0.788 0.675 1.688
2 1.125 2.625 2.138 5.925
3 2.588 5.550 2.424 9.900
4 2.513 6.788 2.100 3.300
Serum -free m edium  (SFM ), fibronectin supplem ented SFM  (SFM  + FBN). R esu lts are expressed as 
cell concentration per flask xlO 5.
F i g .  3 . 3 . 6  Growth curve for D L K P-M  in serum-free medium (SF M ), fibronectin-supplemented  
serum-free medium (SF M  + F B N ), basal medium (Basal) and serum -supplemented m edium  (SS M ), 
R esults are expressed as ce ll concentration per flask  x lO s, results for experim ent 1 are show n.
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3.3.1.3.3 Subcultivation of DLKP-M in serum-free medium
Subcultivation o f DLKP-M was found to be possible in fibronectin supplemented SFM. 
Table 3.3.6 shows two separate subcultivation experiments up to 3 passages for 
DLKP-M.
T a b le  3 .3 .6  S u b cu ltiva tion  o f  D L K P -M
E x p e r i m e n t  1 E x p e r i m e n t  2
Passage no. SFM SFM + FBN SFM SFM + FBN
I 1.650 ± 0.025 10.65 ± 0.300 0.694 ± 0 .169 7.781 ± 0.344
2 - 7.550 ± 1.200 - 3.875 + 0.688
3 - 9.950 ± 0.860 - 8.750 ± 1.312
Serum -free m edium  (SFM ) and fibronectin supplem ented SFM  (SFM  + F B N ). R esults are expressed 
in terms o f  average ce ll concentration per flask xlO 5 ±  standard deviation (n=3).
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3.3.2 DLKPA IN SERUM-FREE MEDIUM
DLKPA is a multiple drug resistant (MDR) variant o f DLKP which was selected to 
increasing concentrations of the chemotherapeutic drug, Adriamycin. It was decided to 
try to develop a system for the growth o f this MDR model cell line in SFM that would 
allow extensive toxicity work to be carried out under defined, serum interference-free 
conditions. A system would then be available that allows the effects o f different 
chemotherapeutic in combination with growth factors, prostaglandins e tc . to be tested 
without the risk o f serum contamination.
3.3.2.1 Morphology of DLKPA in serum-free medium
In SF DLKPA culture, the cells grew much more spread out and tightly attached to the 
flask surface as compared to early passage DLKP cells. Confluency is usually reached 
in SF DLKPA (see Fig. 3.3.7) culture which did not occur in DLKP culture. The 
morphology o f the DLKPA cell line in SFM was quite similar to SSM.
F ig . 3 .3 .7  Growth o f  D L K P A  ce lls  in S I M  - P.3 SF  ce lls
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3 .3 .2 .2  Growth response o f  DLKPA in SFM
The SFM used initially for the growth of CHO-K1 and then DLKP cells, H SFM, was 
used as a basis for the SF growth of DLKPA cells. A  growth curve was obtained over 
a 10 day period for DLKPA cells in SFM, SSM and Basal medium (see Fig. 3 .3 .8 )
time ( d a y s )
Fig.  3 .3 .8  Growth curve for DLK PA ce lls  in  basal medium (Basal), serum-free medium (SF M ) and 
serum-supplemented (SSM ). R esults are expressed as average absorbance at 620nm  ±  standard 
deviation (n=8).
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The ability o f this cell line to grow for long periods o f time in SFM was then 
investigated. Passaging o f the cell line was carried out approximately once every 7 to 
10 days. Long-term growth has been found to be possible with two sets of 
experimental results shown in Table 3.3.7 where one experiment was carried out to 
P. 15 SF (7 months in culture) and another was carried out to P. 14 SF (6 months in 
culture).
Trypsinisation times were found to take on average between 10 to 15 minutes compared 
to the 3 to 5 minutes in DLKP SF culture. This seems to tie in with the microscopic 
observation that the DLKPA cells attach to the substratum much more tightly in SFM 
compared to DLKP SF cells.
3.3.2.3 Long-term cultivation in serum-free medium
T a b le  3 .3 .7  L ong-term  grow th o f  D L K PA  ce lls  in H am 's F 12 SFM
P a ssa g e  n o . E x p er im en t 1 E x p er im en t 2
1 23.375 15.488 ±0.175
2 8.875 14.000 ± 1.575
3 16.400 17.006 ±  2.381
4 13.625 11.375 + 0.438
5 14.525 15.375 ± 0.075
6 21.600 18.375 + 2.925
7 22.188 16.406 ±  1.344
8 18.188 21.650 ± 6.500
9 11.400 12.825 ± 0.900
10 21.188 13.969 ±  1.656
11 12.313 14.325 ± 0.300
12 11.563 8.883 ±0.275
13 18.188 17.563 ±  0.063
14 13.625 25.188 ±0.000
15 17.550 -
R esults are expressed in term s o f  ce ll concentration per flask x lO 5 ±  standard deviation (n=3) for 
experim ent 2.
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3.3.2.4 Cryopreservation of DLKPA cells in SFM
The same procedure was carried out as for DLKP SF cells. The cells were frozen in 
10% DMSO and 0.1% Methylcellulose in SFM as before. Results from two separate 
experiments (Table 3.3.8) show that this SF freezing medium is capable o f supporting 
good viability o f the cells. The freezing technique appears to have no adverse long-term 
effect on the cell line in SF conditions. The cells were also noted to have attached to the 
flask surfaces within one hour o f thawing.
T a b le  3 .3 .8  Serum -free cryoprescrvaiion o f  D L K P A
Cells used % Viability
P .l SF 
P.9 SF
78.66 ±  3.03 
81.23 ± 4 .4 4
V iability  o f  ce lls  after thawing ±  standard deviation (n=6)
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The principal aim o f the DLKPA SF work was to develop a system which enables 
chemotherapeutic toxicity assays to be carried out under defined conditions. A similar 
set o f growth concentration assays were carried out for DLKPA cells as for DLKP 
cells. A  range o f cell concentrations were set up in 96-well plates as before ranging 
from 5 x l0 2 to lxlO 4 cells/ well over a 7 day and 10 day assay period. The cells were 
fixed using the method outlined for DLKP cells, using 50% cold TCA, and stained at 
the end point o f the assay using crystal violet. The following concentration curves were 
obtained for the 7 and 10 day period (Fig. 3.3.9) and show that a cell concentration o f 
3 x l0 3 cells per well over a 10 day period is the most effective concentration o f cells to 
lie well within the linear part o f the crystal violet absorbance curve.
3.3.2.5 Development of assay system for miniaturised in vitro toxicity
assays
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F ig . 3 .3 .9 (a ) C ell concentration curve for D L K P A  ce lls  over a 7 day grow th period
F ig . 3 .3 .9 (b ) C ell concentration grow th curve for D L K P A  cells  over a 10 day period
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3.4 INVESTIGATIONS INTO KERATIN 8 AND 18 EXPRESSION IN 
DLKP AND DLKPA
The DLKP cell line has been described pathologically as a poorly differentiated human 
lung carcinoma. Keratin intermediate filaments are expressed in epithelial cells in a cell- 
and tissue-specific manner. DLKP is normally keratin negative. However, treatment 
of this cell line with the differentiating agent, 5-bromodeoxyuridine (BrdU) over a 5- 
day period, induces expression of K8 and K18, shown by immunocytochemical 
methods (McBride and Clynes, manuscript submitted). BrdU treatment o f a similar 
keratin negative cell line, H82, also results in induction of K8 and K18. These cells 
normally grow in suspension but on treatment with BrdU the cells begin to attach to the 
flask surface. BrdU treatment of a keratin positive cell line, A549, results in an 
increase in the expression o f K8 and K18. However, BrdU treatment of a non- 
epithelial leukaemic cell line, HL60, which are normally keratin negative shows no 
induction o f K8 or K18 filaments.
Studies were carried out to determine if  BrdU can induce similar expression o f keratin 8 
and 18 proteins in DLKPA. The effect o f the highly toxic chemotherapeutic agent, 
Adriamycin, on keratin expression in these cell lines was investigated.
Northern blot analysis has revealed that the levels o f K8 and K18 mRNA are the same 
before and after BrdU treatment. These results seem to suggest that BrdU is acting at a 
post-transcriptional level to reverse the block in keratin 8 and 18 expression in keratin- 
negative DLKP cells. This suggests that BrdU may be exerting its effect directly or 
indirectly on protein translation, or stabilisation o f translation products already present! 
Studies were carried out using the protein synthesis inhibitors, cycloheximide and 
Actinomycin D to determine if  there might be some evidence for a protease causing a 
de-stabilisation or rapid degradation o f a translation product for keratin 8 and 18.
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3.4.1 Effect of BrdU on keratin 8 and 18 expression in DLKPA
DLKPA is a multiple drug resistant (MDR) variant o f DLKP, which was selected to 
increasing concentrations o f the chemotherapeutic drug, Actinomycin. There have been 
varying reports in the literature regarding relationships between multiple drug resistance 
and keratin expression (see Section 4.6.1). Experiments were carried out to determine 
if keratin filaments are expressed in DLKPA, and if BrdU could induce keratin 
expression in a manner similar to DLKP cells. All experiments were carried out in 6- 
well tissue culture plates, including immunocytochemical analyses, using 
concentrations o f BrdU at 0, 1 and 10(iM over a 5-7 day period (as described in Section 
2.13-2.14).
The BrdU-treated cells showed similar morphology to BrdU-treated DLKP cells were 
found at ljiM  and 10(iM concentrations o f BrdU. A l|iM  concentration had little effect 
on morphology, allowing 70-80% survival similar to DLKP. However, 10|aM BrdU 
had a much more pronounced effect on morphology, where the cells were much larger 
in appearance and their cytoplasm was stretched and spread out (Fig. 3.4.1). Similar 
toxicity levels to DLKP were noted at this concentration, with about 20-30% survival.
Table 3.4.1 lists a brief description o f the effect o f BrdU concentrations on the 
morphology o f DLKPA and DLKP cell lines after 7 days exposure to the compound.
T a b le  3 .4 .1  Sum m ary o f  m orphological e ffects o f  brom odeoxyuridine (B rdU ) on D LK P and D LK PA
C e ll L in e C o n t r o l 1 |xM  B r d U 1 0  ji.M B rd U
DLK P -  70% confluent ~ 70-80%  control 
sim ilar m orphology  
to control
~  20-30%  o f  control - 
larger cells and stretched
D LK PA -  60% confluent -  70-80%  control. 
Sim ilar m orphology  
to control
~  20-30%  o f  control - 
larger cells and stretched
178
Immunocytochemical analysis was carried out on the BrdU-treated DLKPA cells. An 
anti-pan cytokeratin Ab was first used, which can detect the following cocktail of 
keratin filaments; cytokeratins 1, 4, 5, 6, 8, 10, 13, 18 and 19.
Negative staining for the pan-cytokeratin Ab was noted in the control, untreated wells. 
However, approximately 10% and 20-30% of cells were found to react positively with 
those Ab’s following treatment with l(iM and lOpM BrdU respectively (Fig. 3 .4 .2). 
Similar results were observed using Abs to the individual keratins 8 and 18. Therefore, 
a similar effect to DLKP is noted on BrdU treatment o f DLKPA.
179
Fig. 3.4.1 M orphology o f DLKP without (a) and (b) w ith 10|iM  BrdU  treatm ent for 7 days
mm.
F ig . 3 .4 .1  M o rp h o lo g y  o f  D L K P A  w ith o u t (a )  and (b ) w ith  10|jM  B rd U  trea tm en t fo r 7 days
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IB
Fig. 3.4.2 B rdU -induced keratin expression  in D L K P A  cells , (a) N o im m unoreactivity w ith anti-pan 
keratin A b w as detected in untreated cells, (b) Positive reactivity in IOjiM BrdU-treated ce lls  with anti­
pan A b. (xlOO)
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3 .4 .2  Effect of Adriamycin on DLKP cells - to try to rule out a toxic 
effect from BrdU resulting in keratin expression
Bromodeoxyuridine at the concentration used in the study was found to be quite toxic to 
the cells (IC50 o f DLKP to BrdU is 2 .6 \ i M ,  IC50 o f DLKPA to BrdU is 1.7^M, Dr. 
Shirley McBride, PhD 1995). Experiments were carried out using the highly toxic 
chemotherapeutic drug Adriamycin, at concentrations which would result in similar 
levels of toxicity to the cells (IC50 o f DLKP to Adr is 0.01|xg/ml approx; while the IC50 
of DLKPA to Adr is 2.5jrg/ml approx.) to try to rule out the possibility that keratin 
expression was induced as a result o f cytotoxic stress to the cells rather than the 
differentiating effect o f BrdU.
T a b le  3 .4 .2  C oncentra tions o f  A driam ycin chosen for assay
C e ll L in e e q u iv a le n t to  1(J.M B rd U e q u iv a le n t to  10|J,M B rd U
D LK P
DLK PA
0.002ug/m l A dr 
0 .4 |lg /m l A dr
0.02(xg/ml A dr 
0.4(0.g/ml A dr
The concentrations o f Adriamycin chosen for DLKP were also used to treat HL60, 
A549 and H82 cells. Experiments were carried out in 6-well tissue culture plates as 
before. Cells were treated with Adriamycin for 5 days, the plates fixed and 
immunocytochemistry performed using Abs to cytokeratins 8 and 18.
No induction o f cytokeratins 8 and 18 was observed in DLKP or DLKPA with 
increasing concentrations o f Adriamycin. In A549 cells, there was no apparent increase 
in intensity o f staining as is usual for BrdU-treated A549 cells. HL60 cells remained 
negative for cytokeratin expession while H82 cells showed no positive reactivity to 
cytokeratins 8 and 18. No adherent cells were observed in the treated wells compared 
to BrdU-treated H82 cells.
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3.4.3 Long-Term Cytokeratin Expression in DLKP Cells
The ability o f DLKP cells to retain cytokeratin expression following removal o f BrdU 
from the medium was examined. Cells were treated with BrdU at 0, 5 and IOjiM  
concentrations for 10 days. After this time, one plate was taken down and fixed 
(PLATE 1), while the second and third plates were fed with growth medium without 
BrdU for 5 days; after which one of the plates was taken down and fixed (PLATE 2), 
while the third plate was passaged - setting up a further two 6-well plates in BrdU-free 
medium. These plates were allowed to grow for a further 7 days, after which one of 
the plates was fixed (PLATE 3), while the other plate was passaged as before, setting 
up two 6-well plates. This serial passaging was carried out twice more (PLATE 4 and 
PLATE 5). Immunocytochemistry was then carried out using Abs to cytokeratins 8 and 
18, with the results shown in Table 3.4.3.
T ab le  3.4.3 L ong-term  keratin  8 and 18 expression in D L K P  B rdU -treated cells
B rdU  conc. CK 8 CK 18
PLA TE 1 5|iM 5-10% +ve 10 % -t-ve
1 OfiM 30% +ve 30% +ve
PLATE 2 5|i,M 5% 4-ve 10% +ve
10|iM 20% +ve 15-20% +ve
PLA TE 3 5|liM -ve 5% +ve
lOfiM 5-10% +ve 5-10% +ve
PLATE 4 5 \ i M -ve -ve
10(lM -ve 5% -i-ve
PLA TE 5 5(iM -ve -ve
lOpM -ve -ve
The results suggest that the cytokeratin positive cells are gradually being “diluted” out 
of the system. However, the cells appear to retain their cytokeratin positivity for at least 
two weeks on the removal o f BrdU from the medium.
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3.4.4 Protein Synthesis Inhibitor Studies on DLKP Cells
All experiments (including exposure to cycloheximide and Actinomycin D & 
immunocytochemical analysis) were carried out in 6-well tissue culture plates, as 
outlined in Section 2.13.
3 .4 .4 .1  C y c lo h e x im id e
Cycloheximide was added to the cells at concentrations ranging from 500ng to 
100|xg/ml for various lengths o f time to try and determine if it can allow the induction of 
keratin expression in DLKP cells.
E x p . l :  used concentrations of cycloheximide used in the literature (Cremisi and 
Duprey, 1987: Paine e t  a l . ,  1992) o f 5 and 10|ig/ml. Cells were treated for 3 and 6 
hours with drug, medium was removed and BrdU-free medium was added for 2 days. 
Immmunocytochemistry was then performed using Abs. to CK 8/18.
Result: Some +ve cells (5%) found in 6hr plates at 5 and 10(4,g/ml, rest -ve including 
3hr plates.
E x p .2 :  used concs. o f cycloheximide - 0, 5, 10, 20, 50 and 100|ig/ml for periods o f 1, 
3, 6, 9.5, 22 and 36hrs. BrdU-free medium was then added for 48hrs, plates fixed and 
immunocytochemistry carried out with Abs to CK 8/18.
Result: Some +ve cells (5%) found in 6 and 9.5hr plates at concentrations of 
cycloheximide from 5-20(lg/ml. All other plates were negative.
E x p .3: used low conc. o f cyloheximide (50ng/ml) over a longer time period i.e . 24, 48 
and 72 hours. Immunocytochemistry again carried out to CK 8/18.
Result: No +ve cells for CK 8/18.
E x p .4 :  similar to experiment 1 but used time periods of 5, 6, 7, 8, 9, 10, 11 hrs with 
cycloheximide at 5 and 10|ig/ml, removed medium and added drug-free medium for 48 
hours. Immunocytochemistry carried out with Abs to CK 8/18 as before.
Result: positive cells were found at all time points, again approx. 5% +ve
The results seem to indicate that cycloheximide may have some effect on the cells, 
especially at 5 and 10|ng/ml for 6-10hrs. However, the number o f positive CK 8 and 
18 cells is quite low.
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3.4.4.2 Actinomycin D
Actmomycin D  has proved to be extremely toxic to DLKP cells at the concentrations 
used in the study, from lOOng/ml to 5000ng/ml. Upon removal o f the drug, the cells 
showed poor recovery over the next 48 hours o f the assay in drug-free medium.
Immunocytochemical analysis o f the cells following treatment showed no induction o f 
keratins 8 or 18 using similar time points to those used in the cycloheximide 
experiments.
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3.5 DETERMINATION OF EPITHELIAL-SPECIFIC AND 
EPITHELIAL-ASSOCIATED MARKERS IN BRDU-TREATED CELLS
The effect o f the differentiation-inducing agent BrdU was examined in an attempt to 
further characterise the new cellular phenotype as observed by Dr. Shirley McBride. 
BrdU has previously been shown to induce the expression o f cytokeratins 8, 17 and 18 
in DLKP cells. Studies were carried out on DLKP and other cell lines, DLKPA, H82, 
A549 and HL60, to determine if BrdU changed the expression o f other epithelial- 
specific markers. The new cellular morphology was noted to be much larger, stretched 
and flattened suggesting a change in the adhesiveness o f the cells. The (3, integrin 
profile of the cells before and after BrdU treatment was also detetmined.
3.5.1 DLKP cells
Bromodeoxyuridine treatment o f DLKP cells results in the induction o f the 
cytokeratins, 8 and 18, as already described in Section 3.4. Morphologically the cells 
were altered on BrdU treatment. The cells appeared much more flattened and stretched 
with and apparent increase in surface area compared to untreated cells. Further 
immunocytochemical studies were carried out on the cells to characterise the new 
cellular phenotype. BrdU assays were carried out in 6-well assay plates as previously 
described in Section 2.13.
3.5.1.1 Cytokeratin 19
This keratin is often expressed in simple epithelia in conjunction with keratins 8 and 18. 
Treatment of DLKP cells with IOjxM  BrdU for 7 days, the induction o f keratin 19 was 
observed with about 10% o f the cells showing positive staining. This level o f induction 
was less than that usually observed for cytokeratins 8 and 18 (usually 30%). Fig.
3.5.1 shows positive cytokeratin 19 staining in BrdU-treated DLKP cells compared to 
negative staining in untreated control cells.
3.5.1.2 Epithelial-specific antigen
ESA is a transmembrane protein that is mainly expressed at the baso-lateral domain of 
epithelial cell membranes. The Ab is use to discriminate cells of epithelial origin from 
cells o f mesothelial origin. There is evidence to suggest that ESA may act as a cellular 
adhesion molecule.
Untreated DLKP cells are negative for ESA but on BrdU treatment for 7 days at a lOpM 
concentration, approximately 70-80% o f the cells are faintly positive for ESA staining
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with about 20% of these cells showing strong positive staining. Fig. 3.5.2 shows 
positive ESA reactivity in BrdU-treated DLKP cells.
3.5.1.3 Desmosomal protein
Desmosomes are thickened parts o f the plasma membrane where cells are tightiy 
attached to their neighbours. They are specifically associated with intermediate 
filaments and are specific to epithelial cells.
Cells exposed to 10|iM BrdU for 7 days were analysed for desmosomal protein 
expression. All cells were negative for this protein before and after treatment with 
BrdU.
3.5.1.4 EGF-R
EGF-R plays a role in cellular proliferation and differentiation. The expression o f  
EGF-R varies frequently in epithelial tumours.
Cell exposed to 10|xM BrdU for 7 days were analysed for EGF-R reactivity. All cells 
were faintly positive before and after treatment with no apparent increase in intensity.
3.5.1.5 Beta-1 integrins
Integrins are very important receptors for extracellular matrix components. There has 
been an increasing interest in the role o f these receptors in cancer, especially during 
invasion and metastasis. Reports from the literature show a trend for the down- 
regulation o f (3j integrins in poorly differentiated and aggressive epithelial carcinomas. 
Because o f the observed morphological changes in DLKP cells after BrdU treatment, 
where the cells become more flattened and stretched suggesting changes in the adhesion 
properties o f the cells, investigations were carried out using antibodies to a range o f  
these integrins.
a , p ,  i n t e g r i n  ( V L A - 1 )
Untreated cells were negative for VLA-1 expression. However on treatment o f DLKP 
cells for 7 days with 10(iM BrdU, induction o f VLA-1 was observed with 
approximately 30% o f the cells showing positive staining. Fig. 3.5.3 shows positive 
VLA-1 staining in BrdU-treated DLKP cells compared to negative staining in untreated 
cells.
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a 2p ,  i n t e g r i n  ( V L A - 2 )
Untreated cells show faint staining in approximately 20-30% of the cells. Treatment of 
the cells with BrdU at a lOpM concentration for 7 days, an upregulation o f expression 
of VLA-2 was observed with approximately 80% of the cells positive. 20% o f these 
cells showed very strong positive staining. Fig. 3.5.4 shows upregulation o f VLA-2 in 
BrdU-treated DLKP cells compared to faint staining in untreated control cells.
a 3p ,  i n t e g r i n  ( V L A S )
Untreated DLKP cells show positive staining for VLA-3 with no apparent increase in 
intensity on BrdU treatment for 7 days.
a 4p ,  in te g r in  (V L A -4 )
Untreated DLKP cells were found to be negative for VLA-4 with no induction of 
expression observed on BrdU treatment for 7 days.
a sp ,  in te g r in  ( V L A S )
Untreated DLKP cells were found to be negative for VLA-5 with no induction of 
expression observed on BrdU treatment for 7 days.
a 6p j in te g r in  ( V L A -6 )
Untreated DLKP cells were found to be negative for VLA-6 with no induction of 
expression observed on BrdU treatment for 7 days.
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F ig . 3 .5 .1  B rdU  induced  cytokeratin  19 staining in DLKP cells, (a) No im m unoreactivity with anti- 
keratin 19 Ab was detected in untreated cells, (b) Positive reactivity in 10(iM BrdU-treated cells with 
anti-cytokeratin 19 Ab.
F ig . 3 .5 .2  B rdU  induced  ESA  staining in DLKP cells, (a) No im m unoreactivity  with anti-ESA  Ab 
was detected in untreated cells, (b) Positive reactivity in 10|xM BrdU -treated cells with anti-ESA Ab.
F ig . 3 .5 .3  BrdU induced a ,  integrin staining in DLKP cells, (a) No im m unoreactivity w ith an ti-a , 
integrin Ab was detected in untreated cells, (b) Positive reactivity in 10(J.M BrdU -treated cells with anti- 
a L integrin Ab.
F ig . 3 . 5 . 4  U pregulation o f  a 2 integrin staining in DLK P cells, (a) Fain t im m unoreactivity with 
anti-Oj integrin A b was detected in untreated cells, (b) Increased positive reactivity in 10(iM  BrdU- 
treated cells w ith anti-o^ integrin Ab.
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3.5.2 Effect of BrdU on the expression of these antigens in other cell 
lines
3.5.2.1 DLKPA
Cells were treated with BrdU for 7 days at a concentration o f 10(iM in all experiments 
carried out.
Cytokeratin 19
Untreated DLKPA cells were found to be negative for keratin 19. Induction o f this 
keratin was observed after BrdU treatment for 7 days, with about 5% of the cells 
positively stained (Fig. 3.5.5(a)).
Epithelial-specific antigen
Untreated DLKPA cells, like DLKP, were found to be negative for the expression of 
ESA. However, after BrdU treatment for 7 days most o f the cells (at least 80%) were 
found to show faint positive staining for ESA (Fig. 3.5.5(b)).
a,ft, integrin (VLA-1)
Untreated DLKPA cells were found to be negative for VLA-1. BrdU treatment for 7 
days resulted in the induction o f this integrin in about 10% of the cells (Fig. 3.5.5(c))..
Desmosomal protein
Untreated- and BrdU-treated cells were found to be negative for the expression of 
desmosomal protein.
EGF-R
Untreated and treated DLKPA cells showed faint positive staining for EGF-R with no 
apparent increase in intensity, similar to BrdU treatment of DLKP cells.
This pattern o f expression in DLKPA cells is the same for DLKP cells with similar 
induction of cytokeratin 18, ESA and a, integrin and no change in the expression of 
EGF-R and desmosomal protein on treatment with BrdU.
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F i g .  3 . 5 . 3  BrdU induced cytokeratin 19, ESA and a ,  integrin staining in D LK PA  cells, (a) No 
im m unoreactivity w ith a n ti-a , integrin Ab was detected in untreated cells, (b) Positive reactivity in 
10|J.M BrdU -treated cells with anti-CK  19 Ab. (c) Positive reactivity in 10|jM  BrdU-treated cells with 
anti-ESA  Ab. (d) Positive reactivity in 10|iM  BrdU -treated cells w ith an ti-a , integrin Ab.
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3.5.2.2 H82
H82 is a human lung cell line and has been classified as variant SCLC. This cell line 
thus has no cytokeratin proteins expressed under normal growth conditions. The cells 
are similar to DLKP in that they express some NE markers. This cell line normally 
grows as aggregates in suspension but on treatment with BrdU, the cells begin to attach 
to the surface o f the wells. Treatment with lOpM BrdU for 7 days results in attachment 
of over 90% o f the cells to the surface o f the wells. It has previously been shown that 
treatment with BrdU results in the induction o f cytokeratin 8, 17 and 18 in H82 cells 
(McBride, 1995). There may also be changes in the expression o f cell adhesion 
molecules in these cells in addition to the alterations in cytoskeletal proteins.
In all experiments, H82 were treated for 7 days with 10(iM BrdU. After this time, 
attached cells were fixed in the 6-well plates while cytospins were made o f the 
suspension cells as outlined in Section 2.14.2. Immunocytochemistry was then carried 
out on these cells.
Cytokeratin 19
Untreated H82 cells were found to be negative for keratin 19 expression. Treatment 
with BrdU resulted in keratin 19 expression in about 10% of treated, attached cells.
ESA
Untreated H82 cells were found to be negative for ESA expression. Treatment with 
BrdU showed no induction o f ESA
oc,P, integrin (VLA-1)
H82 normally are negative for VLA-1. However treatment with BrdU shows an 
induction o f this integrin in about 5% of the cells.
a2P, integrin (VLA-2)
Untreated and BrdU-treated H82 showed negative staining for VLA-2.
Induction o f a , integrin and cytokeratin 19 was observed on treatment with BrdU 
similar to DLKP cells. However, no induction o f ESA or upregulation o f a 2 integrin 
was observed.
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F ig . 3 . 5 . 6  BrdU-induced cytokeratin 19 and a ,  integrin stain ing in H 82 cells. (a) N o  
im m unoreactivity with the an ti-a , integrin A b was observed in untreated ce lls , (b) P ositive  reactivity 
in lOpM -treated cells with anti-C K  19 A b. (c) P ositive reactivity in 10|_iM-treated ce lls  w ith  anti-a , 
integrin Ab.
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3.S.2.3 A549
A549 cells have been classified as human lung adenocarcinoma cells. These cells 
express keratins 8 and 18 but not keratin 17 proteins. Treatment with BrdU results in 
the induction o f expression of keratin 17 and an increased expression o f  keratins 8 and 
18 (McBride, 1995).
Cytokeratin 19
Approximately 30% of the untreated A549 cells were positive for keratin 19. However, 
on treatment with BrdU, there is a strong upregulation o f the expression o f this protein 
with at least 80-90% of the cells positive for keratin 19 (Fig. 3.5.6(a)).
Desmosoinal protein
Untreated- and BrdU-treated A549 cells were found to be positive for expression of 
desmosomal protein with no apparent increase in intensity.
Epithelial-specific antigen
Untreated A549 cells show approximately 20-30% of the cell with positive staining. 
On treatment with BrdU for 7 days, approximately all the cells show faint positive 
staining for ESA (Fig. 3.5.6(b).
EGF-R
Untreated and treated A549 cells were found to be positive for EGF-R with no apparent 
increase in intensity.
a,P, integrin (VLA-1)
Untreated and treated A549 cell were found to be faintly positive for the expression of 
VLA-1.
OC2(3, integrin (VLA-2)
Untreated and treated A549 cells were found to show strong staining for VLA-2 with 
no apparent increase in intensity.
a3Pj integrin (VLAS)
Untreated and treated cells were found to show strong staining for VLA-3 with no 
apparent increase in intensity.
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a 4P] in te g r in  ( V L A - 4 )
Untreated and treated A549 cells were found to be negative for expression o f VLA-4. 
a s(5, i n te g r in  ( V L A S )
Untreated and treated A549 cells were found to be positive for expression o f VLA-5 
with no apparent change in staining intensity.
a 6P j i n te g r in  ( V L A - 6 )
Untreated and treated A549 cells were found to be negative for expression o f VLA-6 
with no apparent change in staining intensity.
196
Fig . 3 .5 .7 (a ) U pregulation o f  cytokeratin 19 staining in A 549  ce lls , (a) Scattered p ositives (30-40% ) 
w ith anti-cytokeratin 19 Ab were detected in untreated ce lls , (b) Upregulation in 10 |lM  BrdU-treated 
cells with anti-cytokeratin 19 Ab.
F ig . 3 . 5 . 7 ( b )  Upregulation o f  E S A  in BrdU-treated A 549  ce lls , (a) Faint im m unoreactivity w ith  
and-E SA  A b was detected in untreated cells, (b) Upregulated p ositive reactivity in 10(iM  BrdU-treated 
cells  w ith anti-E SA  A b.
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HL60 is a human leukaemic cell line and is thus derived from a lineage distinct from 
epithelial and neural crest cell lines. These cells normally grow in suspension and 
therefore cytospins had to be made of these cells before immunocytochemical analysis 
could be carried out (as described in Section 2.14.2).
Untreated and treated HL60 cells were negative for the expression of cytokeratin 19, 
ESA, desmosomal protein, a,(3, integrin, c^p, integrin, a 3p,, a }(3, and a 6(3, integrin and 
positive for the expression of a,p, integrin with no apparent increase in intensity.
Fig. 3.5.8 shows negative staining in untreated and BrdU-treated HL60 cells for anti-a! 
integrin.
3.5.2.4 HL60
F ig . 3 .5 .8  a ,  integrin reactiv ity  in untreated and BrdU-treated H L 60 ce lls , (a) N o im m unoreactivity  
with anti-a , integrin A b w as detected in untreated cells, (b) N o im m unoreactivity in 10|iM  BrdU-treated  
cells w ith an ti-a , integrin Ab.
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3.5.3 Use of serum-free medium to investigate the differentiation effects 
of BrdU in a completely defined system
Investigations were carried out to determine if  BrdU can induce expression o f keratin 
proteins, ESA and integrins in a completely defined system. Serum is completely 
undefined and may have different factors which contribute towards the differentiation 
process and possibly mask some o f the effect o f BrdU.
Experiments were set up in 6-well plates with cells seeded at a concentration o f lx lO 4 
per well and allowed to attach for 48 hours. The serum-free medium used was that 
extensively investigated in Section 3.2.1 and 3.2.2 for the growth o f DLKP cells. 
Cells were treated with lOpM BrdU for 7 days with replenishment o f the medium every 
2 to 3 days. Plates were then fixed and immunocytochemistry was carried out using 
antibodies to cytokeratins 8, 18 and 19, ESA, a , and a 2 integrins as described in 
Section 2.14.
Table 3.5.1 Effect of BrdU on antigen expression of DLKP cells in SFM
Antigen looked at Expression on BrdU treatment
CK 8 induction
CK 18 induction
CK 19 induction
ESA induction
a, integrin induction
02 integrin up-regulation
This is exactly the same trend observed in experiments performed using serum 
supplemented to the medium at a concentration o f 5 %  (v/v).
199
3.5.4 Analysis of induced and upregulated proteins by Western blotting 
and immunoprécipitation techniques.
BrdU-treatment o f DLKP cells resulted in the induction of cytokeratin 19, ESA and cc^, 
integrin expression, observed by immunocytochemical techniques. Quantitation of 
these changes was carried out using Western blotting and the more sensitive 
immunoprécipitation technique.
3.5.4.1 W estern blotting
In all experiments, cell lysates were prepared as outlined in Section 2.16. Cell 
concentrations o f 2 x l0 4 cells per lane were run on 12% polyacrylamide gels for 
detection o f cytokeratin 19 and ESA, which are both 40kDa proteins, under non­
reducing conditions.
For detection o f cytokeratin 19, DLKP cells were treated with BrdU for 7 and 14 days. 
A549, HL60 and MCF-7 were treated with BrdU for 7 days. Fig. 3.5.8 shows the blot 
obtained for a membrane probed with anti-cytokeratin 19 Ab. HL60, A549 and DLKP 
untreated and BrdU-treated cells were run on the gel. MCF-7 cells were used as a 
positive control in the experiment.
The upregulation observed by immunocytochemical staining in A549 BrdU-treated cells 
can clearly be noted from the blot. No protein was detected for treated and untreated 
DLKP or H82 cells, most likely due to the low level o f induction o f cytokeratin 19 
expression. HL60 treated and untreated cells were also -ve for K19 expression.
Fig. 3.5.9 shows a blot for A549 cells treated with BrdU for 48 hours, 5 days and 7 
days to show upregulation o f the keratin 19 with increasing lengths o f time in 10(iM 
BrdU. Again, upregulation o f the protein was observed on BrdU treatment in A549 
cells over the time-course.
For the detection o f ESA, DLKP cells were treated with BrdU for 7 and 14 days. A549 
cells were treated for 7 days. A549 and DLKP untreated and treated cells were run on 
the gels. Fig. 3.5.10 shows a blot obtained for a filter probed with an anti-ESA Ab. 
Upregulation o f ESA can be observed for DLKP-BrdU-treated cells, especially at 14 
days treatment, compared to untreated cells.
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fe fe  a  a  S  S il  l i  §  g  1 ^ 3 3 0 0  rNHäÄTi^l
45 kDa-
—KERATIN 19
FIG. 3.5.9 Western blot showing Keratin 19 expression before and after Bromodeoxyuridine 
treatment for seven days. MCF-7 was used as a positive control.
FIG. 3.5.10 Western blot showing Keratin 19 expression in Bromodeoxyuridine treated A549
cells in a time course assay from 0 to 7 days.
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FIG. 3.5.11 Western blot showing ESA expression before and after Bromodeoxyuridine 
treatment in DLKP and A549 cells.
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3.5.4.2 Immunoprécipitation
This is a more sensitive technique than Western Blotting, which could possibly pick up 
the small changes in expression o f proteins by BrdU treatment.
A  Boehringer Mannheim kit was used in which cell lysates are labelled with biotin. The 
antibody (Ab) to be probed is then added. The Ab-protein complexes are subsequently 
precipitated using Protein A or Protein G beads, depending on the isotype of the Ab. 
The samples are then run on gels, blotted and probed using an anti-biotin Ab, with 
expression detected using ECL (see Section 2.17). Immunoprécipitation was carried 
out using Abs to CK19, a t integrin and integrin. CK19 samples were run on 12% 
gels while a, and integrin samples were run on 7.5% gels. A549 and DLKP cells 
were treated with BrdU for 7 days and then harvested for protein precipitation. In all 
experiments an irrelevant monoclonal antibody was used as the negative control.
Fig. 3.5.12 shows the blot obtained by immunoprécipitation o f keratin 19 protein. 
Upregulation o f CK19 expression was again clearly noted in A549 BrdU-treated cells. 
However, the technique was unable to pick up the changes in expression o f K19 in 
DLKP cells.
Fig. 3.5.13 shows the blot obtained by immunoprécipitation o f a! integrin proteins in 
A549 and DLKP untreated and BrdU-treated cells. SKLU-1 was used as a positive 
control. Induction o f a! integrin in DLKP treated cells can be observed from the blot.
Fig. 3.5.14 shows the blot obtained by immunoprécipitation o f integrin proteins in 
DLKP and A549 untreated and BrdU-treated cells. Upregulation is clearly evident for 
DLKP cells on treatment with BrdU. A lot o f smearing was observed in the negative 
control most likely due to non-specific binding of anti-biotin antibody in the cell lysates. 
However, a definite clear band is observed at approximately 160kDa in the samples 
precipitated with the integrin antibody that is not observed in the negative control.
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FIG. 3.5.12 Immunoprécipitation of Keratin 19 Protein from A549 and DLKP untreated and 
Bromodeoxyuridine - treated cells.
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FIG. 3.5.13 Immunoprécipitation of a-j Integrin protein from A549 and DLKP untreated and 
Bromodeoxyuridine - treated cells. SKLU -1 were used as a positive control.
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FIG. 3.5.14 Immunoprécipitation of a 2 Integrin protein from A549 and DLKP untreated and 
Bromodeoxyuridine - treated cells.
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3.5.5 mRNA analysis of induced and upregulated cytokeratin 19 
expression
Treatment o f DLKP cells with BrdU causes the induction o f CK19, ESA, a, integrin 
and upregulation o f a 2 integrin protein expression. Dr. Shirley McBride determined 
that BrdU appears to act at a posttranscriptional level to reverse a block in keratin 8 and
18 expression in keratin-negative lung cancer cells, e . g .  DLKP and H82, and to 
increase expression in keratin-positive lung cancer cells, A549. Experiments were 
carried out to try to determine if  BrdU acts in a similar way in the control o f  cytokeratin
19 mRNA levels in these cells.
3.5.5.1 RT-PCR of keratin 19 mRNA
RT-PCR was carried out for cytokeratin 19 on BrdU-treated and untreated cells. Sense 
and anti-sense K19 primers (Burchill e t  a l , 1995) amplified a product o f 214 base pairs. 
(See Section 2.21 for primer sequences). A549, HL60, H82 and DLKP cells were 
treated with BrdU for time points o f 0, 15 minutes, 1 hour, 24 hours and 5 days. RT- 
PCR was carried out on RNA extracted from all these cell lines at the time points 
indicated above, as described in Section 2.20-2.23.
The mRNA levels for A549 remained unchanged over the 5 days treatment even though 
a dramatic upregulation of the protein was observed by immunocytochemistry, Western 
blotting and immunoprécipitation. K l9 mRNA was found to be present in DLKP 
untreated cells, with no observed change in the levels o f mRNA transcript over the 5 
days o f treatment even though induction o f the protein was observed by 
immunocytochemistry. Similar results were obtained for H82. HL60 cells showed 
very weak mRNA bands even though the protein was never present before or after 
BrdU treatment.
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FIG. 3.5.15 RT-PCR products resulting from amplification of keratin 19 RNA extracted from 
A549, HL60, DLKP and H82 treated with Bromodeoxyuridine over the time points 
indicated. The primers selected for keratin 19 produced a band of 214 base pairs.
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3.5.6 Extracellular matrix adherence assays
I n  v iv o ,  normal tissue cells interact with the ECM proteins through integrin receptors on 
their cell surface. These interactions are important for maintenance o f tissue integrity 
and for mediating the expression o f genes controlling proliferation and differentiation. 
Tumour cells in  v i v o  also interact with ECM proteins but these interactions are 
frequently altered during carcinogenesis and tumour progression to an invasive and 
metastatic phenotype.
Because o f the observed induction o f the expression o f integrin and the 
upregulation o f the expression o f integrin, a number o f adherence assays were 
carried out using various extracellular matrix (ECM) components. Both integrins are 
collagen and laminin binding. Assays were thus carried out using laminin and Type IV 
collagen. Fibronectin was also used because DLKP has been found to be extremely 
responsive to this ECM component in serum-free media assays. Assays were also 
carried out to a mixture o f these ECM components using basement membrane derived 
from EHS (Engelberth Holm-Swarm Mouse Sarcoma). This gel consists o f collagens, 
non-collagenous glycoproteins and proteoglycans of the ECM.
Wells in 24-well plates were pre-coated with the various substrate proteins, after which 
uncoated sites were blocked with 0.1% BSA as described in Section 2.18. Cells were 
plated in basal Ham’s F12 medium and attachment was observed after 15, 30 and 60 
minutes. For all experiments, except those carried out using EHS, wells were stained 
with crystal violet which, after drying, was eluted with 33% glacial acetic acid (the 
CVDE assay as described in Section 2.10.2) and the absorbances o f the resulting 
solutions were determined spectrophotometrically. Attachment was expressed as a 
percentage o f the control wells which did not contain cells.
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3.5.6.1 Response of BrdU-treated cells to Type IV collagen
Cells were treated with BrdU for seven days and then harvested before plating onto 
Type IV collagen, as described in Section 2.18.
BrdU-treated DLKP cells show increased adherence to type IV collagen over the time 
intervals 15, 30 and 60 minutes.
15mins 30mins 60mins
tim e in m inutes
F ig . 3.5 .14 R esponse o f  untreated and B rdU -treated D LK P cells to type IV collagen
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DLKP cells were treated with BrdU for seven days as outlined in Section 2.18.
BrdU-treated DLKP cells show increased adherence to laminin over the time points 15, 
30 and 60 minutes.
3.5.6.2 Response of B rdU -treated  cells to lam inin
tim e in  m inutes
F ig . 3 .5 .15 R esponse o f untreated  and B rdU -treated D LK P cells to lam inin
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3.5.6.3 Response of B rdU -treated  cells to fibronectin
BrdU-treated DLKP cells show increased adherence to fibronectin over the time points 
15, 30 and 60 minutes.
Fig. 3.5.16 R esponse o f  untreated and B rdU -treated D L K P cells to  fibronectin
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3.5.6.4 Response of B rdU -treated  cells to plastic
BrdU-treated DLKP cells show increased adherence to plastic over the time points 15, 
30 and 60 minutes.
Fig. 3 .5 .17 R esponse o f  untreated  and B rdU -treated D LK P cells to plastic
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3.5.6.5 Response of B rdU -treated  cells to EHS
DLKP cells were treated for 7 days with BrdU and then harvested before plating onto 
wells pre-coated with EHS as outlined in Section 2.18.2. The end-point used in this 
assay was MTT because of difficulties encountered with non-specific staining o f crystal 
violet on the EHS gel. The procedure for the MTT assay is described in Section 
2.18.3. Results were expressed as a percentage o f control wells which did not contain 
cells.
BrdU-treated DLKP cells show increased adherence to basement membrane (EHS) over 
the time points 15 and 30 minutes.
Fig. 3 .5 .18 R esponse o f  untreated  and B rdU -treated D LK P cells to EH S (basem ent m em brane)
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3 .5 .7  Adhesion blockade experiment
Adhesion blockade experiments were carried out in an attempt to reverse the changes in 
adhesive properties o f the DLKP cells treated with IOjxM BrdU as described in Section 
2.19 . An anti-a, integrin antibody was added to untreated and 10|iM BrdU-treated 
DLKP cells and the attachment properties o f these cells to type IV collagen were 
compared to the same cells without antibody treatment. Attached cells were measured 
using the M i l assay as in Table 3 .5 .2 .
Ta b l e  3 . 5 . 2  Absorbance at 570nm  o f  BrdU-treated and untreated D L K P attached to T ype IV C ollagen
15 m ins incubation 30 m ins incubation
Absorbance at 
570nm OfiM BrdU IO^ iM BrdU OfiM BrdU lO p M  BrdU
without Ab  
With Ab
0 .069  ± 0.001  
0 .038  ± 0 .005
0.141 ± 0 .0 1 6  
0 .059  ± 0 .009
0 .129  ± 0 .0 0 4  
0.053 ± 0 .010
0 .2 3 8  ± 0 .0 1 0  
0 .1 4 0  ± 0 .0 2 1
R esults expressed as average absorbance at 570nm  ±  standard deviation (n=3)
Addition o f antibody resulted in a reversal o f  the attachment properties o f  the DLKP  
BrdU-treated cells to type IV collagen at both time intervals as shown in Fig. 3 .5 .1 8 .
F i g .  3 . 5 . 1 8  Reversal o f  attachment properties o f  D L K P  BrdU-treated ce lls  by addition o f  an ti-a , 
integrin A b . R esu lts are expressed as average absorbance at 570nm  ±  standard deviation (n=3), no  
addition o f  A b at 0  and 10 |iM  BrdU (- A b), addition o f  A b  at IO i^M  BrdU (+  A b  10|iM ).
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4.0 D IS C U S S IO N
4.1 GROWTH OF CHO-K1 CELLS IN SERUM-FREE MEDIUM
The Chinese Hamster Ovary (CHO) cell line has emerged as one o f the most important 
and favoured for the commercial production o f recombinant human proteins. These 
cells have been cultured for over 30 years and during that time a large body o f basic 
knowledge on their biochemistry and their genetics has accumulated. Over 80 classes 
of mutants have been isolated from the cell line (Gottesman, 1985) and one o f these, the 
DUK cell line which is dihydrofolate reductase (dhfr) negative, thereby allows the 
selection o f transformants. The CHO cell line has been used for the isolation of 
mutants affecting intermediary metabolism; DNA, RNA, and protein synthesis; 
membrane functions and many complex forms of cell behaviour such as cell growth and 
endocytosis.
There have been many reports in the literature on the development o f serum-free media 
for the growth o f different CHO cell lines. Mendiaz e t  a l. (1986) developed a defined 
medium for the growth of CHO-K1 in their studies on somatic cell genetics. Gasser e t  
a l. (1985) derived a medium for the growth of a wild type CHO cell line. Zang e t  a l. 
(1995) reported on the production o f two recombinant proteins, urokinase-type 
plasminogen activator (uPA) and humanised IgG kappa light chain, in serum-free 
medium. Coppen e t  a l. (1995) reported on the production o f human recombinant 
interferon-y from the CHO-320 cell line which has been found to grow very well in the 
SFM developed by Hayter e t  a l .  (1991). Many researchers grow the recombinant cell 
line initially in serum-supplemented medium which they perfuse out o f the system after 
a number o f days when the required cell density is reached and then the medium is 
replaced by serum-free or protein-free medium. The cells then secrete the recombinant 
protein into the conditioned medium and subsequently purified. Ogata e t  a l .  (1993a,b) 
described the production o f human soluble thrombomodulin in serum-free CHO-K1 
culture by this method while Cole e t  a l. (1993) reported on the production of 
recombinant human thyroid stimulating hormone by similar means.
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4.1.1 CHO-K1 Suspension Culture
This study involved looking at the serum-free media (SFM) formulations investigated in 
Section 3.1 for the growth o f the CHO-K1 cell line in SF suspension and microcarrier 
culture. The only mitogens present in the SFM were insulin and transferrin (see Table
2.7.1 for list of ingredients). It was clearly evident from the first experiments carried 
out that the Ham’s F I2 based SFM did not support the growth of the cells in 
suspension culture even though good growth was always achieved in monolayer 
culture. All the cells were found to be dead using trypan blue staining after 24 to 48 
hours. Pluronic F68 (PF68) was then added at a concentation of 20|xg/ml and after 
optimisation at a concentration o f 50|ig/ml, due to its known protective effect on the 
cells against adverse shear forces (Murhammer and Gooche, 1990; Handa-Corrigan e t  
a l . ,  1989; Papoutsakis, 1991; Michaelis e t  a l . ,  1995). Pluronic F68 supplementation 
resulted in growth o f the cell line in SF suspension culture to a certain extent. Long­
term growth of CHO-K1 cells in suspension culture was also possible with PF68 
supplementation where cells were subcultured up to five weeks.
Experiments were then carried out to compare changes in the plasma membrane fluidity 
(PMF) o f these SF cells with serum-supplemented cells to see if this correlated to the 
poor growth of the cells in serum-free suspension culture. It is generally believed that 
the more fluid the membrane the more shear sensitive the cells are to external forces. 
PMF was evaluated by steady state fluorescence anistropy (rs) of TMA-DPH. An 
increase in rs value indicates a decrease in PMF, hence the cells are more shear resistant. 
Ramirez and Mutharasan (1990) have shown that supplementation o f SFM with 0.5% 
PF68 in the cultivation o f hybridomas results in an increased rs value compared to 
control cultures. A  similar effect was noted in the cultivation of CHO-K1 cells in 
serum-free medium (Fig. 3.1.8). Addition o f PF68 resulted in an increase in rs value 
above unsupplemented SF culture over the 3 day growth period. There is a resultant 
decrease in PMF and a decrease in shear sensitivity in these cells thus allowing them to 
grow. These results and the findings o f Ramirez and Mutharasan (1990) provide 
evidence that PF68 alters the plasma membrane of animals and thus its mechanism of 
action can at least be partly attributed to its property of decreasing the PMF. This 
agrees with the hypothesis o f Murhammer and Gooche (1990) that the protective effect 
of PF68 resides in its ability to intercalate in the plasma membrane. Thus possibly, the 
lack of growth of CHO-K1 cells in SFM without PF68 supplementation could be 
attributed to an increase in shear sensitivity or a decrease in PMF of the cells.
Good growth o f CHO-K1 cells was always achieved in serum-supplemented 
suspension culture. Ramirez and Mutharasan (1992) suggested a possible role for the
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shear protective effect of serum. It is suggested that its protective action may be at least 
in part, to a condensing effect on the plasma membrane fluidity (PMF) by the transfer 
of cholesterol or analogous compounds from the culture medium to the plasma 
membrane. The rs values for CHO-K1 cells growing in serum-supplemented culture 
was found to be higher compared to cells growing for 3 weeks or 6 months in serum- 
free monolayer culture (see Table 3.1.1 and Fig. 3.1.8). Ramirez and Mutharasan
(1992) found that increasing serum concentrations from 0 to 9 %  resulted in an increase 
in rs value for a mouse hybridoma cell line, HB32, during agitated culture. They also 
found that addition of LDL, HDL and cholesterol to these hybridoma cultures in SF or 
complete SSM also decreased their shear sensitivity (rs increases). Serum-free cells 
appear to have a more fluid membrane due to the absence o f cholesterol in the medium. 
Serum is not present, so it cannot protect against hydrodynamic forces. No transfer of 
cholesterol or other lipids to the cellular membane can occur so the cells die rapidly due 
to their increased sensitivity to adverse shear forces. Addition o f PF68 allows the cells 
to grow, thus the cells have been made more resistant to shear forces somehow.
Other surfactants could be tried especially polyethylene glycol (PEG) which has been 
found to promote the growth of a number adherent and non-adherent cell lines in SFM 
(Shintani e t  a l . ,  1988). PEG and another surfactant, PVA (polyvinyl alcohol), are non­
ionic weak surfactants and possibly act by lowering the surface tension o f the medium 
and improving the transport o f metabolites into the cells.
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4.1.2 Microcarrier culture of CHO-K1 cells in serum-free medium
The use of microcarriers to aid growth o f CHO-K1 cell growth in serum in SFM was 
investigated. CHO-K1 cells can grow very well either attached to a substrate or in 
suspension culture. For the large-scale cultivation of cells that will adhere to a surface, 
one o f the most promising and widely used techniques is to grow the cells on the 
surface of microcarriers suspended in media. This method offers a large surface area 
for adherent cells to grow on, allows a simple media/ cell separation and perfusion, 
provides a readily assessed and controlled homogenous culture environment, and can 
also support the growth to over 107 cells/ml for some cell lines (Croughan e t  a l . , 1987). 
However, animal cells on microcarriers are especially susceptible to destruction by 
excessive agitation. This susceptibility is probably due to the lack of a strong protective 
cell wall, the relatively large size o f animal cells and from lack o f individual cell 
mobility. These anchored cells cannot freely rotate or translate and accordingly cannot 
reduce the net forces and torques experienced when they are exposed to excessive 
hydrodymanic forces. Experimental evidence (Croughan e t  a l . ,  1988; Cherry e t  a l . ,
1989) show that cell damage results from the interaction between particles 
(microcarriers) and eddies of a size similar to particle size. These eddy sizes are known 
as Kolmogorov eddy sizes and are responsible for micromixing at a very fine scale. 
Croughan e t  a l . (1988) showed that cells on microcarriers are damaged even at very low 
bead concentrations when the Kolmogorov eddy size becomes approximately equal to, 
or less than, the bead size. Bead to bead interactions also appear to play a role in cell 
damage in microcarrier bioreactors under intense agitation conditions. The frequency 
and severity o f interactions are important determinants o f cell injury; thus agitation 
intensity and microcarrier concentration are important (Cherry e t  a l . ,  1988, 1989).
In these experiments, cell growth was found to be much less in the microcarrier serum- 
free (SF) culture compared to SF suspension culture plus Pluronic F68 (PF68) 
supplementation. The use o f microcarriers afforded a certain degree o f protection on 
the cells against adverse shear forces but it was much less than the protective effect of 
PF68. Further experiments could be carried out using microcarriers plus PF68 
supplementation. Due to the greater susceptibility o f SF cells to shear forces compared 
to serum-supplemented cells, it is important to optimise concentrations o f microcarriers 
in serum-free culture and also to investigate the agitation rate employed, in order to 
reduce the cell damage to the microcarrier culture.
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4.1.3 Low Calcium concentration suspension culture of CHO-K1
Within 24 hours of SF suspension growth, the CHO-K1 cell line has been observed to 
clump extremely tightly compared to cells growing in SS culture. In SF stirred 
suspension culture, there are many reports that CHO cells tend to form aggregates with 
the size distribution ranging up to several hundred cells per aggregate (Coppen e t  
a l . , 1995; Renner e t  a l. , 1993; Lehmann e t  a l . , 1991; Perry e t  a l . ,  1978). Aggregation has 
also been reported for other cell lines; e . g .  human recombinant kidney epithelial cells 
(Peshwa e t  a l . ,  1993); BHK cells (Moirera e t  a l . ,  1995; Perrin e t  a l . ,  1995); and Vero 
cells (Litwin 1992).
Several mechanisms may underly cellular aggregation. Cross linking of cells by DNA 
fromlysed cells was reported by Renner e t  a l. (1993) in the growth o f the CHO-SSF3 
cell line; secretion of lectins by cells was reported by Lehmann e t  a l. (1991); or there 
may be several types o f intercellular junctions involved, such as desmosomes and 
adherens-type junctions reported by Coppen e t  a l. (1995). Usually within the centres 
of the larger aggregates a lot o f necrotic material exists which is probably derived from 
cells dying of nutrient or oxygen deprivation and a build-up of waste materials.
Coppen e t  a l. (1995) found that aggregation of the cell line CHO-32C) producing human 
recombinant interferon-y is caused by the formation o f intercellular junctions. 
Membrane thickening and the presence of dense proteinaceous layers on the 
cytoplasmic faces o f the opposed membranes was observed. They detected the 
presence o f Ca++ dependent cadherins and also found increased expression of vinculin 
and spectrin, which are well characterised cytoskeletal proteins (Geiger e t  a l . ,  1989) at 
the regions o f cell-cell contact. In addition, Coppen e t  a l. observed that their cell line 
showed no accumulations o f DNA within the aggregates by transmission electron 
microscopy (TEM) or DAPI staining. Aggregation was found to be an active process 
associated with exponential growth and not with the death phase as would be expected 
if  DNA molecules were released from lysed cells. They added DNase I to their medium 
either before or after aggregation had begun and no effect on the aggregation of the cells 
was observed.
However, this appears to contradict what Renner e t  a l. (1993) had found with 
CHO.SSF3 cells, i .e . that DNase I supplementation at a concentration o f 100|ig/ml 
resulted in the break up of the aggregates to a single cell suspension within 12 hours of 
addition. Addition o f DNase I to aggregated CHO-SSF3 SF culture also resulted in a 
47% increase in specific growth rate over an 80 hour period and a 100% increase in the 
maximal biomass yield. Also the presence of released DNA within the clusters was
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revealed by DAPI staining and TEM. It is reasonable to assume in their culture that 
shear stress caused by stirring and agitation o f cultures is responsible for damaging 
cells, initiating DNA release and creating new nucleation centres for cluster formation.
The study in this thesis was concerned with reducing the level of aggregation within SF 
CHO-K1 suspension culture by decreasing the amount o f calcium ions in the medium 
and to see if this would increase cellular growth. Little decrease in aggregation was 
noticed from microscopic observations between the high calcium media (Ham’s F12 
SFM, 226|iM  Ca++ and Ham’s F12/DMEM (1:1) SFM, 790|iM Ca^) and low calcium 
(Ham’s F12/MEM.S SFM, 113|iM Ca++) while using a SFM without calcium present 
(MEM.S SFM) resulted in loss o f cellular growth properties completely. Growth of the 
cell line in H/M SFM was quite comparable to the H SFM as seen in section 3 .1 .1 .5 . 
Growth o f cells in H SFM and H/D SFM was also found to be quite comparable. Very 
little difference was seen in the microscopic observations o f natural aggregation 
between the reduced calcium and the high calcium media. However, Peshwa e t  a l.
(1993) showed decreased aggregation o f human recombinant epithelial cell line at a 
lower concentration of calcium chloride in the medium (100|iM compared to 50()|iM).
In this study, as with CHO-SSF3 (Renner e t  a l . ,  1993) the presence o f FCS in the 
culture medium caused a looser aggregation o f CHO-K1 cells as compared to medium 
without serum supplementation from microscopic observations. As serum has direct 
effects on the cell surface and its structural elements, fewer cells are ultimately 
aggregated. Therefore, it appears that the medium type, whether containing high or low  
calcium concentrations, has little effect on the extent o f aggregation in serum-free 
suspension culture o f CHO-K1 cells. Severe aggregation was noted in the low calcium 
medium equivalent to the high calcium media suggesting that the aggregation was 
caused by alternative mechanisms rather than the Ca^-dependent junctions between the 
cells. The most likely explanation is that the shear forces caused by the agitation results 
in many o f the cells dying, releasing their nucleic acids which act like a glue between 
cells, causing the cells to aggregate and eventually leading to death o f cells within the 
clumps, as reported by Renner e t  a l. (1993) for CHO-SSF3 cells.
It is reasonable to assume that in all probability, DNA accumulation between cells is not 
a universal factor in CHO cell aggregation and that aggregation could be associated with 
Ca++ levels in the medium and formation of intercellular junctions, and also with the 
release of lectins from the cells. It is important to elucidate the mechanism(s) of 
aggregation in CHO-K1 cells so that they can be controlled. Comparisons could then 
be made between the growth o f the cell line in SF single cell suspension culture, SF 
aggregated culture and SF microcarrier culture.
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It may be important to inhibit aggregate formation in terms o f  evaluating CHO 
productivity in batch culture. It is important to evaluate whether elimination or 
reduction o f aggregation in carefully controlled chemostat culture improves the specific 
production rate. However, on the other hand, formation o f aggregates can be used to 
effect cell retention in bioreactors, thereby increasing cell concentration and yield o f  
product from the reactor (Peshwa et al., 1993; Moirera et al., 1994). Thus all the 
different methods o f  cultivating animal cells, especially the commercially important 
CHO cell lines, as single cells or as aggregates in suspension culture or attached to 
microcarriers, have to be addressed in terms o f specific growth rate, specific production 
rate, ease o f  cell separation from media containing required product and, o f course, 
expense.
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4.2 LONG-TERM GROWTH OF CHO-K1 IN SERUM-FREE MEDIUM
Many processes which involve a production phase in serum-free medium still require 
the presence o f serum at the cell inoculation stage. This carries some risk o f viral or 
protein contamination o f the final product. Long-term growth of a cell line in serum- 
free media is a good test for a true, feasible SF medium which may be important for 
optimal productivity. Keenan (1994) carried out investigations into the serum-free 
growth of the CHO-K1 cell line using the SFM developed by Mendiaz e t  a l. (1986) as a 
starting base. It was found that this SFM was unable to sustain growth o f the cell line 
over a long period o f time though good growth was usually achieved for the first few 
passage in this SFM. Keenan (1994) found that this SFM was unable to sustain 
growth longer than at most 9 passages or 36 days. One of the main objectives o f the 
study was to increase the length o f time this cell line could be sub-cultured under SF 
conditions and to determine what factor or factors are involved with the death or poor 
growth of the cells after long-term subcultivation. The longest sub-culture that was 
achieved in this study using H SFM was 8 passages (32 days culture) but usually the 
average cultivation length lasted on average between 4 to 6 passages.
4 .2 .1  E x te n s io n  o f  seru m -free  m ed iu m  su b -c u lt iv a tio n  fo r  C H O -K 1
The first series of experiments were carried out using a medium derived from a product 
of the NCTCC, SF Briclone, to try and extend passaging of the cell line. SF Briclone 
was used because of its ability to enhance the clonal growth of hybridomas. The active 
ingredient appears to be IL-6. It was used in all assays at a 5% v/v concentration and 
when added to the H SFM it was found to generally increase cell numbers after 4 days 
cultivation and also extended the passaging of the cells by approximately two passages 
(8 days in culture). SF Briclone was also found to have a proliferative effect on NRK  
cells (Dr. Joanne Keenan, PhD 1994). The Briclone was then fractionated into a 
retentate containing all components > 3000Da and a filtrate with all components < 
3000Da. The lx  filtrate showed the greatest stimulation o f growth over the other 
fractions in a 7 day growth assay. However, subcultivations using the SFM plus 5 %  
filtrate resulted in no improvement in the long-term passaging of the cell line. The lx  
and lOx retentate also showed increased cell numbers over the unfractionated SF 
Briclone supplementation. The lOx retentate generally resulted in lower cell numbers 
than the lx  retentate. However, in the long-term subculture, the opposite effect was 
observed. Perhaps as the cells are subcultured, residual serum proteins are gradually 
being diluted out o f the system and the cells’ requirements for media supplements 
becomes greater. The lOx retentate may be better able to provide these factors thus 
accounting for the observed increased growth over supplementation with other SF
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Briclone fractions. The variability in results suggests that a number o f factors are 
involved in the growth promoting effects (less than and greater than 3000Da). Also the 
condition o f the cells and possibly even damage due to trypsinisation procedures may 
also play a part in these variable results. It was thus decided to discontinue with these 
experiments due to this variability and the undefined nature of SF Briclone. Generally, 
however, the SF Briclone showed increase cell numbers during passaging of the cells 
compared to unsupplemented SFM and the cultivation time was generally extended by 
about a week.
As a consequence, it was then decided to try and extend the long-term sub-cultivation of 
the CHO-K1 cell line in SFM using defined components but without using expensive 
cytokines or hormones. The components tested were BME vitamin solution, Pluronic 
F68, Fibronectin, LDL, DNase I and conditioned medium collected from the CHO-K1 
cell line itself.
BME vitamins is a solution of B vitamins and its effect on the cells at the recommended 
concentration was assessed. No increase in passaging of the cells was observed in the 
two experiments described which suggests that a B vitamin is not being diluted out over 
long-term sub-cultivation.
Conditioned medium from the CHO-K1 cells was collected and used at a 5% 
concentration. However, no increase in passaging of the cells or improvements in cell 
numbers were observed using this CM. This does not necessarily imply that no 
autocrine activity occurs between CHO-K1 SF cells. Possibly the secreted autocrine 
factors may have been extremely labile and the activity may have been lost before it was 
assayed. The overall concentration o f the factor may been too low, or the autocrine 
factor may depend on some component in the SSM for a commitment to cell growth and 
division.
Pluronic F68 was tested because o f its apparent growth promoting activities. 
Bertheussen (1993) used Pluronic F68 at a 20|ig/ml concentration in the SFM 
developed for the growth o f L929, HeLa S3 and a hybridoma cell line, 1E6. A  
concentration of 50[ig/ml o f PF68 was subsequently found to optimally stimulate 
growth o f CHO-K1 cells in monolayer culture (see Fig. 3.1.4). It is often used as an 
additive for serum-supplemented suspension culture to prevent denaturation o f serum 
proteins during agitation (Swim and Parker, 1960) and aids in protecting the cells from 
adverse shear forces as already discussed in 4.1.1. In SFM, PF68 may have growth 
stimulatory properties by acting as a solubilising agent to increase the solubility of 
sparingly soluble compounds (Collett and Tobin, 1977). It is also reported to form
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complexes with other phenols and other small molecules (Marcus e t  a l . ,  1956) which 
may reflect a weak albumin-like property as a detoxifying toxic species in the medium. 
The use o f PF68 in the H SFM extended sub-cultivation by one passage. The PF68 
appears to enhance the growth o f the cells but it does not appear to be enough to extend 
passaging o f the cells significantly.
Fibronectin at a concentration o f 10(ig/ml gave the most promising results so far with an 
increase o f 2 to 3 passages in the long-term sub-cultivation o f the cell line. In late 
passages, with fibronectin as compared to the control flasks where a lot of cellular 
aggregation is usually noted to occur if  the cells have not already died, the cells were 
observed to be nicely spread out and growing well. The requirement for an attachment 
and a spreading factor such as fibronectin is usual for anchorage-dependent cells though 
some cell lines appear to be well capable of attaching and spreading in their absence. 
Hewlett (1991) found that A431 epithelial cells, Vero and MDCK cells are quite capable 
of attachment, spreading and growth in a protein-free medium. However, their principal 
growth parameters are down modulated in the simple SFM. Some anchorage- 
dependent cell lines appear to have a facultative requirement for attachment factors. 
Hewlett (1991) found that the CHO-P cell line when placed in SFM no longer attached 
to the plastic substrate but grew in suspension as an aggregated culture. When the 
medium was supplemented with serum or fibronectin, anchorage-dependent growth in 
the SFM occured. This appears to be the case with the CHO-K1 cell line except that 
aggregation often occurs after a number o f passages in SFM (see Fig. 3 .1.12). 
Mendiaz e t  a l. (1986) and Dr. Joanne Keenan in her Ph.D thesis showed no 
requirement for fibronectin in early passage SF growth. However, it appears that 
control o f the ECM is critical for long-term growth o f the cell line. The long-term 
presence o f fibronectin may play a role in enhancing the synthesis o f ECM proteins so 
that cellular attachment processes can be initiated before the cell is irreversibly damaged. 
Cell attachment appears to be a primary regulator of cell growth, proliferation, gene 
expression and secretion for non-transformed cells (Daniels and Solurch, 1991). In 
these experiments, cultivation was really only increased by 8-12 days. Perhaps a lot of 
the cells had been irreversibly damaged before fibronectin addition or perhaps other 
factors are being diluted out. Other attachment factors which could be tried include 
laminin, collagen or elastin over long-term growth.
Lipoproteins, especially HDL and LDL, are often added to SF formulations. They are 
macromolecular complexes of lipids and apolipoproteins. Nakama and Yamada (1993) 
found that the most effective factor on the SF growth of the human hepatoma cell line, 
HepG2, was LDL supplemented at a concentration of 100ng/ml. Chen e t  a l. (1986) 
showed optimal proliferation of both human EC (vascular endothelial) and SMC
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(smooth muscle cells) with either HDL or LDL at concentrations ranging from 20 to 
60(iM. Thus LDL was investigated to see if a lipoprotein source would increase the 
long-term proliferation of the CHO-K1 cell line. However, no increase in passage 
number was obtained.
Often at high passages in SF monolayer culture o f CHO-K1 cells, aggregation was 
noted to occur. Renner e t  a l. (1993) used DNase I at a concentration of lOOpg/ml in the 
SF suspension growth o f the CHO-SSF3 cell line to avoid aggregation. DNase I was 
added to the SFM at a similar concentration to try to prevent formation of such 
aggregates. Perhaps the cells at high passages in SF culture have suffered a lot of 
trypsinisation damage due to serial passaging of the cells with the subsequent release of 
nucleic acids from lysed cells. Nucleic acids can serve as a kind o f glue causing 
aggregation o f the cells. Thus cells within the centre o f these aggregates would soon 
die due to lack of 0 2 and nutrient availability with subsequent release of more nucleic 
acids and proteases by the cells. As SFM contains no protease inhibitors such as trypsin 
inhibitor, the action o f these extra proteases can damage surviving cells eventually 
causing their own destruction. In the experiment carried out in Section 3.1.3.2 using 
DNase I supplementation, the cells were found to spread out very nicely but no increase 
in passaging o f the cells was obtained. This could possibly have been due to the DNase 
I concentration being slightly inhibitory in monolayer culture or the cells being far too 
damaged after the serial passaging to recover at this stage. Soybean trypsin inhibitor 
could be added to try and reduce damage to the cells.
It would be interesting to test a combination o f the effective factors used, especially 
with fibronectin, Pluronic F68 and also with DNase I. These factors could be added at 
passage 4 as in the experiments described in Section 3.1.3.2 and compared to long-term 
growth with supplements added at passage 1 in SFM. Other components could be 
tested such as growth factors and hormones but this would lead to increases in expense 
and protein content o f the SF formulation. However such experiments would be worth 
trying in order to find out what factors are involved with the poor growth of the cell line 
in long-term serum-free culture.
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4.2.2 Low calcium medium and long-term serum-free growth
A low Ca1^  medium was used to try to reduce aggregation in CHO-K1 SF suspension 
culture, as already discussed in 4.1.3. Firstly, it was decided to see if  this low Ca^ 
medium actually supported the growth of the cell line in monolayer culture before it was 
applied to suspension culture. The results shown in Section 3.1.3.3 indicate that this 
SFM is capable of supporting the growth of the cell line. Most importantly, it appears 
to be capable o f supporting long-term growth of the cell line. A  sub-cultivation lasting 
52 passages (11 months in culture) has been successfully obtained with this medium 
and cellular aggregation has not been a problem. This medium is thus extremely 
successful in the continuous subcultivation of CHO-K1 cells because the other media 
tested with different supplements did not allow growth beyond 7 or 8 passages (one 
month in culture). In the low Ca^ medium, the cells appear to go through a crisis 
stage and then show adaptation to the SF conditions with cell counts often exceeding 
those obtained for passage 1 or 2 cells. The cells in long-term culture appear smaller 
than early passage cells and are not as elongated or as fibroblastic-like, hence more 
space is available for cells to grow leading to higher cell counts.
The Ca++ ion has been proposed as a key component in cell proliferation control 
mechanisms. Ca++ depravation causes normal cells to stop growing (Balk e t  a l. 1973). 
There seems to be a change in regulatory functions of calcium during neoplastic 
transformation (Boynton and Whitfield, 1976; McKeehan and Ham, 1978; Hazelton e t  
a l. 1979; Swierenga e t  a l. 1983; Ribeiro and Armelin, 1984; Klann and Marchok, 
1984) where transformed or tumourigenic cell lines show a requirement for reduced 
Ca++ concentrations, compared to normal cell lines. Before undergoing spontaneous 
transformation, 3T3 cells can be reversibly growth arrested with Ca++ starvation. As 
the cells become spontaneously transformed, they have been found to grow well in low 
calcium medium (Ribeiro and Armelin, 1984).
CHO-K1 cells were found to be incapable o f proliferating in Ca^-free medium. 
However, on addition of Ca^ to the medium, at the concentration found in basal HF12 
or H/M SFM, proliferation of these cells was possible, showing a requirement for Ca++. 
CHO-K1 cells are capable of proliferating continuously in a reduced calcium medium 
(1 13|iM concentration), while higher concentration media (226|jM and 790(iM 
concentration) cause the cells to aggregate after a number of passages and eventually die 
off. The H/D SFM (790|iM Ca^) usually caused the death o f CHO cells after 2-3 
passages while H SFM (226pM Ca++ ) caused death after 4-6 passages, on average. 
CHO-K1 cells are a transformed cell line, thus their requirement for calcium would be 
lower than that for normal or weakly tumourigenic cell lines. The transformed state of
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CHO-K1 and its tendency to aggregate in monolayer (and suspension) culture 
demonstrate that for successful long-term growth of these cells, the calcium 
concentration in the medium should be taken into account. This dependency on calcium 
concentrations for long-term growth has been proven by subculture experiments where 
calcium was added to the low calcium medium (113 pM H/D), to a concentration 
equivalent to H SFM, and caused the cells to aggregate and die off after 3 passages in 
one experiment and 8 passages in a second separate experiment. Perhaps the cells 
show good growth initially in the high Ca^ media (H and H/D SFM) due to the 
presence o f trace serum proteins on the cells. Long-term growth in serum- 
supplemented medium may be due to binding o f exogenous Ca++ by serum proteins 
such as albumin.
The best approach to defining the system involved adding Ca++ to a calcium-free media. 
Adding an excess o f the specific Ca^ chelator, EGTA to growth media lowers the Ca*4" 
concentrations to a level that can damage cell membranes (Durham and Walton, 1982). 
Raising the Ca^ concentration can cause precipitation o f calcium phosphate which, by 
virtue of its particulate nature, can stimulate the proliferation of some cell lines (Barnes 
and Colowich, 1977).
CHO-K1 cells subcultured in high calcium media (H/D SFM and H SFM) show 
increased aggregation at higher passages in SFM compared to lower amounts of 
aggregation in the lower Ca++ medium (H/M SFM). Mattey e t  a l. (1990) showed that 
desmosomal adhesion between MDCK cells in culture may be controlled by 
manipulation of the extracellular Ca++ concentration. As these are adhesive intercellular 
junctions, increasing their numbers would be expected to increase cellular 
adhesiveness. Peshwa e t  a l . (1993) reported on the effect o f Ca++ ion concentration on 
the cultivation of the recombinant human epithelial 293 cell line. This cell line grows as 
aggregates in suspension culture. They found that increasing concentrations of Ca^ 
from 100 to 500pM resulted in an increase in aggregate formation. They also found that 
the viability in lower concentrations appeared to be better than in high Ca++ 
concentrations, possibly due to the diffusional limitations in the high Ca++ aggregates 
because o f the larger size and denser packing of cells. Possibly the effect o f Ca++ on the 
aggregation of 293 is caused by increasing numbers of desmosomal junctions between 
cells. Coppen e t  a l . (1995) found that the SF aggregation o f their cell line, CHO-320, 
is possibly caused by intercellular junctions. They confirmed the presence of Ca^ 
dependent adhesion molecules, cadherins, associated with cell-cell adherent junctions, 
which ties in with the observations of Peshwa e t  a l. (1993). Perhaps the low Ca++ 
concentration o f the H/M SFM, which allowed the indefinite growth of CHO-K1 cells 
compared to H SFM, can partly be attributed to the low concentration of the Ca** ion.
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The low Ca++ medium possibly allows long-term growth due to less intercellular 
junction formation between cells and thus less cellular aggregation. It would be 
interesting to look at the expression of Ca^  -dependent adhesion molecules such as 
cadherins and desmosomes in the low and high Ca*4' serum-free media.
A recent report has shown that transfection of VE-cadherin (vascular endothelial 
cadherin) into CHO and L929 cells confers inhibition of growth (Caveda e t  a l. 1996). 
In other types o f tissue, cadherins can act as tumour suppressors, where reduced 
cadherin expression or activity is associated with tumour cell invasive potential and loss 
o f differentiated characteristics (Takeichi, 1993; Frixen e t  a l. 1991; Vleminckx e t  al. 
1991; Birchmeier and Behrens, 1994). Perhaps growing the CHO-K1 cells long-term 
in SFM causes overproduction of cadherin proteins, which may cause inhibition of 
growth of the cells. Possibly VE-cadherin can transfer growth inhibitory signals 
through association with catenins, intermediate filaments and other cytoplasmic 
molecules (Caveda e t  a l. 1996). It appears that cadherins and catenins can directly 
contribute to inhibition of cell growth, induced by cell density.
Thus the concentration of calcium in cell culture medium has important implications for 
growth of normal and transformed cell types. In primary culture, the media 
conventionally used contain high quantities of calcium, usually above a ImM 
concentration. If a cell line is required, it makes sense to use low calcium media. It has 
been observed in the literature that there is a good correlation between loss of Ca41 
control and progression towards tumourigenicity, as has already been discussed. The 
role o f calcium in the differentiation of many tissues has also to be taken into 
consideration during primary culture. High concentrations o f Ca++ ions induce 
squamous differentiation in epidermal keratinocytes (Lechner e t  a l. 1984; Merchant,
1990) and has been suggested in other epithelial systems (Bologne e t  a l. 1986). Maybe 
this is occurring in CHO cells growing long-term in SFM (high Ca) where Ca44 is 
inducing differentiation in the cell line, forming intercellular junctions (cadherins) and 
intermediate filaments, such as vinculin and spectrin, as observed by Coppen e t  al. 
(1995) in CHO-320 cell line.
Thus, an excellent model now exists to cultivate CHO-K1 cells long-term in SFM 
which may have important consequences for commercial production of recombinant 
proteins in a completely defined system. Continuous subcultivation of the CHO-K1 
cells is now possible.
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4.3 DLKP CELLS IN SERUM-FREE MEDIUM
A model for the growth of a human lung epithelial cancer cell line was then investigated 
in SFM with a view to understanding characteristics of tumour cell growth, adhesion 
properties and differentiation in a completely defined system.
DLKP is a human lung cancer cell line derived in our laboratory by Dr. Geraldine Grant 
from a lymph node biopsy of a primary lung tumour. The tumour has been 
histologically diagnosed as a poorly differentiated squamous carcinoma. Cytological 
(Gilvarry et al., 1990) and cytogenetic (Law et al., 1992) analyses have been reported 
elsewhere. The DLKP cell line has been extensively characterised and appears to be a 
heterogeneous population of cells which appear to interconvert between themselves. 
Three distinct cell populations have been cloned out of the parental population (McBride 
et al., 1997).
Establishing cell lines from lung carcinomas on a routine basis provides an important 
tool to study the disease. Development of serum-free media for the growth of such cell 
lines provides a defined system for investigating the cells. Serum-free media permit 
greater flexibility for manipulating growth conditions by altering levels of hormones, 
growth factors or attachment substrates. The effects of differentiating agents and 
chemotherapeutic drugs can also be evaluated in a defined environment without the 
masking effects of serum. The possibility of multi-dependent mechanisms of growth 
regulation can be more easily investigated under SF culture conditions. Siegfried et al.
(1994) reported on the secretion of gastrin releasing peptide (GRP) by a non-small lung 
carcinoma cell line, A549, adapted to SF growth conditions. This peptide is an 
important growth modulating factor in lung epithelium development and an autocrine 
loop involving GRP and its receptor have been demonstrated in many small cell tumour 
cell lines. Thus the use of SF media has been essential for studying the significance of 
autocrine growth mechanisms.
There are many reports in the literature on the development of serum-free media for 
lung carcinoma cell lines (Brower et al., 1986; Collodi et al., 1991; Gazdar, 1994). 
Over the last 15 years, many SCLC and NSCLC cell lines have been established by 
utilising serum-free, hormone and growth factor supplemented defined media, HITES 
and ACL-4 (Oie et al., 1996).
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4.3.1 Growth of DLKP cells in serum-free medium
The serum-free medium developed by Mendiaz et al. (1986) and farther investigated by 
Dr. Joanne Keenan for the growth of CHO-K1 cells was used as a starting base for the 
growth of the DLKP cell line under SF conditions. The main reason for picking this 
medium was due to its simplified composition and the presence of only one mitogenic 
compound, insulin. The cell line was found to grow quite well in the SF conditions as 
indicated in Section 3.2. However, growth was not nearly as good as that obtained in 
serum-supplemented culture but was better than basal F12 only. Care has to be taken 
when culturing these cells in SFM. The cells need to be fed or passaged every 4 to 5 
days, as after this time many of these cells begin to detach from the flask surface. 
Culture in SFM also appears to influence the morphology of the parental cell line. The 
majority of the cells appear to proliferate in the SFM without actually forming colonies 
compared to the SS culture (see Fig. 3.3.6(a,c)). The cells usually remained quite 
rounded and were loosely attached. After 4 to 5 days many of these cells would detach 
from the flask surface. These cells have been found to be viable because they grow 
very well when they are placed in serum-supplemented culture after pelleting out and 
resuspending the detached cells in SSM.
The ability of DLKP to proliferate successfully in basal medium (up to 3 passages) and 
continuously in defined serum-free medium suggests that these cells are producing 
autocrine growth factors capable of stimulating their own growth. DLKP can possibly 
be characterised as variant SCLC or NSCLC-NE (McBride, PhD 1995) and these are 
characterised by more rapid growth, an undifferentiated morphology and c-myc proto­
oncogene amplification and may be less dependent on external peptide stimulation 
(Carney et al., 1985). Doyle et al. (1990) identified a number of proteins that appear to 
distinguish the CM of classic SCLC with its distinct neuroendocrine phenotype, from 
the more anaplastic variant-SCLC. They have adapted a number of SCLC lines to 
hormone and serum-free medium. These tumour cells are able to produce all of the 
essential autocrine and paracrine factors required for their own growth.
Long-term growth of the cell line has been found to be successful. The cells have been 
successfully subcultured for 2 and a half years in the H SFM. In all long-term sub­
cultivations carried out, the cell counts were found to increase from about passage 8 to 
10 onwards. DLKP cells appear to adapt to the conditions in which they are forced to 
grow where long-term SF cells show increased growth rates to parental cells in serum- 
free and basal media. The 2 year SF cells also appear to grow more slowly in serum- 
supplemented medium compared to their parental counterparts suggesting that serum
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may be slightly cytotoxic to these cells, a case of protein overload! The cells at the 
higher passages in SF culture also appear to become more tightly attached and spread. 
The cellular morphology of these high passage SF cells is quite unlike any of the clones 
which have been derived from the parental population. The SFM appears to influence 
the cell morphology in long-term culture. There appears to be a change in the 
expression of some adhesion proteins as indicated by the better attachment and 
spreading of the cells cultured long-term in serum-free medium. Perhaps the SFM has 
resulted in pushing the cell line along some differentiation pathway with a resultant 
expression of various adhesion and differentiation antigens. Immunocytochemical 
analysis of cells growing for 3 months and two years in SFM showed no change in 
expression of keratin filaments, EGF-R, desmosomal protein, neurofilaments, NCAM, 
serotonin, and a-transglutaminase compared to passage 1 cells in SFM. However, the 
beta-1 integrin profile of the parental cells was found to be slightly different in the 3 
month and 2 year SF cells. There appeared to be a slight increase in expression of a 2 
and a 3 integrins in the long-term SF cells. Expression of a ,, a 5 and oc6 integrins 
remained negative. DLKP express low amounts of a 2 and a 3 integrins and perhaps the 
SF conditions cause them to express more of these integrin proteins as they are already 
inherently expressed, while the induction of expression of the other pj integrins was not 
possible. Ruck et al. (1994) have reported on the growth of a bladder carcinoma cell 
line for at least 2 years in SF conditions. They investigated the antigenic phenotype of 
the cells growing with or without serum using antibodies to a variety of cell surface 
antigens such as ICAM, EGF-R, IGF-1 and other adhesion molecules and integrins. 
All of the antigens were found to be expressed in similar amounts irrespective of 
whether the cells were grown in SF or SS media for two years.
When these long-term SF cells were placed back into serum-supplemented medium 
from about passage 10 onwards, the cell population appeared to be almost totally 
homogeneous compared to the parental population. The cell morphology appeared to 
resemble the DLKP-SQ squamous-like clone. The emergence of a squamous cell 
phenotype in cell lines has been reported previously. Terasaki et al. (1987) have 
reported on the emergence of a squamous cell phenotype in a small cell lung cancer cell 
line by using delipidised serum-supplemented medium which lacks retinoic acid. The 
changes were reversible on addition of RA to the medium. It is possible that the 
absence of this agent from the SFM for DLKP cells caused the cells to differentiate 
towards a squamous phenotype.
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4.3.2 Cryopreservation of DLKP cells in SF conditions
Serum has been shown to be effective in enhancing the survival of frozen cells 
(Dougherty, 1962) and it is thus often added before freezing, even for cell lines that are 
maintained in SF conditions. If serum is used in such systems, many washings and 
long-term recultivation under SF conditions are required for complete removal of 
serum-derived factors. Even with these precautions, use of serum at the freezing stage 
does, to some extent, compromise the serum-free staus of the cells. Thus to maintain a 
true SF system for both DLKP and DLKPA cells, investigations into the SF freezing of 
the cell lines were carried out.
Cryoprotectants are broadly divided on the basis of whether or not they permeate cells. 
Cells are usually permeable to DMSO and glycerol where the cells are protected against 
freezing damage caused by intracellular ice crystals and osmotic effects. Cells are 
usually impermeable to PVP (polyvinylpyrrolidone) and serum proteins (Ashwood- 
Smith, 1987). Methylcellulose, PVP and other synthetic polymers have been used as 
for a number of years as protective agents in low serum media. Yoshida and Takeuchi 
(1991) used Methylcellulose to act as a non-permeating cryoprotectant because of its 
high molecular weight (140,000MW). A combination of a permeating and a non­
permeating compound seem to have the best effect on survival of the cells in freezing 
medium. They found that a combination of 0.1% MC or 3% PVP with 10% DMSO 
resulted in a viability on thawing of between 72-76% for primary mouse astrocytes. 
They found that the percentage of cell attachment was higher when the cells were frozen 
with 0.1% MC and 10% DMSO. Ohno et al. (1988) used this combination for the 
successful freezing of mouse LP.3 cells with an 81% and 74% viability after a 
cryopreservation period of 4 and 6 months respectively. Merten et al. (1995) have used 
the same freezing medium for the successful freezing of a number of important 
industrial cell lines, such as BHK and Vero. The percentage viabilities on thawing 
were much higher than previous reports, greater than 94% for Vero and almost 100% 
for BHK.
Both the DLKP and DLKPA cell lines have been successfully frozen in a SF freezing 
medium composed of 10% DMSO and 0.1% Methylcellulose. Greater than 75% 
viability has generally been obtained for DLKP and greater than 78% for DLKPA 
which are results comparable to other researchers. Further work to try and improve 
viability on thawing could be carried out using PVP or glycerol.
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4.3.3 Improvements in the SFM for the growth of early passage DLKP
The importance of basal medium optimisation for SF growth of cell lines cannot be 
understated. The basal medium provides the cells with many soluble, low molecular 
weight nutrients such as ions, carbohydrates, vitamins, amino acids and nucleosides. 
Barnes and Sato (1979) found that using a 50:50 mix of F12 and DME media is 
essential for the growth and survival of the MCF-7 cell line under SF conditions. No 
growth is observed when DME is used as the basal medium and a suboptimal growth 
rate is obtained with F12. Some cell lines may have defective metabolic or transport 
systems and thus require additional supplementation. Hybridoma cell lines secreting 
high levels of protein shoud be ideally grown in SFM containing a basal medium that is 
rich in amino acids. The work carried out in Section 3.2.6.1 shows that Ham's F12 
basal medium is more effective than F I2/ DME (1:1) in supporting the growth of the 
DLKP cells in SFM.
Insulin is the most common hormone supplement of culture media and is considered to 
be essential for the growth of nearly all cell lines in culture including hybridoma cell 
lines (Glassey et al., 1988). It is included in most culture media at concentrations 
ranging from 5-10|ig/ml which is much higher than physiological concentrations due to 
the short half of the molecule in convential media formulations. For most cell lines in 
SFM, the use of supraphysiological concentrations has been related to the mitogenic 
activity of insulin being mediated through the IGF-1 receptor. Mendiaz et al. (1986) 
have shown that insulin stimulates the growth of CHO-K1 cell line in SFM over a 
concentration range from lng to 10[ig/ml. Murakami and Masui (1980) have shown 
that insulin at a concentration of 0.5^ig/ml is required for the optimal growth of a human 
colon carcinoma cell line in SFM. For DLKP cells, a concentration of insulin of 
2.5|ig/ml was found to give optimal growth stimulation which falls well within the 
range observed by most researchers.
Transferrin is an iron-transport molecule and is a protein constituent of the [3-globulin 
fraction of blood serum. It appears to be an obligatory requirement of most SF media 
formulations as most cell lines investigated under serum-free conditions show a positive 
response to it. Typical concentrations in SFM range from 1 to 30(lg/ml. Transferrin is 
thought to exert its effect by interacting with cell surface receptors and facilitating the 
transport of iron into the cells across the plasma membrane. It also appears to chelate 
deleterious trace elements (Glassy et al., 1988). The results of the transferrin assay 
carried out in Section 3.2.6.3 show that type of transferrin appears surprisingly to be 
slightly inhibitory over the range of concentrations tried. Hewlett (1991) has shown
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that MDCK cell line show no requirement for transferrin when seeded at relatively high 
densities. Mendiaz et al. (1986) found that transferrin was not an essential requirement 
for the cells as FeS04 substituted equally well. Keenan and Clynes (1996) have shown 
that transferrin can be replaced by simple iron compounds for MDCK cells grown and 
subcultured in serum-free medium. Mather and Sato (1979) found that the observed 
growth stimulatory effects on the growth of a mouse melanoma cell line, MR2, in SFM 
were dependent on the absence of FeS04 in the medium. In the absence of added iron, 
there was found to be a fifteen-fold increase in the cell growth at a transferrin 
concentration of l|ig/ml. However, at the same concentration in the presence of FeS04, 
only a two-fold increase in cell numbers was observed. Further work needs to be 
carried out by looking at the effects of transferrin on growth with and without FeS04 
being present in the SFM (FeS04 is present in the H SFM at a concentration of 5|iM).
Successful growth of many anchorage-dependent cells in SFM usually requires the 
addition of attachment factors normally present in serum. Thus a number of attachment 
factors, laminin, fibronectin and Type IV Collagen were investigated to determine if 
DLKP showed improved growth with supplemented attachment factors. Although all 
cells are capable of producing attachment factors, the incorporation of attachment 
factors into a SFM greatly increases the deposition of the extracellular membrane.
Fibronectin is a multimeric glycoprotein associated with a host of biological functions 
including cell growth, adhesion, migration and wound repair (Hynes, 1990) and is 
located in the extracellular matrix of most tissues. Many cell lines have a requirement 
for attachment factors in order to spread and initiate cellular growth. For example, 
fibronectin has been found to be involved in the growth control of a rat ovarian cell line, 
RF-1, at a concentration of 8|ig/ml (Orly and Sato, 1979). Fibronectin at a 
concentration of between 5-10|lg/ml has been found to have a very significant 
stimulatory effect on the growth of the DLKP cell line. In the assays carried out in 
Section 3.2.6.4, almost a two-fold increase in cell numbers was achieved over the 
controls without fibronectin supplementation. The cells were also noted to attach very 
well to the flask surfaces with a more flattened, epithelial-like morphology than in 
unsupplemented SFM. Dr. Shirley McBride has shown that the DLKP cells and the 
three clones derived from this population attach very rapidly to wells coated with 
fibronectin. It appears that fibronectin plays an important role in regulating the growth 
control of the DLKP cell population.
Laminin at a concentration of 5p.g/ml was also found to be stimulatory to the growth of 
DLKP cells in serum-free medium. The cells also appear to form short “neurite-like” 
processes compared to a more squamous, epithelial-like flattened morphology when the
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cells are cultivated in fibronectin supplemented medium. Culture of a retinoblastoma cell 
line, 1-79, in SFM containing lO^g/ml laminin showed similar attachment and 
formation of neurite-like processes (Kyritsis et al., 1986). Higher cell numbers were 
generally achieved for DLKP cells growing in laminin-supplemented medium rather 
than fibronectin supplemented medium. Similar trends were observed in 1003 
embryonal carcinoma cells (Darmon, 1982) and rat epithelial cells (Junker and Heine, 
1987). Laminin has also been shown to induce anchorage-dependent growth and slight 
neuronal differentiation in SCLC cell lines (Giaccone et al., 1992). It would be 
interesting to investigate possible changes or induction of differentiation in DLKP cells 
after treatment with these ECM components, especially with the observed neurite-like 
processes in laminin treated cells. When laminin was added to a retinoblastoma cell line 
in SFM, the cells began to attach to the surface and started to from neurite-like 
processes. After 3-4 days, treatment of the cells with dibutiyl-cyclic AMP (Db-cAMP) 
or sodium butryate resulted in extensive differentiation of the cells. Db-cAMP provoked 
the formation of long ramifying neurite-like processes, whereas butyrate induced the 
appearance of epithelial-like cells with a flat morphology (Kyritsis et al., 1986). 
Laminin appears to have an initiating role in RB cell attachment and differentiation. 
Studies similar to this could be investigated in DLKP cell line which appeals to have 
some degree of neuronal differentiation since it has been shown to express 
neurofilaments (McBride et al., 1997).
Addition of Type IV Collagen to the SFM has been found not to improve the growth of 
DLKP cells in SFM and no apparent change in morphology was observed. This ties in 
with the obsevations made by Dr. Shirley McBride during experiments investigating 
attachment properties of the clones. Poor attachment to Type IV Collagen was always 
observed during time course assays.
Thus, DLKP grow significantly better in SFM when supplemented with the 
extracellular matrix proteins, fibronectin or laminin. The induction and maintenance of 
cell growth, differentiation and normal tissue architecture is a multistep process that 
requires interaction between the cell and the ECM (Rodriguez-Boulen and Nelson,
1989). Basement membrane components have also been shown to stimulate the growth 
of lung tumor cells in vivo (Topley et al., 1993).
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4.3.4 Sensitivity of DLKP to chemotherapeutic drugs in SFM
The sensitivities of the DLKP cell line, both long-term and short-term in SF conditions, 
to a number of chemotherapeutic drugs was determined. VP 16 (etoposide) inhibits 
topoisomerase II activity leading to increased DNA damage. Adriamycin is an 
intercalating agent which also inhibits topoisomerase II activity and blocks DNA 
synthesis and RNA transcription while Vincristine is a tubulin inhibitor which disrupts 
spindle formation during cell division. These three drugs are among the most effective 
single agent responses of anti-cancer drugs used (Cook et a l, 1993). The phenomenon 
of multiple drug resistance (MDR) is often one of the main reasons for the high fatality 
rates associated with the disease. The human multidrug resistance I gene (mdr-1 gene) 
encodes P-glycoprotein, which appears to catalyse the outward transport of anticancer 
agents in cancer cells (Endicott et al., 1989; Gottesmann, 1993). This appears to be 
one of the mechanisms involved in the phenomenon of MDR.
The SFM developed for DLKP cells was used to perform toxicity assays in a totally 
defined system. Serum proteins can inhibit the in vitro cytotoxicity of some anti­
neoplastic drugs while other components of serum, such as growth factors, hormones 
and prostaglandins may affect the toxicity of the drug being tested. Tsai et al. (1996) 
screened 24 human cancer cell lines with nine anticancer agents in both serum-free and 
serum-supplemented medium and found that SSM had a negative effect on the cytotoxic 
action of some of the drugs including methotrexate, 5-fluorouracil and mitomycin C . 
The cellular protective effect on methotrexate and 5-fluorouracil are mediated via 
hypoxanthine and thymidine contained in undialysed serum (Yoshida et al., 1978; 
Martin et al, 1980; Sobrero et al., 1986). Cisplatin and vincristine have been found to 
bind avidly to serum proteins (Donigan and Owellen, 1973; Wilson, 1986). Many 
growth factors and hormones exert their effects at such low concentrations that even 
small changes in concentration from one serum batch to another could result in a lot of 
result variation. Serum-free medium allows such assays to be carried out without risk 
of such variability and thus allows the concentration of such factors to be varied when 
actually required.
For VP16, it was observed that the IC50 values were higher for the cells P.22 in SF 
compared to P.l SF or SS culture, a 1.8-fold increase was noted. This difference was 
much more significant for cells exposed to Adriamycin where the P.22 cells showed a 
3-fold increase in IC50 value over normal culture serum-supplemented cells (P.l SS). 
The P. 1 SF cells also showed a 0.5-fold increase in IC50 value compared to the same 
cells assayed in SSM. This general trend was not observed for cells assayed in
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Vincristine where the cells were found to be extremely sensitive to the drug in SFM. 
Perhaps the reason for this increase in IC50 value for two of the drugs tested in SFM is 
due to the fact that the cells grow more slowly in SFM. Many of the effects of MDR 
drugs occur during DNA replication, thus a cell line with a high turnover rate may be 
effected to a greater extent than one which divided at a slower rate. Due to the faster 
growth rate of SS cells, the IC50 value is lower for these cells. Tsai et al. (1996) found 
that cell lines tend to be more sensitive to different drugs when they are tested in the 
particular medium type in which they preferentially proliferate.
Perhaps removal of serum from the system has caused the increased expression of the 
mdr-1 gene. There have been reports of increased mdr-1 expression caused by serum- 
starvation which would mimic the conditions observed in this SFM where the only 
mitogenic factor present is insulin. Expression of mdr-1 gene appears to be activated 
by various environmental stresses. For example, in human neuroblastoma and colon 
cell lines, differentiating agents such as retinoic acid and sodium butyrate increase 
expression of P-glycoprotein (Bates et al., 1989). Heat shock and arsenite have also 
been found to increase its expression in human renal cancer cell lines (Chin et al.,
1990). Tanimura et al. (1992) have shown that the human mdr-1 promoter can be 
activated by serum deprivation in two human cancer cell lines, KB and SW-13. This 
group used an assay system using chloroamphenicol acetlytransferase (CAT) gene 
driven by the human mdr-1 gene promoter for their study. The presence of serum 
appears to be inhibitory to the activation of the mdr-1 promoter because the addition of 
serum to the cells cultured in SFM resulted in decreased CAT expression. Muller et al.
(1995) have shown that the P-glycoprotein half-life of 4 different cell lines was 
normally between 14 to 17 hours. However, removal of serum from the medium 
results in the half-life increasing by 4- to 6-fold depending on the cell line. This 
observed serum effect suggests the involvement of growth factors in the control of P- 
glycoprotein stability and underlines the importance of culture conditions in determining 
the actual toxic effects of drugs. They also found that the effect of P-glycoprotein half- 
life is reversible when serum is added back. For the long-term SF cultured cells, 
especially for Adriamycin, a reduction in IC50 values was noted between the SF and SS 
assays which could be indicative of a return to the original half-life of the P- 
glycoprotein normally observed in serum-supplemented culture. Although overall there 
is not a significant change in IC50 values between SF and SS assays, a definite 3-fold 
increase in IC50 value was observed for Adriamycin between P.22 SF cells and parental 
cells normally assayed in SSM.
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RT-PCR analysis could be carried out on these long-term or short-term SF cells to see 
if there has been an increase in the expression of the mdr-1 gene. The protein is 
expressed normally at extremely low levels in DLKP serum-supplemented cells and is 
often undetectable even by RT-PCR analysis (O' Driscoll, 1994).
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4.4 GROWTH OF DLKP CLONES IN SERUM-FREE MEDIUM
The growth capacities of the DLKP clones were found to vary under serum-free 
conditions. DLKP-I was found to be the only clone among the three that was capable of 
proliferating in the SFM investigated for DLKP. DLKP-I appeared to be the most 
independent of exogenous growth and attachment signals. This suggests that DLKP-I 
is producing the autocrine factors which DLKP-SQ and DLKP-M are lacking and 
enables these cells and the parental population to grow in defined, serum-free 
conditions. This may explain why the growth rate of DLKP-I in defined SFM often 
exceeds that of DLKP, as in the mixed heterogeneous parental population, this clone 
accounts for only 30% of the total population.
However, addition of a single factor, fibronectin, was found to be capable of 
stimulating growth of DLKP-SQ and -M. Subcultivation of these clones was also 
possible with fibronectin supplementation. Thus, attachment factors may be what 
DLKP-I produces allowing them to proliferate in SFM without supplementation of an 
attachment factor. One interesting observation was that the morphology of DLKP-I 
was similar to DLKP-M in this supplemented SFM. It has been suggested that DLKP-I 
may be an intermediate phenotype between those of -SQ and -M or possibly a stem cell­
like population which can give rise to either of the two other phenotypes, depending on 
culture conditions. On prolonged culture in serum-supplemented medium, DLKP-SQ 
and -M can interconvert with -I but DLKP-SQ and -M do not appear to interconvert 
directly (McBride et al., 1997). Thus, cultivating DLKP-I in SFM supplemented with 
fibronectin may push them towards the DLKP-M phenotype.
A useful model now exists to further investigate interconversion between these 
subclones of the heterogeneous DLKP population. DLKP and its clonal variants may 
prove to be a useful model for the study of tumourigenic progression. The adhesion 
properties of metastasising cells are extremely complex (Birchmeier and Behrens, 1994) 
and their interactions with ECM proteins must allow for substrate adhesion and 
motility. DLKP-M were found to have unusual attachment properties to fibronectin 
where the cells were found to adhere rapidly to the protein and then detach again; thus, 
they may represent a metastatic-like phenotype in the parental DLKP population 
(McBride et al., 1997). The apparent ability of DLKP-I to interconvert to DLKP-M 
with fibronectin supplementation should allow this possible metastatic potential to be 
further investigated. The interconversion process is observed in serum supplemented 
conditions but the undefined nature of serum prevents this process being controlled, 
hence the ideal use of a totally defined system to continue these investigations.
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4.5 GROWTH OF DLKPA CELLS IN SERUM-FREE MEDIUM
Multiple drug resistant variants of the DLKP cell line have been established in our 
laboratory (Clynes et al., 1992) as models for MDR in non-small cell carcinoma cell 
lines. DLKPA is one such variant which was selected by subjecting the cells to 
increasing concentrations of the drug adriamycin and is several more times resistant 
than DLKP to a range of toxic compounds. The cell line shows a 300-fold increase in 
resistance to adriamycin compared to DLKP.
The growth of the cell line was investigated under SF conditions, both in short term and 
long-term culture, with a view to developing a system that allows the effects of different 
chemotherapeutic drugs alone or in combination with other factors such as growth 
factors, hormones or prostaglandins to be tested without the risk of serum interference 
and variability in results. Cryopreservation of the cell line under serum-free conditions 
was also possible using a combination of 10% DMSO and 0.1% Methylcellulose in 
SFM.
The SFM used for both DLKP and CHO-K1 SF culture, H SFM, was found to support 
the growth of the cell line both in short-term culture, over a period of 10 days and in 
long-term culture. It appears that indefinite culturing of the cell line is possible in SF 
conditions. The morphology of the DLKPA cell line in SFM is similar to that in serum- 
supplemented culture. Unlike DLKP SF cells, the DLKPA cells grow very tightly 
attached to the flask surface and are also much more spread out. The cells also grow to 
confluency and in colonies unlike DLKP SF culture. Many researchers have noted 
alterations in cell morpholgy during selection of drug-resistant cell lines (Biedler, 
1981,1975). These changes in morphology appear to be more pronounced and obvious 
in a controlled SF environment. There have been reports in the literature of a 
relationship between P-glycoprotein expression and cellular differentiation. Treatment 
with differentiating agents such as RA have shown to result in increased expression of 
P-glycoprotein (Mickley et al., 1989; Bates et al., 1989). Biedler et al. (1991) have 
shown altered intermediate filament protein expression in multi-drug resistant 
neuroblastoma cells compared with their sensitive counterparts. Expression of cellular 
adhesion molecules due to the very tight attachment of the DLKPA cells in SFM should 
be investigated to demonstrate changes in cellular phenotype. Possibly changes in 
cellular adhesion molecules may be related to the differentiated state of this MDR cell 
line.
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4.6 INVESTIGATIONS INTO KERATIN 8 AND 18 EXPRESSION IN 
DLKP AND DLKPA
Novel induction of keratin 8 and 18 expression with BrdU treatment of keratin-negative 
DLKP cells has been observed (McBride and Clynes, manuscript submitted). 
Experiments were carried out to determine if a similar induction of keratin expression 
by BrdU could be demonstrated in DLKPA cells. Studies were also carried out to 
determine if keratin expression was a result of cytotoxic stress by BrdU rather than a 
differentiating effect, using an extremely toxic anti-cancer drug, Adriamycin. Long­
term K8 and K18 expression was also investigated in DLKP cells. Protein synthesis 
inhibitor experiments were also carried out to try to determine if there might be a protein 
causing de-stabilisation or degradation of keratin filaments in keratin-negative DLKP 
cells. There appears to be strong evidence that K8 and K18 expression is regulated at a 
post-transcriptional level.
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4.6.1 Effect of BrdU on keratin 8 and 18 expression in DLKPA
DLKPA is a 300-fold adriamycin resistant variant of the human lung carcinoma cell 
line, DLKP. The cell line is also more resistant to a range of anti-cancer drugs 
including VP 16, vincristine and cisplatin (Clynes et a l,  1992). There have been 
varying reports in the literature regarding relationships between multiple drug resistance 
and keratin filament expression. Intermediate filaments, along with microtubular 
proteins, play a key role in the maintenance of cell shape and in the spatial organisation 
of the cellular organelles. They are also thought to be involved in the modulation of 
membrane transport (Mills and Mandel, 1994). Thus, changes in the intermediate 
filament content and structure could potentially alter the cellular cytoskeleton and affect 
a multitude of cellular events, including drug transport. L cells (mouse fibroblasts) 
transfected with cytokeratins 8 and 18 exhibited a multiple drug resistance phenotype 
when exposed to a number of drugs including adriamycin, methotrexate and vincristine 
(Bauman et a l, 1994). An increased level of cytokeratin 8 expression was observed in 
resistant variants of the human ovarian cancer cell line, OAW42, (Moran et a l, 1997). 
On the other hand, Parekh and Simpkins (1995) have shown that a cisplatin-resistant 
human ovarian cell line contained markedly lower levels of cytokeratin 18 when 
compared to the sensitive parental cells. This group has also shown that the cisplatin- 
resistant variants are hypersensitive to the cytotoxic effects of taxol, vincristine and 
vinblastine. Decreased levels of cytokeratin 14 was also reported in a cisplatin-resistant 
variant of a human squamous cell carcinoma cell line (Katabami et a l, 1993).
The multiple drug resistant cell line, DLKPA, was found to be negative for the 
expression of keratin filaments using a pan-cytokeratin antibody and antibodies to 
keratins 8 and 18. Treatment with BrdU induced expression of keratin 8 and 18 
proteins with an apparent change in morphology, similar to that observed in BrdU- 
treated DLKP cells. Thus keratin filament protein expression does not appear to be 
associated with multiple drug resistance in DLKPA cells. However, it would be 
interesting to carry out some toxicity or drug transport assays on BrdU-treated cells to 
see if there are any changes in resistance to the various anti-cancer agents.
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4.6.2 Toxic effect of BrdU
Bromodeoxyuridine at the concentrations used in the study was found to be extremely 
toxic to the cells. To rale out the possibility that cytokeratin expression was a result of 
cytotoxic stress caused by BrdU, experiments were carried out using concentrations of 
the highly toxic chemotherapeutic drag, adriamycin, that would result in a similar level 
of toxicity to the cells. No induction of cytokeratins 8 or 18 was observed in DLKP, 
DLKPA, H82 and HL60 cells, and no upregulation of expression was observed in 
A549 cells. The induction/ upregulation of keratin expression is due to/ caused by the 
differentiating, and not the cytotoxic, effects of BrdU.
4.6.3 Long-term keratin 8 and 18 expression in DLKP cells
The effect of BrdU on induction of keratin 8 and 18 expression in DLKP appears to be 
reversible. Removal of BrdU from the medium results in the cells retaining K8 and 
K18 positivity for at least two weeks. As the cells were being continually passaged, the 
number of keratin positive cells gradually decreased. Twenty-eight days after removal 
of BrdU from the medium, all the cells were found to be negative for K8 and K18 
expression. The experiments which have been done do not distinguish between two 
possibilities; the cells induced to express cytokeratins are terminally differentiated and 
are diluted out during subculture; or expression is gradually lost if BrdU is not 
continuously present. A combination of these two events could also be occurring. 
Further experiments could be performed to determine if these keratin positive cells are 
capable of replicating. Double-labelling immunofluorescence studies could be carried 
out using antibodies to keratins 8 or 18 and proliferation markers such as Ki67 or 
PCNA. The keratin positive cells could also be sorted using flow cytometry and these 
cells could then be investigated for ability to replicate. If BrdU has induced a degree of 
differentiation, these cells may also have slower growth rates compared to the parental 
untreated cells.
4.6.4 Protein synthesis inhibitor studies on DLKP cells
BrdU has been found to induce keratin 8 and 18 expression in DLKP cells at a post- 
transcriptional level (McBride and Clynes, manuscript submitted). This suggests that 
BrdU may exert its effect directly or indirectly on protein translation, or stabilisation of 
translation products already present. Keratin 8 and 18 proteins are already present in 
A549 cells before treatment and are upregulated following BrdU treatment. It thus 
seems plausible that a stabilisation of keratin translation products is occurring rather 
than an induction of translation. Perhaps in DLKP and H82, a rapid degradation of 
keratin proteins in untreated cells results in their being undetectable by 
immunocytochemical methods.
One of the hypotheses put forward was that a protein may be causing rapid degradation 
of these keratin proteins. Cycloheximide and Actinomycin D protein synthesis inhibitor 
studies were carried out to try and determine if there might be some evidence for a 
protein causing de-stabilisation or rapid degradation of translation products for keratins 
8 and 18. The principal behind the experiment was that cycloheximide and actinomycin 
D would prevent synthesis of the protein thus allowing stabilisation and resultant 
expression of the keratin filaments. Cycloheximide treatment for 6 to 10 hours at 
concentrations ranging from 5 to 10|ig/ml had some effect on the cells with a definite 
induction of K8 and K18 expression, observed by immunocytochemistry. Levels of 
expression were less than that observed for BrdU-induced K8 and K18 expression. 
This is probably due to cycloheximide compromising the synthesis of the keratin 
proteins themselves. However, the results were found to be promising and do lend 
some weight to the proposal that BrdU may be stabilising keratin translation products 
and thus acts at a post-transcriptional level to regulate control of K8 and K18 
expression in epithelial cell lines. Cycloheximide has been shown to induce keratin 
expression in other cell lines. Cremesi and Duprey (1987) demonstrated that treatment 
of an undifferentiated embryonal carcinoma cell line led to the transcriptional induction 
of the endo A gene, which is the mouse homologue of cytokeratin 8.
Similar studies carried out using Actinomycin D showed no induction of keratin 8 and 
18 expression. This may be due to these two protein synthesis inhibitors having 
different mechanisms of action on the cells.
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4.7 STUDIES TO INVESTIGATE THE DIFFERENTIATING EFFECT 
OF BRDU IN HUMAN LUNG CANCER CELL LINES
When DLKP are grown in SFM, there appears to be a change in the morphology of the 
cells especially when the medium is supplemented with the extracellular matrix proteins, 
fibronectin and laminin. Treatment of DLKP with BrdU has been shown to induce the 
expression of epithelial specific proteins with a dramatic change in morphology. The 
cells become more flattened and spread. The effect of the differentiation-inducing agent 
BrdU was examined in an attempt to further characterise the new cellular phenotype 
with a particular emphasis on the expression of adhesion receptors such as integrins. 
The response of these cells to various ECM proteins was also examined to investigate 
possible changes in the adhesive properties of the cells.
4.7.1 Determination of epithelial-specific and epithelial-associated 
markers in BrdU-treated cells
The new cellular phenotype was noted to be much larger, stretched and flattened, 
suggesting a change in adhesion properties of the cells. There appears to be a trend for 
the down-regulation of (3j integrins in poorly-differentiated epithelial tumours of the 
lung (Smythe et al., 1995; Roussel et al., 1994), colon (Pignatelli et al., 1990) and 
breast (Zutter et al. 1995). A decrease in integrin expression may favour tumour 
invasion and unregulated growth (Ziober et al., 1996). Collagen-laminin binding 
integrin expression has often been seen to correlate with the degree of pathological de­
differentiation of the primary tumour, with the more poorly-differentiated tumours 
exhibiting lower levels of expression (Bonkhoff el al., 1993; Korhonen et al., 1992). 
DLKP has been classified as a poorly-differentiated carcinoma of the lung and appears 
to be highly malignant and aggressive, which may be reflected in its successful 
proliferation in serum-free medium (See section 3.2). Thus, the (3j integrin profile of 
these cells before and after BrdU treatment was examined.
I found that treatment of DLKP with BrdU changes the expression of a number of the 
(3, integrins. Induction of a , integrin expression has been shown by 
immunocytochemistry and immunoprécipitation. There have been few reports in the 
literature on the association between a, integrin and the invasive/metastatic behaviour of 
tumour cells. However, decreased levels of a, are found in human metastatic melanoma 
(Schadendorf et al., 1993) and axillary métastasés of the breast (Gui et al., 1994). 
Loss of a! integrin has been observed in lung adenocarcinomas, compared with strong 
expression in normal lung pneumocytes (Roussel et al., 1994).
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Upregulation of a 2 integrin was also observed by immunocytochemistry and 
immunoprecipitation. More information on a 2 integrin exists in the literature, though it 
is somewhat contradictory (See Section 1.4). Overall, it appears that invasive breast 
cancer has the strongest correlation with lack of a2 integrin expression and the 
differentiation state of the tumour. High levels of a 2 are found in normal breast ducts 
and ductules. However, these levels fall in moderately differentiated, and are markedly 
reduced or completely absent in, poorly-differentiated ductal carcinoma and breast 
disease (Zutter et al., 1995; Arihiro et al. 1993). Reduction in a 2 integrin expression 
has been observed in poorly-differentiated non-small cell carcinoma of the lung 
(Smythe et al., 1995), but it appears that down-regulation of a2 may be associated with 
the differentiation status, but not metastasis, of the NSCLC. This may tie in with 
observations made by Dr. Shirley McBride (PhD 1995) where faint positive staining 
was noted in DLKP and two of the clones (DLKP-I, DLKP-SQ), but the clone which 
appears to possibly have metastatic properties, DLKP-M, has a stronger a2 integrin 
expression. Normal bronchial and alveolar epithelial cells express high levels of this 
integrin (Damjanovich et al., 1992; Mette et al., 1993). Thus DLKP is an excellent 
model to further investigate the metastatic potential of those cells before and after 
treatment with bromodeoxyuridine.
No change in the expression of a 3 integrin was observed by immunocytochemistry in 
BrdU-treated DLKP cells. In most normal epithelia, a 3 integrin is restricted to the basal 
and suprabasal cells and is generally absent in more differentiated cells and may be 
involved in cell-cell adhesion events (Symington et al., 1993; Carter et al., 1994). It 
appears to be altered in some tumours with the presence of a 3 integrin correlated with 
tumour progression and high expression in metastatic lesions (Bartolazzi et al., 1993). 
Strong expression of a 3 integrin was observed in DLKP cells which may correlate with 
the low degree of differentiation of this tumour cell line. DLKP was also established 
from a primary lymph node metastasis which may explain the high expression of this 
integrin in the cell line. No apparent change in expression of this integrin was observed 
by immunocytochemical techniques.
The expression of a 4(3, integrin was also investigated in DLKP cells. This integrin is 
not usually expressed in any significant amounts in normal or malignant lung tissue 
(Damjanovich e ta i,  1992; Mette et al., 1993). No induction of a 4 integrin expression 
was observed in BrdU-treated DLKP cells.
BrdU has been found to upregulate expression of a 3, a 5, and a 6 integrin expression in 
a human melanoma cell line (Thomas et al., 1993). However, no reports have been 
found in the literature on the induction and upregulation of integrin proteins in response
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to differentiation agents in human epithelial cells lines. The mechanism of action of 
BrdU in differentiation is unknown but the induction and upregulation of integrin 
expression may afford an excellent opportunity to investigate this mechanism. The 
literature on regulation of integrin expression is extremely sparse and DLKP provides 
an excellent model to further investigate integrins and their role in differentiation and 
cancer progression.
The finding that keratin 8 and 18 expression in DLKP was induced by BrdU treatment 
suggested the value of looking at the expression of keratin 19. Keratin 19 is often co­
expressed with keratins 8 and 18 in simple epithelial tissues. Induction of keratin 19 
was observed in BrdU-treated DLKP cells, though the level of induction was less than 
that observed for keratin 8 and 18 (5% compared with 20%).
The expression of epithelial specific antigen (ESA), which is also known as epithelial 
glycoprotein (EGP), was also investigated in DLKP cells treated with BrdU. DLKP 
and its clones are normally negative for expression of ESA (McBride et al. 1997). 
However induction of this protein has been observed by immunocytochemistry and 
Western blots, by treatment with BrdU. EGP protein expression is exclusive to 
epithelial cells (Momberg et al. 1987; Moldenhauer et al. 1987) and is usually expressed 
at the basolateral surface of the majority of simple cuboidal or columnar, 
pseudostratified columnar and transitional epithelia (Spurr et al. 1986; Edwards et al. 
1986; Burmol et al. 1988). The function of this protein is unknown, though the gene 
has been cloned by a number of different investigators (Szala et al. 1990; Stmad et al. 
1989; Simon et al. 1990). EGP was suggested to play a role in fundamental cell-cell or 
cell-matrix interactions of epithelial cells because it was found to have sequence 
homology to nidogen, a component of the extracellular matrix (Simon et al. 1990). 
Litvinov et al. (1994) have shown that EGP expression can supress invasive colony 
growth of L cells, a fibroblast cell line, in EHS-matrigel. They suggest that in EGP- 
negative epithelial tissues, the de novo expression of the molecule in tumour cells may 
be critical at early stages of tumourigenesis. They suggest a role similar to E-cadherin, 
the main type of intercellular adhesion of epithelia, which is often found down- 
regulated in poorly-differentiated carcinomas and later stage carcinomas. Re- 
introduction of EGP into EGP-negative cell lines may be capable of diminishing the 
strength of normal-tumour cell adhesions and thus reduce the invasiveness of a tumour 
cell line into normal surrounding tissue.
The effect of other differentiating agents on the expression of ESA has been 
investigated in epithelial cell types. DMSO has been shown to reduce ESA expression 
in human colonic epithelial cells, while sodium butyrate had no effect in these cells
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(Omary et al. 1992). The marked change in the expression of ESA after BrdU 
treatment should provide a useful model to study potential functions for ESA, especially 
if its function as a cellular adhesion molecule, which may have a role in tumour 
differentiation and progression, is proven.
The effect of BrdU on the expression of cytokeratin 19, ESA and some of the beta-1 
integrins was also investigated in other lung epithelial cell lines, DLKPA, H82 and 
A549, and in a non-epithelial cell line, HL60.
Treatment of DLKPA showed a similar induction of cytokeratin 19, ESA and a, 
integrin expression with no change in expression of EGF-R and desmosomal protein. 
These results are similar to those found for the parental drug-sensitive cell line, DLKP.
Treatment of A549, a human lung adenocarcinoma, with BrdU had a very dramatic 
effect on cytokeratin 19 expression. Before BrdU treatment, 30% of the cells were 
usually positive for keratin 19 expression but after treatment for 5 to 7 days, at least 80- 
90% of the cells were found to be positive by immunocytochemistry. This upregulation 
was clearly demonstrated by Western blots and immunoprécipitation of keratin 19 
proteins. Upregulation of keratins 8 and 18 was also observed in DLKP after BrdU 
treatment (McBride and Clynes, manuscript submitted). However, this was not as 
dramatic an upregulation as that observed for keratin 19. Expression of EGF-R and 
desmosomal protein was found to be similar before and after BrdU treatment. 
Upregulation in expression of ESA was also observed on BrdU treatment. However, 
no apparent change in expression of a, and a 2 integrin was observed in this cell line 
which is different to DLKP. A549 are quite a well-differentiated cell type and already 
inherently express a, integrin and high levels of a 2 integrin.
H82, a variant-SCLC cell line, was also investigated for the expression of these 
proteins after BrdU treatment. DLKP has been found to express some antigens typical 
of V-SCLC classification. This cell line has been shown to differentiate towards a more 
tightly aggregated, classic SCLC morphology in the presence of retinoic acid (Doyle et 
al., 1989). Treatment of H82 with BrdU results in induction of K8, K17 and K18 
(McBride and Clynes, manuscript submitted). The cells which usually grow as 
aggregates in suspension begin to attach to the flask surface and spread becoming more 
epitheloid in appearance on BrdU treatment. Induction of keratin 19, and of a! and a 2 
integrins was observed in a small number of these attached cells (<5%). The 
expression of ESA was found to remain negative after BrdU treatment which differs 
from that observed in DLKP BrdU-treated cells.
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HL60, a leukaemic cell line which grows as single cells in suspension, did not express 
keratin 19, ESA, a,, a 2 or a 3 integrins before or after BrdU treatment.
It thus appears that BrdU is capable of inducing differentiation along lineage-specific 
pathways. It is incapable of inducing expression of epithelial-specific markers such as 
keratin 19 and ESA in a non-epithelial cell type such as HL60. It is also incapable of 
inducing beta-1 integrin expression in these cells as these integrins are most commonly 
expressed in epithelial cells which require these receptors in order for them to be 
anchored to the basement membrane through integrin ligand-ECM interactions.
4.7.2 Effect of BrdU in serum-free medium
Induction of keratin 8 and 18, ESA, oc,(3, integrin and upregulation of oc2P1 integrin was 
also observed when serum-free medium was used. This shows that BrdU is working 
on its own in the system without interference from factors found in serum which may 
contribute towards the differentiation process. The use of serum-free medium in such a 
system is ideal for the use of physiologically relevant differentiating agents such as 
retinoic acid and interferons.
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4.7.3 Messenger RNA studies
RT-PCR analysis was carried out to determine if the induction and upregulation of 
keratin 19 by BrdU was a result of alterations in the transcription of the gene. The 
mRNA levels in A549 were remained unchanged over the 5 day treatment even though 
protein levels were significantly upregulated, as demonstrated by 
immunocytochemistry, Western blotting and immunoprécipitation of keratin 19 protein. 
Keratin 19 mRNA was also detected in DLKP and H82 prior to treatment with BrdU. 
No increase in keratin 19 mRNA transcripts was apparent after BrdU treatment for 5 
days even though induction of keratin 19 protein was clearly evident by 
immunocytochemistry. Keratin 19 mRNA was also detected in HL60 cells at much 
lower concentrations before and after treatment even though expression of K19 protein 
was never detected by immunocytochemistry or Western blots. Several reports 
describe the detection of keratin mRNA transcripts in cells which do not express the 
corresponding protein. Burchill et al. (1995) detected K8, Kl 9 and K20 mRNA in 
normal blood cells. Thus, the presence of K19 mRNA is not too surprising in HL60 
cells which are in fact a leukaemic cell line.
Much remains to be discovered about the mechanisms which control expression of the 
various keratin proteins. Most of the studies have shown regulation at the 
transcriptional level (Roop et al., 1988; Blouin et a l,  1992). Retinoic acid has been 
demonstrated to regulate keratin 19 expression at the post-transcriptional level in 
keratinocytes (Crowe, 1993). Translational (Tyner and Fuchs, 1986) and post- 
translational (Bisgaard et al., 1994) control of keratin expression have also been 
reported. However, no reports have appeared in the literature on the mechanism of 
regulation of keratin expression by BrdU. Pampinella et al. (1996) observed K8 and 
K18 expression in rabbit serosal cells following BrdU treatment while untreated cells 
expressed only keratin 18. However, mRNA levels were not measured. K8 and K18 
mRNA appears to be regulated in DLKP and H82 cells at the post-transcriptional/ 
translational level showing similar levels of expression of keratin 8 and 18 mRNA 
transcripts in untreated and treated cells by RT-PCR and Northern blots (McBride and 
Clynes, manuscript submitted). No upregulation of K8 and K18 mRNA was observed 
in A549 while HL60 was also found to express low amounts of K8 and K18 mRNA 
transcripts. It appears that keratin 19 expression is regulated at the post-transcriptional/ 
translational level in a similar manner to keratins 8 and 18 in these epithelial cell lines.
It was not possible to carry out RT-PCR studies on the integrins due to the lack of 
availabilty in the literature of complete gene sequences for the a, and a 2 integrins. Only 
cDNA sequences for these genes have been reported (Briesewitz et al., 1993; Takada
251
and Hemler, 1989). Thus, it was not possible to design primers because of the danger 
of primer sequences spanning introns and amplifying genomic DNA rather than the 
actual gene of interest. Northern blotting was carried out using a rat a, integrin cDNA 
probe (Ignatius et al., 1990) but I was unable to get the probe to detect human RNA 
from the various cell lines tested. Further studies will be concerned with making 
human cDNA probes for both these integrins to tiy to elucidate how BrdU is working 
to induce and upregulate the expression of such proteins.
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4.7.4 Change in adhesion properties of BrdU-treated cells
BrdU treatment of DLKP cells resulted in induction of a,p, integrin and upregulation of 
a 2P, integrin. Both these receptors are collagen and laminin binding. BrdU-treated cells 
also show a change in morphology, with the cells becoming more stretched and 
flattened, possibly indicative of a change in adhesion properties of the cells.
Functional attachment assays were thus carried out in response to these changes in 
receptor expression and cellular morphology. The DLKP treated cells were found to 
show increased adherence to all three ECM proteins looked at, fibronectin, laminin and 
Type IV collagen, over the 15, 30 and 60 minute time intervals investigated. Increased 
adherence of treated cells to EHS was also observed. EHS is composed of collagens, 
non-collagenous glycoproteins (such as laminin and fibronectin) and proteoglycans of 
the basement membrane, and would be present in the basement membrane in vivo. 
Treated cells also showed increased adherence to plastic, though the rate of attachment 
to plastic was much slower than the rates observed for laminin or fibronectin.
Poorly-differentiated and invasive cell types often showed down-regulation of epithelial 
cell-cell attachments, thus altering normal cell-matrix interactions which may enable 
metastasising cells to migrate and invade the basement membrane. BrdU-treated cells 
show greater adherence to collagen and laminin which may be associated with the up­
regulation of the collagen and laminin binding a t and a 2 integrin. These cells also 
appear to attach better to the basement membrane (EHS). Possibly, the DLKP cell line 
has lost some of its metastatic capabilities with the change in expression of such 
proteins, as well as the ESA protein. The cells may then be less inclined to move 
around the body as a metastatic cell type, and remain anchored to the site in which the 
primary tumour originally occurred. The induction of such proteins may make DLKP a 
less migratory cell type.
Changes in the adhesiveness of cells has been reported previously in response to BrdU 
and retinoic acid treatment. Thomas et al. (1993) found increased adherance of 
melanoma cells to Type IV collagen after BrdU treatment. Ross et a l (1994) found that 
retinoic acid treatment of F9 embryonal cells results in increased expression of the p, 
subunit of integrin receptors. A consistent, small increase in attachment of F9 
carcinoma cells to plastic as well as gelatin, laminin and fibronectin after RA treatment 
of these cells was observed.
Invasion assays using Matrigel and the determination of expression of matrix-degrading 
enzymes by these BrdU-treated cells could show changes in the possible metastatic
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5.0 CONCLUSION AND FUTURE WORK
5.0 CONCLUSION AND FUTURE WORK
A serum-free medium has been developed which supports the continuous, long-term 
cultivation of CHO-K1 cells. It appears that the concentration of calcium in the medium 
is critical to this long-term growth in serum-free medium but not in serum- 
supplemented medium. Cultivation of the cells in high calcium media results in 
cessation of growth after 4-6 passages on average, while the use of a low calcium SFM 
allows the cells to proliferate continuously. This may have important considerations for 
primary culture and for other cell lines that fail to proliferate in SFM. Traditional media 
use high calcium concentrations, usually above a ImM concentration. High 
concentrations may induce differentiation in these cells and suppress proliferation thus 
preventing their long-term culture. There is also a good correlation between loss of 
Ca++ control and progression towards tumourigenicity where transformed cell lines 
often show a reduced requirement for calcium compared to normal cells. This suggests 
that it is of considerable importance to consider the calcium content of the medium 
before proceeding with the culture of specific cell types. Employment of such a 
medium investigated for CHO-K1 cells would be of considerable importance. The 
development of a SFM that allows continuous proliferation of CHO-K1 cells may also 
have important consequences for the commercial production of recombinant proteins in 
a completely defined system.
CHO-K1 cells can be cultivated in suspension culture in SFM when Pluronic F68 or 
microcarriers are added to the spinner flasks. Cell death usually occurs within 24 hours 
when the SFM is not supplemented with Pluronic F68. This appears to be due to the 
effects of shear forces in the spinners caused by changes in fluidity of the membrane 
(PMF). A change in PMF shown by fluorescence anistropy measurements correlates 
with the poor growth of the cells where a decreased PMF value was associated with an 
increase in shear sensitivity of the cells. The SFM could be scaled up to assess the 
growth of the cells in larger scale suspension culture. Other shear protective agents and 
recombinant SFM supplements (especially insulin or transferrin) could also be 
investigated in these systems.
Successful cryopreservation of CHO-K1, DLKP and DLKPA was achieved in SFM 
using methylcellulose or polyvinylpyrrolidone to replace serum in the freezing medium. 
This is of particular interest because the use of serum at the freezing stage compromises 
the serum-free status of the cells, especially if they are being cultured long-term in 
SFM.
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The DLKP and DLKPA cells have been found to grow continuously in SFM and 
appear to adapt to the conditions in which they are forced to grow after a period of time 
in SFM. This is of benefit when performing chemotherapeutic drug toxicity assays 
where often serum proteins may mask the effect of the drug, and small changes in 
serum composition may affect the cytotoxicity of the drug. Differentiation studies could 
also be carried out in SFM when investigating the effects of physiological 
differentiating agents such as retinoic acid, interferons, etc. Serum is too ill-defined to 
carry out such studies with a good degree of accuracy.
Serum-free medium has also been developed for the clonal variants of the DLKP 
parental cell line. It appears that the intermediate-like phenotype, DLKP-I, may be 
producing its own attachment factors including fibronectin, which the other two clones 
are incapable of producing. This clone can grow in SFM without fibronectin 
supplementation whereas the other two clones cannot. The development of SFM for 
the three clonal populations of DLKP is a potentially useful model to study 
interconversion among a heterogenous tumour cell population. This process could then 
be controlled or manipulated more easily in a defined, SFM because of the ill-defined 
nature of serum-supplemented medium.
Treatment of DLKP with the differentiation-inducing agent, BrdU, resulted in changes 
in the expression of a number of integrins on the cell membranes. Induction of a, 
integrin and upregulation of a 2 integrin was observed in treated cells. This appears to 
be an epithelial-specific effect, in this case, as no change in integrin expression was 
observed in HL60 leukaemic cells. These changes in integrin expression also resulted 
in a functional change in the cells. The cells became more adherent to a number of 
ECM proteins, laminin, collagen and fibronectin, and also to basement membrane 
(EHS). This change in adhesive properties of the cells was capable of being reversed 
by the addition of an anti-ocj integrin blocking antibody.
The induction and upregulation of integrin receptors by a simple, chemical differention- 
inducing agent in lung epithelial cells has not been reported previously, though a report 
has been found in the literature demonstrating a change in integrin expression in 
melanoma cells by treatment with BrdU (Thomas et al., 1993). Further studies with 
DLKP cells may aid in the elucidation of control of integrin expression in lung epithelial 
cells. The literature is quite scant on information about the specific role of the a, 
integrin in normal cells. The DLKP cell model which may represent a poorly- 
differentiated stem cell-like lung population appears to be a particularly clean system to
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investigate such mechanisms of regulation and normal function. Studies should also be 
carried out on the effect of BrdU on the expression of the (3j subunit of these integrins.
Many of the (3, integrins are down-regulated in poorly-differentiated epithelial cancers 
and this may have implications for increased invasive and metastatic potentials of the 
cells. Many of these integrins are down-regulated in DLKP cells where the only fi, 
integrin that is expressed in significant amounts is the a 3 integrin. It would be 
interesting to see if BrdU treatment of DLKP induced a change in the invasive potential 
of these cells by performing in vitro Matrigel invasive assays.
Treatment of DLKP with BrdU also induced the expression of other epithelial specific 
markers including epithelial specific antigen and keratin 19. RT-PCR analysis of 
keratin 19 mRNA before and after BrdU treatment suggests that BrdU is working at the 
post-transcriptional/ translational level to overcome the block preventing proper 
translation of keratin mRNA transcripts. Epithelial specific antigen is thought to be a 
cellular adhesion molecule. However, very little is known about its normal function 
and its role in tumour progression. An excellent opportunity thus exists with the DLKP 
differentiation model to further study the regulation and function of this protein.
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